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Abstract 
ERCC1 is a gene essential for the repair process of UV—induced DNA damage known 
as Nucleotide Excision Repair (NER). Deficiencies in this DNA repair mechanism have 
been associated with the skin cancer prone human syndrome Xeroderma Pigmentosum 
(XP) and also with Cockayne's Syndrome (CS) and Trichothiodistrophy (TTD). The 
main role of RERCC1 is to act as a NER endonuclease but it has also been proposed 
that it may have a role in recombination. 
The ERCC1 knock out (k/o) mouse model was first described by McWhir et al. in 1993 
. McWhir and co-workers described ERCC 1—deficient mice as being severely runted, 
dying before weaning at approximately three weeks of age from hepatic failure, having 
severe aneuploidy and polyploidy in their liver and presenting elevated levels of p53 in 
this tissue. This k/o model shared no similarities with any of the already known NER 
deficiency—associated syndromes which led to the theory that a deficiency in the other 
non—NER ERCC1 function(s) may be responsible for the observed differences. The aim 
of this project was to gain a better understanding of the precise mechanisms behind 
this atypical phenotype. Indeed, studies carried out on both liver tissue and primary 
fibroblast material have resulted in the development of a theory for the ERCC1 k/o 
phenotype. 
ERCC1—deficient and wild type primary fibroblasts showed the same response to UV 
damage in terms of DNA replication arrest after UV. This behaviour, however, differed 
significantly from that observed in human cells. ERCC1—deficient cells were shown both 
to induce p53 with lower UV doses than their wild type counterparts and to induce 
the cyclin—dependent kinase inhibitor, p21, in response to UV in a p53—independent 
manner. From the liver tissue studies a number of conclusions can be derived which 
are outlined below. 
Levels of p21 transcript were also shown to be elevated in ERCC1 deficient livers and 
this increase of p21 was p53—independent. In order to get a more accurate picture 
of the cell cycle status in these hepatocytes the DNA synthesis levels as measured 
by the BrdU incorporation rates and cycling status were studied. Hepatocytes of 
ERCC1—deficient animals were shown to have reduced levels of DNA synthesis when 
compared to their wild type counterparts and, through the combination of BrdU, Ki67 
and centromeric staining, it was also concluded that the most likely explanation for 
the aneuploidy and polyploidy we see in these livers is that these cells are arrested in 
G2. Another point that emerged when morphometric studies were carried out in wild 
type, ERCC1-/-, p53-/- and p53/ERCC1 double null livers, was that binucleation is 
repressed in the ERCC1 k/o hepatocytes. Although the absence of p53 does not rescue 
the liver phenotype that is seen in the ERCC1 k/o mice, it results in the bypass of the 
repression of binucleation , as shown by wild type levels of binucleate hepatocytes in 
ERCC1/p53 double null livers. 
When all this data is taken together it is possible to think of a likely explanation for 
the observed ERCC1 k/o phenotype. Briefly, ERCC 1—deficient livers are subject to 
1  McWhir, J. and Selfridge, J. and Harrison, D.J. and Squires, S. and Melton, D.W.(1993) Mice with 
DNA-repair gene (ERCC1) deficiency have elevated levels of p53, liver nuclear abnormalities and 
die before weaning. Nature Genetics 5:217-224 
endogenous damage that cannot be repaired, this damage results in the activation of 
two separate pathways, one mediated by p53 and one mediated by p21. Severe, accel-
erated hepatocyte polyploidisation as a response to the existing endogenous damage 
results in the observed prematurely aged appearance of the liver. This together with 
an impairment of liver growth, probably mediated by p2l(as shown by elevated lev-
els of hepatocytes arrested in G2), results in early hepatic failure and the observed 
premature death. 
No human syndrome has yet been identified as being caused by a defect in ERCC1, so 
a subsidiary aim of this project was to see if any human condition could be attributed 
to an ERRC1 deficiency. Taking as a starting point the prematurely aged appearance 
of the ERCC1 k/o mice, a rare human premature ageing syndrome called Hutchinson-
Gilford progeria (HGP) was selected as a possible candidate for an ERCC1-related 
human condition. Primary fibroblasts derived from a HGP patient showed decreased 
levels of ERCC1 protein, but no evidence for mutations in the ERCC1 gene was found. 
However, an impaired p53 response to UV—irradiation was observed. Overall, this work 
has opened the doors for the study of premature ageing in humans in relationship to 
NER and p53. 
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1.1 DNA Repair 
1.1.1 Damaging agents 
The DNA from living organisms is constantly exposed to various agents that affect its 
integrity by chemically or physically modifying its structure. Damage to DNA can be 
caused in a number of distinct ways that fall under one of the following two general 
categories: spontaneous or environmental in origin. 
Amongst the first category are base mismatches, and abnormal base pairing occurring 
from deamination of bases (cytosine to uracil, adenine to hypoxanthine and guanine to 
xanthine). Such oxidative deamination can also result from the action of the mutagen 
nitrous oxide. Apurinic and apyrimidinic sites can occur spontaneously or through the 
action of DNA glycosylases on altered bases. Among the environmental factors are the 
ionizing radiation which can activate clastogenic factors that mediate the formation 
of breaks in either or both DNA strands, alkylating agents which are chemical agents 
that damage DNA by introducing bulky adducts and chemicals such as mitomycin C 
as well as UV irradiation which can damage DNA by introducing inter or intrastrand 
crosslinks that ultimately can impair subsequent transcription and translation pro-
cesses (Friedberg et al., 1995). 
Various single enzyme and complex multi-step DNA repair systems are operational in 
the cell to ensure proper functioning and faithful transmission of genetic information. 
Examples of the latter class of repair pathways are nucleotide excision repair (NER), 
1 
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base excision repair, post-replication repair and recombination repair. These systems 
have in general a broad lesion specificity. For example, NER recognises and eliminates 
a wide spectrum of structurally unrelated lesions such as UV-induced photoproducts 
(cyclobutane pyrimidine dimers -CPDs- and (6-4) pyrimidine pyrimidones -(6-4)PDs-), 
(bulky) chemical adducts and certain types of crosslinks, whereas recombination repair 
is required for the removal of X-ray -induced double-strand breaks and interstrand 
crosslinks (Bootsma and Hoeijmakers, 1994). 
1.1.2 NER 
Ultraviolet light and ionizing radiations are often used as prototype DNA—damaging 
agents because of their ease of delivery to cells and their relative specificity for dam-
aging nucleic acids versus other cellular components. These two types of genotoxic 
agents differ in the spectra of DNA damage they produce, and consequently the repair 
pathways that deal with them are also different. In mammalian cells the photoprod-
ucts (mainly cyclobutane pyrimidine dimers) caused by UV are repaired exclusively by 
the Nucleotide Excision Repair pathway (NER). NER is the most extensively studied 
repair system'and it processes damage by locating the lesions, excising an oligomer 
carrying the damaged nucleotides and synthesising a repair patch using the opposite 
strand as a template (Sancar and Tang, 1993; Hanawalt, 1995; Wood, 1997b). 
The biological consequences of the UV lesions depend on the DNA sequence con-
text, the relative efficiency of repair, and the particular end point (e.g., cell survival, 
mutation induction, or inhibition of DNA replication -see Replication section 1.2- or 
transcription). In addition, the same NER system that protects skin cells by removing 
UV photoproducts also acts on a number of bulky chemical adducts and may protect 
internal tissues against cancer (Thompson, 1998). Some of the interstrand crosslinks 
produced by agents such as mitomycin C, cisplatin and meiphalan are probably re-
paired by a recombinational mechanism that requires certain components of the NER 
pathway and other, unidentified gene products (Thompson, 1998). Although NER can 
act as a 'backup' system for other repair pathways such as base excision repair, there 
is no backup system for NER. In addition, bulky lesions that remain unrepaired by the 
For a review on the subject see Sancar, 1993; Hanawalt, 1995; Wood, 1997b 
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time DNA is replicated are potentially mutagenic and have to be dealt with through 
other damage-tolerance mechanisms known as post-replication repair (see Replication 
section 1.2). 
NER in E. coli 
The NER mechanism is well understood in Escherichia coli in which six proteins UvrA, 
UvrB, UvrC, UvrD, polymerase I (Poll) and ligase (Lig) are necessary and sufficient 
to carry out this process in vitro (Sancar and Tang, 1993). UvrA and UvrB form 
the UvrA2B complex which has helicase activity enabling it to bind to the DNA and 
move along it searching for abnormalities. On recognition of damaged DNA the Uvr 
A subunit dissociates, leaving UvrB bound at the site of damage. In this position, 
Uvr B recruits a Uvr C subunit, forming an incision complex. The single strand 
incisions occur seven nucleotides upstream of the lesion and three or four nucleotides 
downstream. Another protein, Uvr D acts along with Pol I to release a damage-
bearing 12-13mer oligonucleotide and the bound Uvr complex. Finally, the resultant 
gap is filled in by Pol I and then ligated. 
NER in eukaryotes 
Less is known however, about the biochemistry of the NER process in eukaryotic 
cells. In the yeast Saccharomyces cerevisiae mutant analysis and gene cloning have 
demonstrated the existence of more than 10 genetic loci implicated in excision repair 
(Friedberg et al., 1995). These genes are defined by the RAD3 epistasis group. 
Habraken and co-workers (Habraken et al., 1993) suggested that following the recog-
nition of DNA lesions by RAD14, helicase activity of RAD3 and RAD25 enables a 
RAD1/RAD10 complex to access the site of damage, nicking the double stranded 
DNA. Subsequent helicase action produces a single strand which can then be incised 
by RAD2. This results in the removal of a lesion within an oligonucleotide. 
The majority of the RAD genes that are required for the damage-specific incision 
of DNA during nucleotide excision repair are conserved in, and may be functionally 
related to NER proteins in other eukaryotes, including humans. Evidence in support 
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of this idea comes from studies with the yeast RADiO and the human ERCC1 genes. 
Expression of Rad 10 protein in Chinese hamster mutant cells defective in ERCC1 
results in partial complementation of both UV sensitivity and defective nucleotide 
excision repair. Similarly, the human XPD cDNA (see below) can rescue the lethality 
of a Rad 3 disruption mutation in yeast cells. 
1.1.3 NER in mammalian cells: NER syndromes 
The isolation of genes involved in nucleotide excision repair in bacteria and in yeast 
by phenotypic complementation of DNA damage-sensitive repair-defective mutants, 
lead to similar studies with mammalian cells. Two mammalian cell systems have been 
extensively studied in this regard. One consists of a series of rodent cell lines selected 
in the laboratory for defective nucleotide excision repair, following the mutagenesis 
of established cell lines (see below). The second consists of cell lines derived from 
three repair-defective human hereditary diseases 2 (Bootsma and Hoeij makers, 1994), 
xeroderma pigmentosum (XP), Cockayne's syndrome (CS) and a photosensitive form 
of trichothiodistrophy (TTD). 
xeroderma pigmentosum 
XP, indicating dry or parchment skin with pigmentation abnormalities, is a prototype 
of a multigenic human disorder in which mutations in several genes cause similar pheno-
types (Boulikas, 1996). There are seven complementation groups of naturally occurring 
XP cell lines XP-A to XP-G. Up to now, these groups can be explained on the basis of 
single-locus mutations rather than a corecessive inheritance model (Thompson, 1998). 
The severity of the repair deficiency varies amongst these groups, being least severe in 
groups D and E. 
Clinical features 
XP is an autosomal recessive disease which occurs at a frequency of 10-6  in the 
United States. XP patients have reduced ability to repair the damage induced by UV 
2  The data presented in this section regarding NER syndromes has been taken from Thompson, 1998. 
Refer to this review for additional references. Additional comprehensive reviews on the subject can 
be found in Bootsma, 1994 
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light (Cleaver, 1968), which results in skin cancers on sun—exposed body sites at very 
early ages (before the age of 20, with a median age of onset of 8 years). A variety of 
complications are associated with the sun—exposed areas of the skin (see Table 1.1 and 
Fig. 1.1). The eyes and the tip of the tongue are often affected (Kraemer et al., 1987; 
Kraemer et al., 1994). The onset of both early dermatological symptoms of XP and 
tumour growth is correlated with the extent of DNA repair deficiency as measured by 
cell survival curves and incision activity (Thompson, 1998). 
Neurological dysfunction is present in 20% of XP patients (XP-A > XP-D = XP-G) 
and is progressive. It includes hyporefiexia, sensorineural deafness, mental retarda-
tion, and microcephaly, which are associated with neuronal degeneration from loss of 
neurons, specially in the cerebellum and cerebral cortex (Thompson, 1998). These ab-
normalities are sometimes associated with slow growth and delayed secondary sexual 
characteristics. The neurological dysfunction also seems to be correlated to the degree 
of repair deficiency and is thought to arise from unrepaired oxidative damage in the 
brain. 
Cellular features 
Cells derived from XP patients are hypersensitive to killing by UV radiation or chemi-
cals that produce bulky adducts. Hypersensitivity to UV varies widely both within and 
amongst complementation groups and also, the XP cells are more prone to UV—induced 
neoplastic transformation than normal cells. 
A DNA repair deficiency in XP cells was first demonstrated by Cleaver in 1968 using 
repair synthesis and autoradiography (Cleaver, 1968). The phenotypic heterogeneity 
(different levels of repair synthesis) seen amongst the XP fibroblasts prompted genetic 
complementation analysis. Seven NER complementation groups were found to exist, 
which implied that many gene products were required to carry out the repair process 
that is deficient in XP cells. What is more, the residual repair in XP-C cells is clustered 
in a small fraction of the genome, now known to contain active genes (Thompson, 1998). 
Also, some XP-G cells show sensitivity to ionizing radiation, which appears to derive 
from a defect in repairing oxidative damage (Thompson, 1998). 
XP patients show a high incidence of mutations, particularly in the skin tumours, 
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Characteristics XP TTD CS 
Clinical features 
Cutaneous photosensitivity - or + + 
Pigmentation disturbances +a - - 
Ocular abnormalities (sunlight) ++ - - 
Oral abnormalities + - - 
Actinic keratoses + - - 
Basal and squamous cell ++ - - 
carcinomas, melanomas 
Neurological abnormalitiest' - or + + ++ 
Slow rate of growth - or + + ++ 
Impaired sexual development - or + + + 
Sensorineural deafness - or + + ++ 
Mental retardation - or + + ++ 
Ichthyosis (fish-like scaly skin) - ++ - 
Brittle hair - ++ - 
Peculiar facies - +c +c 
Cataracts/pigmentary retinopathy - + ++ 
Dental caries - + ++ 
Cellular features 
Intrinsic chromosomal instability - - - 
Hypermutability + - or + + 
Excision repair in bulk DNAd + - or + - 
Excision repair in transcription- + - or + + 
dependent repair 
Table 1.1: Comparison of clinical and cellular features of XP, TTD and CS. 
arftaits  that are hallmarks of the disease are indicated by (++), and traits that are 
sometimes associated with the disorder are indicated by (+); unassociated traits are 
shown by (-). 
bThese  features are present in about 20% of XP patients. The molecular basis of the 
neurological dysfunction in XP differs from that of CS and TTD (see main text). 
'The facial abnormalities of TTD and CS overlap in term of protruding ears. TTD 
often has a receding chin and a small thin or beaked nose, whereas CS tends to have 
large nose and projecting jaw. 
dxp...0 is exceptional in being deficient in repairing bulk DNA, but proficient in tran-
scription coupled repair. 
This Table has been adapted from Thompson, 1998. 
affecting mainly the p53 tumour suppressor gene. This is a direct effect of the muta-
genic consequences of failing to repair DNA damage (Thompson, 1998). The variant 
form of XP (XP-V), although clinically indistinguishable from other XP groups, is 
normal for excision repair and forms a single complementation group. Apparently, 
XP-V has a reduced ability to elongate nascent DNA strands when replicating past 
Figure 1.1: (A,B) Two XP patients (undefined complementation group); the patient 
in panel A subsequently showed decline of the central nervous system. (C,D) A CS 
patient at ages 4 and almost 7 years, respectively. (E,F) Two TTD patients. Taken 
from Thompson, 1998. 
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UV damage. XP-V cells are only slightly sensitive to killing by UV radiation but they 
are several fold sensitive to mutation induction and transformation by UV. At the 
molecular level, XP-V cells show error prone DNA replication in the presence of DNA 
damage (Thompson, 1998). 
trichothiodistrophy 
Clinical features 
TTD is an autosomal-recessive disorder characterised by sulfur-deficient brittle hair, 
scaly skin, and physical and mental retardation. Patients may also have an unusual 
facial appearance, and altered body proportions. TTD comprises a variety of rare 
sulfur-deficient brittle hair disorders. Within them, the photosensitive form of TTD 
has been named PIBIDS (Photosensitivity, Ichthyosis, Brittle hair, Impaired intelli-
gence, Decreased fertility, and Short stature). Approximately 50% of TTD patients 
show severe photosensitivity linked to deficient excision repair like that seen in XP 
cell lines, particularly XP-D. However, TTD patients do not show the same sort of 
skin abnormalities associated with XP (see Table 1.1 and Fig. 1.1), and there is no 
predisposition to skin cancer associated with TTD. Another difference between TTD 
and XP patients is the origin of the neurological abnormalities, which in TTD is pre-
dominantly due to demyelination. Prenatal diagnosis for TTD is available based on 
defective DNA repair in families known to carry mutant alleles (Thompson, 1998). 
Repair deficiency 
Complementation analysis of TTD cell lines found that most UV-sensitive TTD lines 
fall within the XP-D complementation group. Indeed, the cloned XPD gene was found 
to be able to correct the repair deficiency in the TTD cells. This could only be explained 
when the XPD gene was found to play a role in both NER and transcription. 
TTD cell lines are characterised by a broad genetic heterogeneity (Thompson, 1998) 
and recently two more complementation groups of TTD have been identified. One of 
them corresponds to the XP-B group and the other has been shown to be defective in 
the TTD-A protein which is part of the basal transcription factor TFIIH (Thompson, 
1998). 





CS patients suffer from postnatal growth failure and progressive neurological dys-
function, with frequent involvement of cutaneous photosensitivity, deafness, cataracts, 
pigmentary retinopathy and dental caries. In addition a dwarfed appearance, dispro-
portionately long arms and sunken eyes. This disease has the appearance of premature 
ageing with a median life span of 12 years. CS patients do not show predisposition to 
skin cancer or the skin abnormalities associated with XP, despite showing sun sensi-
tivity. As with TTD, CS patients' neurological abnormalities are due to demyelination 
in nerve tissue (see Table 1.1 and Fig. 1.1). In a few rare individuals, features of both 
CS and XP are found (XP-CS). The association of CS has been reported for XP-B, -D 
and -G groups. 
Repair deficiency 
CS cells are hypersensitive to killing by UV radiation and bulky adducts mutagens, 
although their sensitivity is approximately four— to eight—fold, which is less than the 
most sensitive XP cell lines. CS have also been recently reported to show moderate 
sensitivity to ionizing radiation. Although repair synthesis and dimer removal are 
normal in the bulk DNA of CS cells after UV radiation, the recovery of DNA synthesis 
seen in normal cells fails to occur in CS cells. CS cells also fail to recover RNA 
synthesis, which pointed toward a defect in these cells in the repair of DNA damage 
in transcribing regions of DNA. Cell fusion experiments with more than 30 CS cell 
lines have identified two complementation groups that are distinct from XP (CS-A and 
CS-B). Most patients belong to the CS-B group. 
CS-A and CS-B cell lines are defective in the repair of active genes after UV damage, 
specifically with a lack of repair of the transcribed strand. There is also a slight defect 
in the repair of the nontranscribed strand. CS proteins have been proposed to play a 
role in the promoting of access to damage by the repair proteins and more specifically, 
they may play an essential role in the initiation of transcription after damage is repaired 
by routing the repair/transcription TFIIH factor, from repair to transcription. 
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1.1.4 Human NER genes and proteins 
Genetic and biochemical analysis 
Initial complementation studies that led to the identification of XP, Cs and TTD 
groups were mainly based on analysis of replication repair capability (unscheduled 
DNA synthesis, UDS) of the different cell lines. Assays employing cell extracts to 
measure NER have identified defective repair in a number of XP cell lines and have 
helped to determine overlap between XP cell lines and phenotypically similar rodent 
repair mutants. Thus, transfection of rodent mutants of which there are 11 comple-
mentation groups, with human genomic DNA, has resulted in the identification and 
molecular cloning of a series of complementing genes designated ERCC (for Excision 
Repair Cross Complementing) denoting the fact that rodent cell lines were corrected 
for mutant phenotypes by human DNA. These are called ERCC1, ERCC2, ERCC3, 
ERCC4, ERCC5, ERCC6 and ERCC8. XP and ERCC lines partially overlap (Wood, 
1997a). ERCC2 is equivalent to XP-D, ERCC3 to XP-B, ERCC5 to XP-G, ERCC6 
to CS-B, ERCC8 to CS-A and the proteins encoded by ERCC4 and XP-F are equiv-
alent (Reardon et al., 1993) (for more detail see below and Table 1.2). It is note-
worthy that most mutants in rodent groups 1 and 4 show extreme sensitivity to DNA 
crosslinking agents, a feature not identified among human NER mutants. These groups 
show extreme hypersensitivity (10- to 100-fold) to mitomycin C, cisplatin, melphalan, 
diepoxybutane, and other agents that produce interstrand crosslinks. High sensitiv-
ity to crosslinking agents is not associated with XP or CS cells, but it is one of the 
hallmarks of cells from Fanconi's anaemia, which have normal NER. Thus, the rodent 
mutants in groups 1 and 4 are unique amongst the different NER-deficient phenotypes 
in mammalian cell mutants (Thompson, 1998). 
Genes identified using rodent cell mutants 
ERCC1 
The main focus of this thesis is on ERCC1, the first mammalian DNA repair gene 
to be cloned by virtue of its ability to complement the UV-sensitive CHO line 43-3B 
(Westerveld et al., 1984). The gene is approximately 15 kb in size and is located on 
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human chromosome 19q13.2 where it is closely linked to another human NER gene 
designated XPD(ERCC2). The ERCC1 cDNA has an open reading frame (ORF) 
that gives rise to a 1.1 Kb transcript encoding a product of 297 amino acids with a 
calculated molecular mass of approximately 32.5 kD which contains a nuclear location 
signal and a putative DNA binding motif. Mutations in the ERCC1 cDNA that are 
responsible for the phenotype observed in the mutant CHO cell lines 43-3B and UV-4 
have been recently identified (Hayashi et al., 1998). Tests of protein-protein interaction, 
in vivo and in vitro have demonstrated specific interactions between the human ERCC1 
protein and those encoded by the XPA (Park and Sancar, 1994; Nagai et al., 1995; 
Li et al., 1994a; Li et al., 1995) and ERCC4(XPF) genes (see below) (Biggerstaff 
et al., 1993; van Vuuren et al., 1993; Park and Sancar, 1994; van Vuuren et al., 1995; 
Bessho et al., 1997). The human ERCC1 gene was used as a hybridisation probe to 
isolate the corresponding mouse gene. The mouse and the human genes are highly 
conserved, although the mouse gene encodes one more amino acid. Overall there is 
85% amino acid identity between these two genes. The C-terminus of the human 
ERCC1 protein is homologous to the C-terminal region of the E. coli UvrC protein 
(Moolenaar et al., 1998) and, also, the translated sequences of the mouse and human 
ERCC1 genes are homologous with those of the Saccharomyces cerevisiae RADiO gene 
and the Saccharomyces pombe swilO gene (Rodel et al., 1992), and as mentioned before, 
expression of Rad 10 protein partially complements ERCC1 deficient cells. The human 
ERCC1 gene has also been shown to complement the DNA repair deficiency of swilO 
mutants of fission yeast (Rodel et al., 1997). RADiO has been shown to associate 
with RAD1 in S. cerevisiae to form an endonuclease (Tomkinson et al., 1993; Bardwell 
et al., 1994) that takes part in the mitotic recombination pathway and is required 
for double—strand break—induced recombination (Ivanov and Haber, 1995), and swilO 
associates with the RAD1 homolog RAD16 in S. pombe (Carr et al., 1994), where it is 
thought to form an analogous endonuclease. 
Bearing in mind the homology between RADiO and ERCC1, the latter may also be 
involved in a recombinational repair mechanism. A puzzling characteristic of ERCC1 
comes from phenotypic correction experiments carried out with this gene in DNA 
repair deficient cell lines. Interestingly enough, when introduced to cell lines from XP 
groups ERCC1 failed to correct the existing repair defect (van Duin et al., 1988; van 
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Duin et al., 1989). Nevertheless, the ERCC1 gene product is known to play a critical 
role in the nucleotide excision repair process as shown by rodent cell lines with a 
defect in ERCC 1 which are hypersensitive to the toxic effects of agents including UV, 
acetylaminofluorene, 4-nitroquinoline-1-oxide and mitomycin C. This has led to the 
speculation that mutations in ERCC1 may be developmentally lethal. Alternatively, 
the hypothesis exists that ERCC1 defects may be associated with a different phenotype, 
not represented among existing XP or CS groups (McWhir et al., 1993a). As mentioned 
above, as well as a role in NER, ERCC1 may have other key functions. This is a 
recurring theme with NER proteins (see XPB/XPD below). The possible involvement 
of repair proteins in translational and transcriptional control has been proposed as the 
basis for the neurological and other not obvious NER related problems such as retarded 
physical and sexual development, as seen in some XP and CS patients (McWhir et al., 
1993a). 
In the case of ERCC 1, there are clues that point towards an involvement of this pro-
tein in recombination repair as well as in NER (Sargent et al., 1997) which comes 
from evidence that ERCC1, and also ERCC4(XPF) mutants, are extremely sensitive 
to crosslinking agents such as mitomycin C, cisplatin and psoralen (van Duin et al., 
1986; Sijbers et al., 1996a; Zdzienicka et al., 1987; Thompson et al., 1994)(see section 
1.1.5). However, recent experiments with rodent cells suggest that in mouse, ERCC1 
is not essential for the recombination—mediated repair of interstrand crosslinks and 
that ERCC1 may have an additional role in a process called illegitimate recombination 
(Melton et al., 1998). In conclusion, the fact that NER proteins seem to have more 
than one specific role and the different patterns of NER shown by humans and rodents 
(Mitchell and Hartman, 1990) combine to indicate that the consequences of ERCC1 
deficiency are likely to be complex, and may differ between mice and humans. 
The ERCC4 (XPF) gene 
As already mentioned above, the S. cerevisiae ERCC1 homolog, Rad 10 protein, forms 
a stable and specific complex with Radi protein, another component of the NER family 
of genes. Since human cells possess a RADiO homolog, it is reasonable to expect that 
they also have a homolog of the S. cerevisiae RAD1 gene. This is indeed the case and 
the gene is designated ERCC4. This gene has been mapped to human chromosome 
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16pl3.13-pl3.2 by somatic cell hybridisation and very recently it has been shown to 
be the same protein as XPF (Sijbers et al., 1996b). It is interesting to note that there 
are also indications that the polypeptide encoded by the human ERCC1 and ERCC4 
gene interact to form a stable complex in living cells which has been referred to as 
the ERCC1/XPF complex (Aboussekhra et al., 1995). XPF has been shown to share 
protein sequence homology with other eukaryotic genes involved in recombination, 
such as MEI-9 (Drosophila melanogaster), and Rad16 (Schizosaccharomyces pombe) 
(Brookman et al., 1996). 
The ERCC2(XPD), ERCC3(XPB) and ERCC6(CSB) genes 
XPD was cloned using the same basic strategy used to isolate ERCC1 and ERCC4. It 
is approximately 15 to 20 kb in size, and like ERCC1 is located on human chromosome 
19. The gene is organised into 22 exons separated by 23 relatively small introns. Like 
the ERCC1 translated sequence, that of the XPD gene is homologous with a yeast 
NER gene, in this case the yeast RAD3 gene. The purified protein has been shown to 
be a DNA-dependent ATPase with DNA helicase activity whose properties are very 
similar to those of the yeast Rad3 protein. Defects in XPD gene have been associated 
with the TTD syndrome (Takayama et al., 1996). 
The human XPB gene was cloned by phenotypic complementation of cells from the 
rodent mutant line RCG3. The gene has been localised to human chromosome 2. 
The cloned gene is 35-45 kb and contains at least 14 exons. The XPB cDNA has an 
ORF of 782 codons, which would encode a polypeptide of 89.2 kDa and examination 
of the amino acid sequence suggests that, like the polypeptide encoded by the XPD 
gene, the putative XPB polypeptide is a DNA helicase, but with a 3'-45' polarity 
as opposed to the 5'-*3' polarity of the XPD helicase. This has been confirmed by 
biochemical characterisation of the purified protein. The XPB cDNA complements 
the UV sensitivity and NER defect in cells from the XP-B genetic complementation 
group. Interestingly enough, the patient from whom this cell line was established also 
manifested the clinical features of CS, suggesting that a single gene defect is associated 
with two clinically distinct hereditary diseases, the implications of which will be dealt 
with in following sections. Interestingly, the XPB and XPD DNA helicases have also 
been shown to be components of the p53-mediated apoptosis pathway (Wang et al., 




The human CSB gene has also been cloned by phenotypic complementation and may 
be as large as 100 Kb, with at least 21 exons. Its ORF encodes a protein of 108 kD and 
it is included in the chromosomal region 10qll-21. It also corrects the UV sensitivity of 
CS-B cells, suggesting that CS group B represents a defect in this gene. Examination 
of the amino acid sequence of the translated CSB ORF suggests that it too might be 
a helicase. 
The ERCC5(XPG) gene 
The cloned gene has an ORF of 1,186 codons and is expected to encode a polypep-
tide of 133 kDa. ERCC5 protein corrects defective nucleotide repair in extracts of 
human XPG cells and rodent ERCC5 cells but has no effect when added to extracts of 
other repair-defective cell lines. Like the yeast Radi-RadlO and Rad2 endonucleases, 
XPG protein cleaves bacteriophage M13 DNA, and it shows a substrate specificity for 
duplex/3' single strand DNA junctions (O'Donovan et al., 1994) which makes this pu-
tative endonuclease an attractive candidate to cut duplex DNA with such a junction 
at a site of base damage, specifically 3' to the site of damage (Matsunaga et al., 1995). 
XPG has also been found to bind to PCNA and to share sequence elements with the 
PCNA—binding regions of FEN-1 and p21 (Gary et al., 1997). 
No complementing human genes have been identified for rodent mutants in groups 7, 
9 and 10. This is mainly due to the modest sensitivity of these cell lines to UV, which 
makes the effective selection procedures for isolation of genes a very difficult task. 
Genes identified using human cell mutants 
As it happens with the nucleotide excision repair-defective bacterial, yeast, and rodent 
mutants mentioned above, the UV irradiation-sensitive phenotype of XP cells in culture 
invites a molecular approach to the study of xeroderma pigmentosum through the 
cloning of XP genes by phenotypic complementation of human cells. Attempts to do 
so, however, have been largely unsuccessful due to the low stable transfection frequency 
of human cell lines. The reason for this remains unknown but there are studies pointing 
to the low efficiency with which DNA sequences are stably integrated and expressed in 
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human cells compared to rodent cells, that makes the difference even more prominent 
in those human cell lines specifically defective in cellular responses to DNA damage. 
The XPA gene 
The human XPA gene is 25 Kb in size and is split into 6 exons. Sequencing the human 
and murine XPA cDNA showed a single ORF predicted to encode a polypeptide of 273 
amino acids with a molecular weight of approximately 31 kD. The XPA gene maps 
to human chromosome 9q34.1 and there is a 95% homology between the mouse and 
human sequences at the amino acid level. ERCC1 seems to interact specifically with 
XPA both in vivo and in vitro to form a stable complex whose function is explained 
below (Li et al., 1994a; Park and Sancar, 1994). An initial determination of the domain 
that mediates this interaction in both ERCC1 and XPA has also been accomplished 
through amino acid sequencing and structural sequence analysis. XPA is a zinc finger 
DNA binding protein that has been reported to possess a higher affinity for damaged 
double stranded DNA than for undamaged double stranded DNA (Robins et al., 1991). 
Thus, ERCC1 along with the rest of the incision complex may be loaded and possibly 
oriented to the site of damage by this protein (Nocentini et al., 1997). This model 
is supported by protein-protein interaction studies showing that it is indeed the case 
that not only ERCC1 but also the ERCC1-ERCC4(XPF) complex associates with XPA 
(Park and Sancar, 1994). 
The XPC gene 
The XPC cDNA has an ORF that can encode a polypeptide of approximately 106 kD, 
with a basic p1. It shows some homology to the S. cerevisiae Rad4 gene, and northern 
analysis of normal human cells has revealed a single transcript of approximately 3.8 Kb. 
It has been mapped to human chromosome 3p25. The yeast homolog Rad4 is found 
complexed with Rad23 as part of a the nucleotide excision repair factor 2 (NEF2) 
(Schauber et al., 1998; Jansen et al., 1998; Guzder et al., 1998) and has been shown 
to preferentially bind to damaged DNA (Jansen et al., 1998; Guzder et al., 1998). 
Similarly, the XPC protein copurifies with the human homolog of Rad23, a 43 kD 
partner, HHR23B, or sometimes it is found to be bound to a similar protein HHR23A 
(Sugasawa et al., 1997). XP-C cells are unique amongst XP groups in that they 
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they manifest only a slight defect in nucleotide excision repair in transcriptionally 
active genes, but appear to be more severely defective in the repair of transcriptionally 
silent regions of DNA (Kantor et al., 1990). One implication that can be drawn from 
this observation is that XPC protein is not required for, and does not participate in, 
the preferential repair of template strand damage in transcriptionally active genes. 
In XP-C cells, the low levels of XPC protein may be preferentially recruited to a 
repairosome complex that participates in the repair of transcriptionally active DNA. 
This theory, however, has not yet been confirmed (Friedberg et al., 1995). On the other 
hand, there is a possibility that, in XP-C cells, damage on the transcriptionally active 
DNA strand is detected by RNA polymerase II (Tornaletti and Hanawalt, 1999). The 
arrested RNA polymerase would in turn be used as a signal by TFIIH, which would 
subsequently determine that the lesion to be repaired is in the transcribed strand 
(Tornaletti and Hanawalt, 1999). In this model, in the non—transcribed DNA, the 
XPC complex would carry out a similar role. XPC has been termed the 'initiator' of 
global genome repair (Sugasawa et al., 1998). XPC has been shown to preferentially 
bind to damaged DNA, like its yeast counterpart, and to make a stable footprint at a 
damaged DNA site (Wood, 1999). Since XPC is one of the NER factors that shows 
a preference for damaged DNA, it has been proposed that XPC binds tightly to a 
lesion—distorted region of DNA and alters the DNA structure so the DNA is rendered 
accessible for the other NER components. If the DNA structure is sufficiently distorted, 
XPC is dispensable (Wood, 1999). 
The GSA (ERCC8) gene 
Using functional CSA cDNA isolated from a pEBS7 cDNA library (Thompson, 1998), 
SV40—transformed CS-A fibroblasts were rescued, which led to the identification of 
the CSA gene. The CSA sequence maps to human chromosome 5 and encodes a 
protein that belongs to the WD repeat family of proteins, which appear to have a 
variety of regulatory functions (Thompson, 1998). The rodent ERCC8 group, which is 
represented by a mouse lymphoma mutant (US31), corresponds to CSA. 
Gene' Human Gene, ORF, Chrom. Protein, Yeastb Properties 
disease kb aa kD equiv. 
ERCC1 ? 15 297 19q13.2 33 RadlOp Endonucleolytic incision (5'-side of damage); complexed with XPF; in- 
teraction with XPA; recombination functions? 
XPA XP-A 25 273 9q34.1 31 Radl4p Damage recognition/DNA binding; zinc finger motif; binding to RPA 
and ERCC1-XPF complex 
XPB/ERCC3 XPB-CS 45 782 2q21 89 Rad25p/ 3'-+5' helicase; member of TFIIH complex; essential for transcription 
TTD Ssl2p initiation; formation of preincision complex 
XPC XP-C 24 940 3p25.1 106 Rad4p Specific to global repair pathway; complexed with HHR23B; binding to 
ssDNA; stabilisation of preincision complex 
XPD/ERCC2 XP-D, 19 760 19q13.2 87 Rad3p 5'-*3' helicase; member of TFIIH complex; essential for transcription 
TTD, initiation; formation of preincision complex 
XPD-CS 
DD131 XP-E? ? 1140 11q12-13 127 ? Recognition/DNA binding of UV photoproducts and some bulky le- 
sions; absent in some XP-E lines 
XPF/ERCC4 XP-F 30 916 l6pl3.l3 104 Radip Endonucleolytic incision (5'-side of damage); complexed with ERCC1; C) 
interaction with XPA, recombination functions? 
XPG/ERCC5 XP-G, 32 1186 13q33 133 Rad2p Endonucleolytic incision (3'-side of damage); junction-specific nuclease; 
XPG-CS interaction with XPC? 
CSA/ERCC8 CS-A ? 396 5 44 Snf2p Preferential repair of active genes; repair of transcribed strand; tran- 
scriptional regulator? 
CSB/ERCC6 CS-13 -85 1493 10q11.2 168 Rad26p Preferential repair of active genes; repair of transcribed strand; tran- 
scriptional regulator? 
HHR23A ? ? 363 19p13.2 40 Rad23p Ubiquitin-like N-terminus; identified by homology with HHR23B, a 
homolog of RAD23 
HHR23B ? ? 409 3p25.1 43 Rad23p Specific to global repair pathway; complexed with XPC; ubiquitin-like 
N-terminus 
p62TFIIH ? ? 548 11p14 62 Tfblp Component of TFIIH; essential for viability 
p44TFIIH ? ? 395 5q1.3 44 Ssllp Component of TFIIH; essential for viability; TFIIA-like zinc finger 
motif 
p52TFIIH ? 7 436 6p2l.3 52 Tfb2p Component of TFIIH; essential for viability; TFIIA-like zinc finger 
motif 
LICi 46BR 53 919 19q13.2 102 Cdc9p Nick closure in the final step of repair 
Table 1.2: Cloned human nucleotide excision repair genes and their encoded proteins. In addition to the proteins listed, the complete 
excision repair reaction requires trimeric RPA, additional components of the TFIIH complex, polymerase accessory factors RFC, PCNA, 
and polymerase S/c (Nichols and Sancar, 1992; He and Ingles, 1997). The data on p52TFIIH was taken from Marinoni, 1997. (For more 
detail on these proteins refer to the Replication section below).  
'By agreement the name XPB has replaced XPBC and ERCC3, and so forth, but ERCC names can be preferable in certain contexts. 
bS cerevisiae 
This Table has been adapted from Thompson, 1998. 
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1.1.5 NER in mammalian cells: Biochemical mechanisms 
Knowledge of the actual mechanisms and protein functions in the NER pathway 3 is 
mostly based on in vitro studies involving both recombinant proteins and purified pro-
teins obtained by chromatographic methods from cells or tissues (Aboussekhra et al., 
1995). Figure 1.2 presents an outline of the steps involved in the nucleotide excision 
repair mechanism in global DNA. Although the NER reactions presented in this Figure 
are outlined as a series of individual steps, these reactions may well be concerted and 
form a continuum where there is no need for the formation of stable intermediates 
(Thompson, 1998). Excinuclease is a term that has been introduced to refer to the 
excision nuclease activity that cuts on both sides of the damaged site. 
Damage recognition 
The fact that XP-A patients present a very severe form of XP and that XP-A cell lines 
are highly UV sensitive, suggests that XPA plays a key role in NER by recognising the 
damaged site on the DNA. Support for this comes from experiments that have shown 
that XPA presents higher affinity for UV—irradiated DNA than for undamaged DNA 
(Thompson, 1998). It also presents higher affinity for single—stranded undamaged DNA 
than for double—stranded undamaged DNA. Its sequence has a zinc finger motif and 
in cell—extract assays, no repair incision is observed in the absence of XPA. Different 
mutations in XPA may also have subtle effects on damage recognition. 
Replication protein A (RPA) is also involved in damage recognition (Sancar, 1994). 
RPA is a heteromeric complex that comprises the subunits p'TO, p32 and p14 (also 
known as HSSB). RPA is essential for the incision step of the repair reaction and in 
addition it has been shown to be required for the replication of the SV40 chromosome 
in vitro. It binds to ssDNA through the p70 and p32 subunits and also binds to XPA 
in a cooperative fashion (Saijo et al., 1996). 
XPA also binds specifically to ERCC1 (Li et al., 1994a; Park and Sancar, 1994) and 
the regions of XPA that are necessary for this interaction have been mapped (Li et al., 
The data presented in this section regarding NER biochemical mechanisms has been taken from 
Thompson, 1998 and Wood, 1997. Additional comprehensive reviews can be found in Sancar, 1994. 
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Figure 1.2: Model of NER in the global DNA repair pathway. The roles of XPE and 
XPC-HHR23B complex are not well understood. Adapted from Wood, 1997. 
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1995). It has been proposed that this interaction may also enhance damage recognition 
(Nagai et al., 1995). In addition, XPA interacts with the TFIIH factor. All these 
interactions suggest that XPA plays a key role a recruiting NER proteins. 
DNA damage binding protein (DDB) or XPE binding factor (XPE-BF) is another 
protein that seems to be required for the recognition step, but its specific role remains 
unknown (Thompson, 1998). 
Mechanism of open complex and dual incision formation 
The mechanism of open complex and dual incision formation has been studied in 
detail using in vitro cell free extracts (Mu et al., 1996; Evans et al., 1997). Additional 
information has been recently derived from experiments using electrophoretic mobility 
assays and DNase I footprinting assays (Wakasugi and Sancar, 1998). XPB and/or 
XPD helicases seem to be involved in the unwinding of the DNA duplex before incision. 
XPD unwinds the DNA in a 5' to 3' direction and XPB unwinds in the opposite 
direction. Both proteins are subunits of the basal transcription factor TFIIH, which 
is required to initiate transcription of most RNA polymerase II class genes (see below 
for implications of this fact in human NER syndromes). As mentioned before, XPA 
interacts with TFIIH, which suggests that TFIIH is recruited to the site of damage 
by XPA with the possible help of RPA which would stabilise the open DNA complex 
until the incision step takes place. 
The mechanism of lesion removal in mammalian cells involves endonucleolytic incision 
on both sides of the damaged DNA as in E. coli but with a much larger distance 
between the lesion and the 5' incision site (Evans et al., 1997). The excised fragment is 
approximately 27-29 nucleotides long which corresponds to one incision at the third to 
fifth phosphodiester bond on the 3'-side of the lesion and a second incision at the 22nd 
to 25th phosphodiester bond on the 5'-side. Each incision is carried out by a different 
nuclease activity (see Fig. 1.2). 
The 3'-side incision 
XPG is a single—strand specific endonuclease that acts on the 3'-side of the lesion 
(O'Donovan et al., 1994) and precedes the 5'-side incision. XPG has homology with the 
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human FEN1 (flap endonuclease), which cleaves the 5'-single-stranded end at a single-
strand to double-strand junction. Targeting of XPG to the lesion may be mediated by 
RPA which is required for both the 3' and the 5' incision steps (Thompson, 1998). 
The 5'-side incision 
This step is carried out by a complex composed of ERCC1 and XPF (Park et al., 
1995; Matsunaga et al., 1995). This complex is necessary and sufficient to carry out 
this incision in vitro. The purified ERCC1-XPF complex has a preference for single-
stranded DNA and the single-stranded part of a DNA duplex containing a bubble 
region (deLaat et al., 1998). Anti-ERCC1 antibodies inhibit the 5'-incision specifically, 
resulting in uncoupled 3'-incision in a defined system. The ERCC1-XPF complex is 
analogous to the yeast (S. cerevisiae) Radi-RadlO endonuclease complex (Tomkinson 
et al., 1993), which cuts specifically at the junction of a Y-shaped DNA and only in the 
strand with the 3'-single-stranded terminus (Bardwell et al., 1994). Targeting of the 
ERCC1-XPF complex is likely to occur through the action of XPA. RPA may confer 
structure-specific incision activity to both ERCC1-XPF and XPG (Thompson, 1998). 
Role(s) of XPC-HHR23B 
The exact role(s) of the XPC-HHR23B complex is still unknown. Although XPC is 
normally found complexed to HHR23B in vivo, in the highly purified, reconstituted 
excision nuclease assay, there is no requirement for HHR23B. XPC is required for in 
vitro incision of substrates and for transcription coupled repair in vivo. The complex 
may help to stabilise the open DNA structure at the 3'-side of the damage and help 
target the incision nuclease activities to ensure appropriate specificity. Recently, XPC 
has been proposed to be the 'initiator' of global genome repair (Sugasawa et al., 1998) 
(see section 1.1.4). 
Excision of damaged segment 
In vitro analysis seems to indicate that the excised oligomer (still bound to protein) is 
released from the DNA duplex by the incision nuclease machinery without assistance 
from the repair synthesis proteins. 
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Synthesis and ligation 
PCNA and RFC 
The DNA polymerase accessory factor, proliferating cell nuclear antigen (PCNA, see 
Replication section 1.2 for further information on PCNA in the context of replication), 
is required in vitro for the repair synthesis step, but not for the incision step (see 
Fig. 1.2). PCNA increases excision efficiency and it has also been shown that it 
may be necessary for repair synthesis in vivo (Li et al., 1996; Miura et al., 1996). 
These observations have led to the implication of DNA po1ymerase- or -c in the 
polymerisation step of repair (see Replication section 1.2 for more information of pol-S 
and -e). The polymerase accessory factors PCNA and RFC may be required to displace 
the incision proteins from the postincision complex. The trimeric PCNA protein, which 
acts as a clamp to increase the polymerase processivity, requires RFC (a multimeric 
complex consisting of 5 subunits) for its loading onto the DNA. 
DNA ligase 
The final step of the repair process requires the action of a DNA ligase. Four different 
DNA ligases have been identified but their roles are still under characterisation. DNA 
ligase I participates in DNA replication and evidence for its involvement in excision 
repair comes from a single human cell line, 46BR, isolated from a patient with a complex 
syndrome, including photosensitivity (Webster et al., 1992). 46BR cells, which have 
mutations affecting both alleles of the LIG 1 gene, are somewhat UV—sensitive and 
show an abnormally high level of incision—associated breaks after UV treatment. 
Functional heterogeneity of NER proteins 
The nucleotide excision repair/transcription relationship4 
At this point it would be interesting to note how XPB and XPD proteins also form 
part of the machinery involved in RNA polymerase II-dependent transcription (Drap-
kin et al., 1994). Protein immunoprecipitation and correction of defective phenotype 
assays indicate that XPD protein is an integral component of human factor TFIIH (the 
For a review see Friedberg, 1996; Hanawalt, 1994. 
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multiprotein complex required for the initiation of basal transcription by RNA poly-
merase II) and is required for both transcription and NER (van Vuuren et al., 1994; 
Hanawalt, 1994). What is more, purified preparations of TFIIH have been shown to 
contain the NER protein XPB(ERCC3) (Schaeffer et al., 1993). As mentioned be-
fore, TFIIH has another three components, p62 and p44, p34 (Humbert et al., 1994) 
and a fourth, p52 (Marinoni et al., 1997). The significance of this bifunctionality is 
demonstrated by the fact that it is also preserved in yeast. What the exact implica-
tions of such a characteristic are is something that still remains to be seen, but the 
fact that these proteins are involved in both repair of DNA and transcription-related 
processes opens up a broad range of highly interesting questions about the role they 
may play in the pathology of syndromes such as XP, Cs or TTD where complications 
not directly related to DNA repair deficiency, i.e., mental retardation and impaired 
sexual development, are seen (Prakash et al., 1996). It also raises the logical question 
of whether other proteins already identified as being part of the NER machinery and 
whose properties up to now seem to point towards more complicated functions than 
that of DNA repair alone could also have a prominent role in transcriptional control 
and other DNA metabolism processes. 
The nucleotide excision repair/recombination repair relationship?5 
As already mentioned, ERCC1, and also ERCC4(XPF) mutants, are extremely sensi-
tive to crosslinking agents such as mitomycin C, cisplatin and psoralen which suggests 
that these mutant cell lines are defective in the repair of interstrand crosslinks. 
It is known that in E. coli the repair of interstrand crosslinks occurs in three basic 
steps: dual incisions of one strand by (A)BC endonuclease, homologous pairing with 
a sister duplex mediated by RecA, and finally dual incisions in the second strand by 
(A)BC endonuclease. Interstrand crosslinks are also removed from mammalian cells 
but there are no details on the mechanism(s) that repair this type of damage (see 
Fig. 1.3). Based on mutagenesis studies, it has been hypothesised that crosslinks are 
removed from human cells by two mechanisms. In error—prone repair, following the 
dual incisions a DNA pol fills in the gap by passing the lesion to generate a three— 
For a report of recent advances on this subject see Recent advances in DNA repair and recombination 
(Iwanejko and Jones, 1998). 
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strand intermediate that is then repaired like any other endonuclease substrate. In the 
error—free mechanism, dual incisions on one strand are followed by strand transfer from 
the intact duplex and ligation, and dual incisions of the second strand are followed by 
release of the crosslink and repair synthesis, in a manner similar to crosslink repair in 
E. coli (see Fig. 1.3). The exact role played by ERCC1 in the recombination repair 
mechanism, if any, is not known but the fact that its yeast homolog, RADiO along with 
the yeast XPF homolog, RAD1, has been shown to take part in mitotic recombination 
(Bardwell et al., 1993; Bardwell et al., 1994), seems to support the idea that ERCC1 
is likely to be involved in this type of repair. 
More recent evidence derived from experiments carried out by Melton and co—workers 
(1998) suggests that although ERCC1 is likely to be involved in homologous recom-
bination it is not an essential component of that repair mechanism. Melton et al. 
propose that ERCC1 is also involved in a process called illegitimate recombination, 
which is used by rodents to prevent the accumulation of double strand breaks adjacent 
to unrepaired lesions on replicating DNA (Bierne and Michel, 1994). 
The ERCC1 paradox 
Mice homozygous for ERCC1 disruption, which has no counterpart among human 
disorders, showed unexpected pathologies, including runting at birth (see Fig. 1.4), 
early death, liver aneuploidy, and elevated p53 levels in liver, brain and kidney (McWhir 
et al., 1993a), possibly due to the lack of repair of spontaneous oxidative damage to 
DNA. On the other hand, mice carrying disruption mutations in the XPA and XPC loci 
were found to mimic XP patients in their pathology. They showed greatly increased 
susceptibility to UV radiation— and chemical carcinogen—induced skin tumours (deVries 
et al., 1995; Nakane et al., 1995), along with other skin and eye lesions consistent with 
the human disease. XPA-/- transgenic mice appeared physiologically normal at birth 
and did not develop (by 18 months) the nervous system pathology seen in XP patients. 
In addition, a mouse model has also been developed that carries a point mutation 
in the XPD gene and mimics the TTD syndrome. TTD mice present brittle hair, 
developmental abnormalities, reduced life span, UV sensitivity, and skin abnormalities 
(de Boer et al., 1998). 
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Figure 1.3: Model for the repair of DNA interstrand crosslinks. (A) Cross—linked 
DNA. (B) The UvrABC endonuclease cuts the DNA generating incisions which flank 
the cross—link (incision 1). (C) It is proposed that the 5'-3' exonuclease of Pol I then 
generates a gap 3' to the site of the cross—link, which is a substrate for RecA—mediated 
recombination. (D) During recombinational repair of the gap, an invading homologous 
DNA strand displaces the cross—linked oligonucleotide. (E) Once recombination is 
completed, the second DNA strand is incised by the UvrABC endonuclease (incision 
2), leading to the excision of a complex 11-mer or 12-mer oligonucleotide structure. 
(F) DNA repair is completed by repair synthesis and ligation. Taken from Friedberg, 
1995. 
The less severe effect of XPA mutations compared with ERCC1 mutations in the mice 
suggests an involvement of the ERCC1 gene in some critical process during development 
other than NER, perhaps a role in recombination repair or cell cycle control (control 
of replication and mitosis, see next sections). This thesis tries to investigate these 
possibilities. 
Premature ageing syndromes: A link with DNA repair processes? 
There are several rare conditions in man that are associated with premature ageing. 
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Figure 1.4: A) Photograph of a s20 day-old wild type mouse and its ERCC1-deficient 
littermate showing the runted appearance of the transgenic ERCC1-/- mouse. B) 
Haematoxylin-eosin liver sections from 20 day-old ERCC1 -/- mice; 40x magnifi-
cation. Left panel: wild type liver section (note homogeneous distribution of small 
nuclei); right panel: ERCC1-/- liver section showing some small nuclei (normal) and 
a number of enlarged aneuploid and polyploid hepatocyte nuclei (black arrows). 
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Hutchinson-Gilford progeria, Werner's syndrome and Cockayne's syndrome, but the 
groups also includes Bloom's syndrome, ataxia telangiectasia and Down's syndrome. 
Hutchinson-Gilford progeria is a rare genetic disease with a birth incidence of 1 in 8 
million and caused by a mutation of unknown origin (see Chapter 6 for more details). 
Werner's syndrome is an autosomal recessive disorder with a prevalence rate of 1 in 
10 million people. Unlike progeria, where the phenotype of the patients is apparent 
in early infancy, Werner's syndrome is not apparent until the third or fourth decade 
(progeria of the adult). Cockayne's syndrome has already been described elsewhere in 
the previous sections in the context of NER-related syndromes. Bloom's syndrome is 
characterised by severe pre- and postnatal growth deficiency, a sun-sensitive erythe-
matous face, hyper- or hypo-pigmented skin lesions and variable immunodeficiency. 
Ataxia telangiectasia (AT; see Replication section 1.2 and Chapter 4) and Bloom's syn-
drome have been extensively studied to establish the genetic basis of various cancers. 
A summary of the most prominent characteristics of these syndromes is presented in 
Table 1.3. 
Progeria Werner's 	Cockayne 's Bloom's AT 
Onset 	 Infancy 3rd decade 2nd year 	Infancy Infancy 
Death (decade) 	2nd 	5th/6th 	2nd 	2nd/3rd Childhood 
Stunted growth present present present present present 
Abnormalities 
Skin 	 present 	present 	present 	present absent 
Skeletal present present present present absent 
Muscular 	present present 	present 	absent 	absent 
Visual impairment absent 	present present absent n.r. 1 
Mental deficiency 	absent absent 	present 	n.r. 	n.r. 
Photosensitivity absent2 absent present present present 
Cancer risk 	absent 	present 	absent 	present present 
Table 1.3: Characteristics of some premature ageing syndromes. 1 n.r. stands for not 
reported; 2  Although patients suffering from progeria do not present photosensitivity 
there are reports that cells derived from these patients present defects in repair syn-
thesis and show abnormalities in their response to UV damage (Lipman et al., 1989; 
Wang et al., 1990; Wang et al., 1991). Adapted from Dyer and Sinclair, 1998. 
Cockayne's syndrome has already been mentioned in the context of DNA repair since 
cells derived from CS patients show impaired DNA repair ability and hypersensitivity 
to UV (see above). Defects in the XPB and XPD helicases have been identified as being 
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the cause of the phenotype shown by some of the cell lines derived from XP-CS patients 
(see above and Table 1.2). Bloom's syndrome cells present chromosomal instability and 
chromosomal breaks are a common feature of these cells. BS patients are homozygous 
for defects in encoding the BLM gene on the long arm of chromosome 15 which has 
been identified as being a helicase (Ellis et al., 1995). In addition, the gene responsible 
for Werner's syndrome has also been identified as a helicase on chromosome 8 (Yu 
et al., 1996). Furthermore, cells from ataxia telangiectasia patients show spontaneous 
chromosomal instability and are hypersensitive to the effects of ionizing radiation. 
Overall, it seems that these syndromes support the idea that ageing and DNA repair 
are intimately related (see Chapter 6 for more information) in that ageing may result 
from an imbalance between DNA damage, DNA damage responses (see Replication on 
damaged DNA template, section 1.3 and Cell Cycle Control, sections 1.5 and 1.6 for 
further information on this topic) and repair. 
1.2 DNA Replication: A Mechanistic Overview 
The complementarity of the two DNA strands first suggested by Watson and Crick was 
an obvious clue as to how DNA replicates. All replication processes simply involve the 
melting apart of those two strands followed by the polymerisation of each complemen-
tary strand on the resulting single—stranded templates. However, in many cases, the 
complexity of the enzymatic machinery involved in DNA replication is greater than 
would have been expected, given that the information necessary to encode two daugh-
ter genomes is encoded in the parental genome in such a simple way. This complexity 
has presumably evolved to increase the efficiency and fidelity of DNA replication and 
to ensure that the process of DNA replication is coordinated with other events in the 
life of a cell. Below I will try to lay out the basics of the DNA synthesis process paying 
special attention to the relationship between DNA replication  and the repair of DNA 
damage. A summary of the replication proteins known to date is presented below and 
in Table 1.4. 
6  For a complete review of the subject it is recommended to read DNA Replication in Eukaryotic Cells 
(DePamphilis, 1996) and references therein. 
CHAPTER 1. INTRODUCTION 
	
29 
Protein Replicative Function 
DNA polymerases 
pol-a:primase DNA polymerase, primase 
pol-8 DNA polymerase, 3' to 5' exonuclease 
pol-e DNA polymerase, 3' to 5' exonuclease 
Accessory proteins 
RPA single-stranded DNA binding 
PCNA poi-ö and poi-c processivity factor 
RFC loads PCNA onto template 
Nucleases 
ribonuclease Hi Okazaki fragment maturation 
FEN-1(MF-1) Okazaki fragment maturation 
Others 
DNA ligase I joins Okazaki fragments 
topoisomerase I unlinks parental strands 
topoisomerase II unlinks parental strands and progeny duplexes 
Table 1.4: Cellular replication proteins. Adapted from Brush, 1996 
1.2.1 Protein-protein interactions at the replication fork 
The viral T antigen, pol-o:primase and RP-A are required for the initiation of DNA 
replication in the SV40 system. Several studies have provided evidence for the interac-
tions among these three proteins (for references see Brush and Kelly, 1996) and these 
interactions are likely to be important factors that contribute to the efficiency and 
specificity of the initiation reaction. Unwinding of the SV40 origin requires both T 
antigen and RP-A. Once the DNA is unwound, the interaction between pol-a and T 
antigen is likely to play a role in the efficient priming on the RP-A-covered, single-
stranded template. Priming is also likely to be influenced by an RP-A/primase inter-
action, which has been shown to occur in vitro. Confirmation of similar interactions in 
mammalian origins of replication awaits the identification of the cellular counterpart(s) 
of T antigen. 
Protein-protein interactions also play an important role in the elongation phase of 
DNA replication. For example, the processivity of poi-6 is absolutely dependent on 
its interaction with PCNA, which is topologically linked to the template DNA. There 
is no evidence to show interaction between the polymerases pol-S and pol-e and other 
replication proteins. 
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Molecular interactions among proteins may also be important in the final stages of 
DNA replication, when the Okazaki fragments are joined to form a continuous DNA 
chain. The specific requirement for DNA ligase Tin the ligation of the resulting Okazaki 
fragments may reflect the strict requirement for specific contacts between this protein 
and other proteins involved in the maturation of daughter strands. 
Moreover, interactions between replication proteins and other cellular factors have also 
been described. These interactions are likely to play a role in the regulation of DNA 
replication, although their functions are not totally clear. For instance, RP-A is known 
to interact with the transcription factors p53, GAL4 and VP16 and the repair proteins 
XPA and XPG (for references see Brush and Kelly, 1996). In fact, RP-A is required 
for in vitro Nucleotide Excision Repair (NER) where it takes part during DNA repair 
synthesis (Friedberg and Wood, 1996). Additionally RP-A is required for damage 
specific incision (see Friedberg and Wood, 1996 and references therein). The yeast 
homolog of the heterotrimeric protein RP-A is encoded by the RFA genes. Mutations 
in the RFA1 gene of S. cerevisiae result in yeast strains abnormally sensitive to UV, 
which suggests that RP-A may also have a role in NER in vivo. 
PCNA is also required for the repair synthesis step of NER in mammalian cells in vitro, 
and there is also evidence that PCNA is involved in vivo (see Friedberg and Wood, 
1996 and references therein). These observations and data obtained from experiments 
using chemical inhibitors, implicate pol-6 or p01-f in the repair synthesis step. DNA 
pol-c has been shown to be active in NER in vitro, where the presence of RP-A and 
replication factor C (RFC) is also required. As shown in Table 1.4, RFC seems to be 
required to load PCNA onto the DNA template. 
More recent evidence comes from studies of the anatomy of the DNA replication fork 
achieved by reconstitution of SV40 DNA replication in vitro (Waga et al., 1994). In 
this refined model it has been shown that DNA pol-a:primase functions primarily 
to synthesise RNA-DNA primers for initiation of DNA replication at the origin and 
for priming each Okazaki fragment. A polymerase switching reaction which requires 
replication factor C and PCNA allow two molecules of DNA pol-ö to replicate both 
strands of the double helix at the same time (Waga et al., 1994). 
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In summary, there seems to be a number of essential protein-protein interactions among 
the replication proteins themselves and also among the replication proteins and proteins 
that are part of the NER machinery (XPA, XPG) or that function as regulators of the 
cell cycle (p53). Also, some of the replication proteins play an active role in the NER 
process itself (RP-A, RFC, PCNA). This suggests that these two cellular functions are 
intimately related and below special attention will be paid to this fact. 
1.3 Effects of DNA damage on DNA Replication 
When DNA is damaged by UV irradiation, ionizing radiation or chemicals, it must 
be repaired to prevent genomic alterations that could otherwise give rise to mutation, 
death or the appearance of cancer cells. In order to avoid this, cells have evolved a 
number of mechanisms to repair their DNA, and to prevent DNA replication until the 
damage is repaired (Lu and Lane, 1993) (see next section). 
Somewhat paradoxically, however, the number of lesions that a cell can tolerate without 
significantly losing its capacity to reproduce is surprising. In fact, quite often lesions 
are not eliminated before the portion of the genome where they are located is replicated 
or transcribed. For instance, XP human fibroblasts are defective in NER and therefore 
can not repair the damage caused by UV. However, 37% of these cells manage to 
survive after UV doses that cause considerable damage to their DNA (approx. 16000 
dimers per genome) (Meneghini et al., 1981). 
It is reasonable to assume that the replication apparatus can not proceed normally 
through a DNA structure that contains a helix-distorting factor (such as the pyrimidine 
dimers caused by the UV), but somehow the cell manages to deal with these and other 
lesions during replication. What are the biological implications of DNA replication on 
a damaged template? How does a cell react to DNA damage in terms of replication? 
What are the mechanisms that cells use to tolerate DNA lesions? What replicative 
behaviour would be expected after DNA damage from cells that can not repair DNA? 
In this section special attention will be paid to provide an answer for these questions 7 . 
For an extensive, comprehensive review on this subject see Meneghini et al., 1981. Also see Friedberg 
et al., 1995, Chapters 10-12 
CHAPTER 1. INTRODUCTION 
	
32 
1.3.1 The biological effects of DNA lesions 
The most extensively studied mammalian system to investigate the biological conse-
quences of DNA lesions has been the Xeroderma Pigmentosum (XP) cell strains. As 
mentioned before (DNA Repair section 1.1), these cell lines are fibroblasts derived 
from patients with the disease xeroderma pigmentosum and are characterised by a 
defect in the repair of some DNA lesions (mainly pyrimidine dimers). These cells are 
particularly useful to compare their response to DNA damage with that of wild type 
cells. 
Effects on cell killing 
Using a method for the measurement of the disappearance of pyrimidine dimers after 
UV irradiation and correlating this with the survival after different doses of UV, it 
was possible to see that NER proficient cells eliminate 80% of the dimers in 2 days 
whereas the XP cells (XP-A complementation group), although originally having fewer 
dimers, eliminate only a very small fraction during a 4-day period. The dose of UV 
light that results in a survival of 37% of the cell population in wild type fibroblasts is 
2.6 J/m2 . For XP cells it is 0.4 J/m 2 (Haseltine et al., 1980). This dose is still capable 
of producing a high number of dimers per genome. Since the XP cells can not repair 
this damage and still 37% of them manage to survive, it is likely that lesions must 
somehow be tolerated without significantly affecting the survival of the cell. However, 
the overall consequence of the persistence of dimers in the genome is the reduced 
survival of the XP cells compared to the repair-proficient controls, for the same doses 
of UV light. These two statements do not necessarily contradict each other. If we 
assume that a certain number of dimers correspond to a lethal event, it is logical to 
think that the burden of dimers that gives one lethal event per cell in a repair proficient 
cell population is bigger than that in an XP cell population, since in the wild type cell 
population most of those dimers will be eliminated by the excision repair mechanism. 
Other experiments performed under conditions that allow cells to repair their DNA 
before undergoing replication (by synchronising them in a pre-replicative state) also 
show that DNA lesions have a deleterious effect on cell survival. Under these condi-
tions, when DNA repair proficient cells are irradiated in confluence (this arrests the 
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cells at a pre—replicative state) and released after various lengths of time, they show 
a gradual increase in survival (Meneghini et al., 1981). On the other hand, XP cells 
show no or little survival increase under the same conditions. 
Cell mutation 
Mutations are another effect of DNA lesions. Proof of this also comes from the com-
parison between normal human and XP cells. At the same UV dose, the frequency of 
mutations induced by UV light is higher in XP cells than in normal cells. Nevertheless, 
at equitoxic UV doses, the mutation frequency in XP cells is the same as that induced 
in normal cells. An equivalent reason to the one given above applies here. In normal 
cells, where DNA lesions are repaired, the number of dimers required for a lethal event 
to occur is much higher, but probably these cells end up with the same lesion burden 
as the XP cells at the time the mutation event takes place. It is interesting to note 
that fibroblasts derived from patients with an XP variant (these cells show the same 
excision capability as normal human cells) nevertheless shows a higher mutation rate, 
even at equitoxic doses (Maher et al., 1976). 
When cells are subjected to the liquid holding technique, (i.e., irradiated while synchro-
nised in a pre—replicative state so that time for repair before entering replication can 
be controlled by controlling the time at which the cells are released post—irradiation), 
normal human fibroblasts prevented from replicating for several days show background 
(unirradiated) mutation levels, whereas XP cells continue to have the same high mu-
tation frequency and do not show a reduction with time (Maher et al., 1979). 
All this evidence tends points towards a role for pyrimidine dimers in the production 
of mutations (for a review on this topic refer to Friedberg et al., 1995, Chapter 12). 
Cell transformation 
XP and ataxia telangiectasia patients have provided clues towards a direct link between 
unexcised lesions and cancer. These patients are characterised by having an increased 
incidence of specific types of cancers (skin cancers mainly) and their cells lack the 
ability to repair certain type of lesions (for more detail refer to the previous section: 
DNA Repair). 
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However, human cells are transformed with difficulty in vitro so other systems such as 
the more easily transformed mouse 3T3 cells have been used to test the relationship 
between unexcised DNA lesions and cell transformation. 3T3 cells have been subjected 
to the liquid holding technique and assayed for transformation. If after exposure to the 
damaging agent 4-nitroquinoline-1-oxide (4NQO) these cells are allowed to repair their 
DNA in a non-replicative state, a decrease in the frequency of oncogenic transformation 
occurs and this decrease has been shown to be directly related to the rate of enzymatic 
removal of the 4NQO-induced adducts from the DNA of the cells (Meneghini et al., 
1981). This seems to indicate that in fact, the accumulation of DNA lesions leads to 
the transformation of these cells. 
These experiments have not been carried out with the mouse XP-equivalent cells, but 
this a control experiment that needs to be carried out. If unexcised DNA lesions are 
indeed responsible for transformation, these cells, when subjected to the liquid holding 
technique, would maintain their frequency of transformation even after long periods in 
the pre-replicative state. 
Sister chromatid exchanges 
The biological significance of sister chromatid exchanges (SCE) comes through its 
possible relationship to mutagenesis and carcinogenesis. SCE consists of the exchange 
of homologous parts of sister chromatids in mitotic cells. SCE Is a phenomenon that 
involves exchanges of double-strand DNA and several mutagenic and carcinogenic 
agents are known to enhance it in mammalian cells. 
The fact that UV-irradiated cells pass through a period of DNA synthesis before SCEs 
are produced seems to point towards a role for unexcised lesions in the formation of 
SCEs (Meneghini et al., 1981). Regarding this point it is important to know what 
happens to the replication process/machinery when a lesion in the DNA is reached. 
Does the cell bypass the arrest caused by the lesion? From the evidence discussed in 
this section this appears to be the case, but how does the cell manage to do this? Is 
this process faithful or structural alterations in the DNA arise with it that in the end 
lead to several biological end-points? These questions are addressed in the following 
section. 
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1.4 Replication on a Damaged Template 
The study of this particular aspect of the cell biology is not easy due to a number of 
reasons. Firstly, the normal replication process in mammals is very complicated and 
the knowledge about it is still poor. Secondly, different mammalian systems may have 
different ways of dealing with the problem and it is difficult and risky to extrapolate 
from one system to another. Thirdly, the experimental methodology that has been 
used to elucidate this problem, namely sucrose-gradient centrifugation, is subjected 
to methodology variations which makes the standardisation of the conclusions derived 
from the data difficult. 
1.4.1 Replication on a damaged template in bacterial systems and 
lower eukaryotes 
In order to introduce the subject, I will discuss the processes of replication on damaged 
templates in bacterial systems. The knowledge of these mechanisms is more complete 
in bacterial systems and it will serve to introduce some concepts that will later be used 
in the discussion of the mammalian process. 
When the replication machinery reaches a pyrimidine dimer, synthesis of DNA is 
blocked at that point and replication resumes at a point beyond it, resulting in the 
creation of a gap opposite the lesion (Rupp and Howard-Flanders, 1968) (see Fig. 1.5). 
Although there is no conclusive proof that the gap is located opposite the dimer, there 
is some evidence that points towards this fact. For example the size of the daughter 
strand synthesised after UV irradiation, as measured by alkaline sucrose gradients, is 
approximately the same as the interdimer distance (Rupp and Howard-Flanders, 1968). 
The repair of the gap in bacterial systems is mainly carried out by a single strand ex-
change mechanism which fills the gap with undamaged DNA from the opposite isopolar 
parental strand. This process requires the Rec A and Lex A genes, amongst others 
(Friedberg et al., 1995). This recombination process provides the bacteria with a way 
to avoid replication of the damaged region, but it creates a gap in the parental strand. 
This gap is however easily filled in by repair synthesis (Meneghini et al., 1981). This 
mechanism has been termed both 'post-replication repair' and 'recombinational repair' 
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Figure 1.5: Schematic model of the mechanism of gapped DNA synthesis. When the 
growing fork reaches a lesion (represented by the solid triangles) in the parental strand, 
replication of the daughter strand terminates (I). Replication reinitiates further along 
the template. This leaves gaps in the daughter strand (II) which are subsequently 
filled by de novo synthesis or recombination (see Fig. 1.6) (111). Adapted from Doniger, 
1978. 
Bacterial cells, in addition, seem to have another way of dealing with unexcised lesion 
during replication. This is the process called 'translesion synthesis' where a 3'-5' editing 
exonuclease activity associated with the bacterial DNA polymerase is responsible for 
the block in DNA synthesis at the lesion. The stalled polymerase would arrest and 
would start incorporating and removing nucleotides opposite the lesion. This would 
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Figure 1.6: Schematic view of the postreplication repair mechanism in bacteria. Thick 
lines represent parental DNA containing dimers (solid triangles). Thin lines represent 
daughter DNA synthesised after irradiation. Two different exchange processes occur 
with equal probability: (A) The gap is filled in with isopolar undamaged parental 
DNA, which creates a gap in this latter DNA (IA). This gap is later filled by repair 
synthesis (lilA). Ultimately, the dimer remains in the parental strand. (B) The region 
containing the dimer is exchanged with the isopolar daughter strand, creating a dimer-
free template opposite the gap (IIB)which can be used to direct the filling of the gap 
(TuB). Ultimately, the exchanged dimer remains in the daughter strand. Adapted from 
Meneghini et al., 1981. 
in turn induce a SOS mechanism which somehow suppresses the exonuclease activity 
of the polymerase, thus resulting in replication past the lesion with an increase in the 
possibility of error (for a detailed description of the SOS response see Friedberg et al., 
1995, Chapter 10). In E. coli, translesion synthesis is thought to be carried out by Pol 
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III together with at least three accessory proteins, the SOS—controlled umuDC gene 
products and the activated form of RecA (Friedberg et al., 1995; Woodgate and Levine, 
1996). However, translesion synthesis in E. coli also has an umuDC—independent 
component, which points towards an underlying higher complexity of this strategy 
(Napolitano et al., 1997; Baynton et al., 1998). Apparently, there is an indication 
that, in bacterial systems, recombination repair predominates over translesion synthesis 
(Ganesan and Seawell, 1975; Woodgate and Levine, 1996). 
In budding yeast, S. cerevisiae, the components of the RAD6 pathway seem to be 
responsible for most of the yeast's resistance to DNA damage and for almost all induced 
mutagenesis (Baynton et al., 1998). Although less than half the genes involved in 
the replication of damaged DNA have been cloned, recent studies have allowed the 
identification of protein functions that participate in this pathway. The heterodimeric 
complex Rad6-Rad18 has been proposed to recognise single—stranded DNA associated 
with stalled replication forks at damaged sites (Baynton et al., 1998). Once recruited, 
the complex may ubiquitinate components of the replication machinery, promoting 
replication recovery. Translesion replication in S. cerevisiae is thought to be carried out 
by DNA polymerase (, which contains one catalytic subunit encoded by the gene REV3 
and at least one other gene product encoded by the REV7 gene and has been shown 
to be able to replicate through damage sites (thymine—thymine dimers) (Nelson et al., 
1996). The REV1 gene product, which has a weak homology with the E. coli umuC 
protein (Nelson et al., 1996), has been shown to insert cytosine preferentially across 
from a template abasic site, creating a lesion terminus that can be easily extended by 
Pol ( (Baynton et al., 1998). In addition, Rev3 DNA polymerase has recently been 
shown to be required for translesion synthesis in vivo (Baynton et al., 1998). 
1.4.2 Replication on a damaged template in mammalian cells 
It is apparent that despite the existence of lesions in the replicating DNA, the DNA 
synthesis machinery still manages to proceed with replication. In fact, as discussed be-
fore, 37% of XP cells containing 16000 unexcised dimers per genome are able to survive 
and replicate. Direct proof that replication can proceed in the presence of DNA lesions, 
comes from experiments performed with CHO cells. When UV—irradiated, replicated 
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and unreplicated DNA derived from these CHO cells contain the same amount of 
dimers, so the replication machinery must have bypassed the lesions. 
In this same experiment it was possible to determine that these cells carry out a 
minimal amount of dimer excision (about 30% in 24 hours after a dose of 5-10 J/m2 ) 
and that this process does not preferentially take place ahead of the replication fork 
as a way of clearing the way for the replication machinery (Meyn et al., 1974). The 
same is true for normal human fibroblasts although these cells are better at removing 
the dimers (approximately 50% in 24 hours) than their rodent counterparts (Waters, 
1979). An account of the different mechanisms used by mammalian cells to bypass the 
lesion—induced replication arrest and the factors that influence this recovery is given 
next. 
1.4.3 Factors that influence recovery from DNA replication arrest 
after DNA damage 
Studies have shown that DNA replication in mammalian cells is inhibited by UV light 
(Cleaver, 1965; Klimek and Vlasinova, 1966). In rodent cells the extent and duration 
of DNA synthesis blockage is both cell—line and fluence—dependent (Griffiths and Ling, 
1989) and the same is the case with human cells. Wild type human cells do not show 
significant blockage following exposure to 2.5 J/m2 , but after exposure to 5 J/m2 , they 
show significant blockage as shown by DNA fibre autoradiography (Griffiths and Ling, 
1989). This arrest lasts for 5 hours after which the segment lengths return to control 
values. Excision repair—deficient human cells, on the other hand exhibit significant 
blockage both immediately and 5 hours after irradiation with the low UV dose (2.5 
J/m2 ). 
DNA excision repair has been proposed as the main agent behind the removal of 
the dimers (Klimek and Vlasinova, 1966; Cleaver, 1965) and the recovery from DNA 
synthesis arrest. However, fibroblasts derived from patients with Cockayne's syndrome, 
show no recovery of DNA synthesis after UV, even though these cells can carry out 
excision repair of dimers (Lehmann et al., 1979). This suggests that although DNA 
excision repair is necessary for the recovery of DNA synthesis after UV irradiation it 
is not sufficient. Are there any other factors that contribute to that recovery? 
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The rate of recovery of DNA synthesis after UV depends on several factors: 
the number of cells in S phase, 
the number of active replicons per cell 
the size of the replicons (Cleaver et al., 1983) 
the rate of DNA elongation and 
the excision repair capacity of the cells (Cleaver et al., 1983). 
Cells tend to accumulate in S phase after UV irradiation, but their number only de-
creases after recovery has taken place, so DNA recovery must take place in cells that 
are in S (going through active DNA replication). Also, if the number of active replicons 
would increase after UV it could lead to a recovery in the rate of DNA synthesis. Fi-
nally, a recovery in the rate of DNA replication would also be achieved if cells acquired 
the ability to replicate lesion-containing templates more efficiently. 
Cycloheximide has been reported to induce a significant reduction in the rate of DNA 
synthesis recovery. However, a specific inhibitor for DNA synthesis, fiuordeoxyuridine, 
has no effect on recovery after UV (Lehmann, 1979). This suggests that protein syn-
thesis is necessary to achieve DNA synthesis recovery and that this is done through a 
pathway different from excision repair, since excision repair does not require protein 
synthesis. 
This situation is different in CHO cells. These cells seem to require DNA synthesis to 
reach the recovery state. When CHO cells are synchronised in Gi and irradiated with 
5 j/M2  of UV, their rate of DNA synthesis (as measured by the rate at which DNA 
achieves hybrid buoyant density, in the presence of BrdU) drops to 70% of the control 
in the first S phase but becomes normal in the second S phase. Holding the cells in G  
does not increase the rate of recovery, so in order to achieve DNA recovery, it seems 
necessary that the cells go through an S phase. Only 25% of the dimers are eliminated 
in these cells after 5 J/m 2 , so excision repair does not seem account for such recovery 
(Meyn et al., 1977). 
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It is possible that recovery is in fact due to both excision repair and/or an inducible 
mechanism(s) that may involve de novo protein synthesis. Normal human fibroblasts 
have both mechanisms and they recover efficiently and fast. In the case of rodent cells, 
their repair capacity is very poor and they would be more dependent on the inducible 
process(es) (Meyn et al., 1977; Meneghini et al., 1981). But, what happens when 
NER is not functional? What other mechanisms can account for the recovery of DNA 
replication after the DNA damage—induced arrest of DNA synthesis in rodent cells? A 
review of these alternative processes is given below. 
1.4.4 Dealing with unexcised lesions: Mechanisms of replication ar-
rest recovery 
In general, the process by which cells manage to replicate DNA that contains lesions 
is known as postreplication repair (PRR). PRR is used here as an equivalent term for 
elongation of DNA synthesis on damaged templates. PRR has been conventionally seen 
by alkaline sucrose gradients. Cells are grown in the presence of radioactive thymidine 
for a short time and then put in normal medium for different amounts of time. The 
centrifugation of the DNA of these cells in the alkaline sucrose gradients reveals an 
increase in the size of the nascent DNA strand with time. In UV—irradiated cells, this 
elongation is delayed as compared to the unirradiated controls, and this delay has been 
shown to be most likely due to the presence of lesions on the parental DNA strands. 
PRR has been shown to occur in a variety of cells and by techniques other than sucrose 
sedimentation gradients (Meneghini et al., 1981). 
Cordeiro—Stone et al. showed that SV40—transformed XP cells that had been irradiated 
had a lower rate of DNA elongation than the control cells (Cordeiro-Stone et al., 
1979). Similar results have been obtained using DNA fibre autoradiography to study 
the inhibition and recovery of DNA synthesis in V-79 Chinese hamster cells (Dahie 
et al., 1980): a reduced rate of fork displacement was detected in irradiated V-79 
cells, suggesting that dimers do constitute a temporary block for the DNA replication 
machinery during the first 5 hours after exposure. Within 10 hours, however, the 
lesions are apparently repaired or modified (or the replicative enzymes altered) so that 
DNA chain growth is no longer arrested (Dahie et al., 1980). 
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Different cells may have different types of PRR. One case is that of cells derived from 
patients suffering from an XP variant form. These patients are clinically identical to 
XP patients but their cells show normal capacity for NER of dimers. Apparently, these 
cells have an impaired PRR, and are most likely defective in the process of translesion 
synthesis (Cordonnier et al., 1999). 
DNA synthesis inhibitors such as hydroxyurea, cytosine arabinoside, and excess of 
thymidine are also inhibitors of PRR. This indicates that PRR and DNA synthesis 
may share some enzymatic components. Caffeine and theophylline are very specific 
inhibitors of PRR. They do not have an effect at moderate doses in untreated control 
cells, but they specifically inhibit DNA elongation at moderate doses in rodent cells 
treated with DNA—damaging agents. In human cells inhibition of PRR by caffeine 
is not observed, with the exception of XP variant (Lehmann et al., 1975; Meneghini 
et al., 1981). 
The PRR mechanism(s) would involve a recombination process between the damaged 
region of the template and an homologous homopolar sequence of DNA which has 
not been damaged, therefore avoiding the direct replication of the damaged DNA. 
This process or processes (referred to as mechanism(s) of alternative copy) would not 
be mutagenic. Another way of dealing with unexcised lesions would be the direct 
replication of the portion of DNA containing the lesion (referred to as translesion 
synthesis). This type of repair would be expected to be highly mutagenic. 
Mechanisms of alternative copy 
Recombination 
Techniques successfully employed in bacterial cells to demonstrate the existence of 
recombinational processes failed in mammalian cells (Lehmann, 1972; Meneghini and 
Menck, 1978). 
A more direct approach to the problem was taken by Meneghini et al. who showed that 
in fact there was evidence for a very low—frequency recombinational process between 
the daughter and the parental strands of DNA (refer to Fig. 1.6) whose frequency is 
reduced to even lower levels as time after irradiation increases (Meneghini et al., 1981). 
CHAPTER 1. INTRODUCTION 	 43 
Meneghini proposes that this mechanism is probably active soon after the damage is 
inflicted and another mechanism takes over at later times. Proof for the existence 
of recombinational processes also comes from the strand break rejoining process in 
mammalian cells, which has biphasic kinetics. It has been suggested that the fast 
component of this process reflects the direct DNA strand rejoining, whereas the slow 
component reflects in fact recombinational processing (Friedberg et al., 1995, Chapter 
12). 
Branch migration 
This mechanism also involves recombination with an alternative isopolar template (see 
Fig. 1.7). If the replication fork reaches a lesion the daughter strand at the opposite 
lesion-free template continues replication for a certain period of time, leaving behind 
the other daughter strand halted at the lesion and a single strand region ahead of it. 
Branch migration then takes place, bringing back the replication fork to the point of 
the lesion and allowing the blocked daughter strand to switch templates from parental 
strand to the isopolar daughter strand which had already gone ahead and undergone 
replication. 
However, direct attempts to demonstrate the presence of gaps in the daughter strand 
opposite CPDs to provide evidence for the PRR model have been unsuccessful (Menegh-
mi, 1976; Clarkson and Hewitt, 1976). There are therefore, doubts as to the precise 
position of those gaps in relation to the lesion and whether the gaps are formed only 
in the lagging strand (Meneghini et al., 1981), or in both the leading and the lagging 
strand (Lehmann, 1979). 
Translesion synthesis 
In this process a direct copy of the damaged template takes place. As opposed to 
recombination and branch migration this mechanism is supposed to be highly muta-
genic. If translesion synthesis takes place one would expect to find cells that survive 
UV irradiation with a high number of mutations per cell. Studies carried out in the 
HGPRT locus of excision-defective XP cells point towards this possibility (Meneghini 
et al., 1981). Mammalian fibroblasts in culture have a high probability of surviving 







Figure 1.7: Schematic representation of the branch migration mechanism. When the 
fork reaches a lesion (represented by the solid triangles) in the parental strand, repli-
cation of the daughter strand terminates while replication of its sister continues for a 
short distance (I). Then by branch migration, the parental strands reanneal, displacing 
the daughter strands which in turn hybridise with each other (II). The longer sister 
strand then serves as a template for the shorter one. After synthesis occurs, branch 
migration proceeds in the reverse direction until the normal replication fork is formed 
and fork movement can proceed (III, IV). Adapted from Doniger, 1978. 
when their genome contains up to 50000 unexcised dimers, which means that they 
can actually tolerate such a burden of mutations (Meneghini et al., 1981). In addition, 
excision—repair deficient B. coli produces point mutations after a dose of 0.6 J/m 2 with 
a frequency that is an order of magnitude lower than that of mammalian cells (10 in 
bacteria compared to 10 in mammalian cells). This seems to point to the fact that 
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translesion synthesis is a common feature in mammalian cells. The human and mouse 
homologues of the yeast S. cerevisiae REV3 gene, which encodes the catalytic subunit 
of DNA polymerase , have been recently cloned (Gibbs et al., 1998; van Sloun et al., 
1999). The human REV3-homolog , hREV3, maps to the chromosome lp32-33 and 
encodes an mRNA of approximately 10 Kb, with variable expression depending on the 
tissue examined (Xiao et al., 1998). The human gene encodes an expected protein of 
3,130 residues (Lin et al., 1999), about twice the size of the yeast protein (1,504 aa). 
The sequence of the expected protein suggests that it is the catalytic subunit of a DNA 
polymerase of the poi type (Gibbs et al., 1998; Lin et al., 1999). 
Joining of adjacent replicons 
A lesion may function as a premature termination point for a replicon (Park and 
Cleaver, 1979). This fork could be relieved by chain growth from the adjacent un-
blocked fork. This model would provide an explanation for the observed long term 
interruptions in the daughter strands, which would occur when two forks approaching 
from adjacent origins are blocked at two distinct dimers. This model also has the 
advantage of not requiring the formation of gaps for it to be plausible. However, the 
evidence points towards the existence of such gaps. Meneghini proposes a modifica-
tion of Park and Cleaver's model in which the confluence of adjacent forks, one being 
blocked by a dimer, causes the formation of gaps (see Fig. 1.8). This theory has later 
been put forward by other authors (Spivak and Hanawalt, 1992; Painter, 1985) 
1.4.5 Co—regulation of DNA synthesis and DNA repair 
It is not known how DNA damage inhibits DNA replication and yet allows DNA repair. 
Proteins such as replication protein A (RPA, also known as human single—stranded 
DNA—binding protein, HSSB), proliferating cell nuclear antigen (PCNA), activator 
1(A1, also known as replication factor C, RFC) and DNA polymerase 8 (pol-6) have 
all been implicated in both processes. 
When normal cells are exposed to genotoxic agents, the levels of p53 tumour—suppressor 
protein rise, inducing p21 Cipl/Wafl (p21) (El-Deiry et al., 1993). p21  has two func- 
tions. First it is an inhibitor of cyclin—dependent kinases, possibly causing cells to 







Figure 1.8: Schematic representation of the joining of adjacent replicons. Replication 
is assumed to be discontinuous at the lagging strand and 0 represents the Origin of 
Okazaki fragments. The replication fork at left is blocked at the dimer (represented 
by a solid triangle), whereas the one at the right is moving toward the dimer (I). After 
reaching the block (II) DNA synthesis resumes in the lesion—free template but remains 
arrested on the lesion—containing template, giving rise to the gap (III). 
arrest at the Gi phase of the cell cycle (Cox, 1997; Lin et al., 1996)(see next sections: 
Cell Cycle Control I, section 1.5 and II, section 1.6). Secondly, it interacts with PCNA 
to inhibit DNA replication without affecting PCNA function (Cayrol and Ducommun, 
1997; Chen et al., 1996b; Jackson et al., 1995; Li et al., 1994b; Waga et al., 1994). 
There is evidence to suggest that cells exposed to UV irradiation are inhibited in the 
synthesis phase (S), rather than at the G1—S boundary (see next sections: Cell Cycle 
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Control I , section 1.5, and II, section 1.6). DNA synthesis in UV-irradiated cells is 
significantly inhibited while repair occurs (Lu and Lane, 1993) and HeLa cell extracts 
show reduced capacity to support DNA replication in vitro as the level of UV-induced 
S-phase arrest increases (Carty et al., 1994). 
In fact, S-phase arrest occurs not only by a decrease in replicon initiation but also by 
inhibition of the replication-fork progression (Lehmann et al., 1975; Lehmann, 1981; 
Park and Cleaver, 1979; Kaufmann et al., 1980; Painter, 1985). Inhibition of replicon 
initiation after UV is actively regulated by a trans-acting mechanism, but it is not 
clear what the mechanism behind inhibition of chain elongation is, nor whether a cis 
effect caused by the damage in the replication fork itself plays a role in replication 
arrest (Ryan et al., 1994). The fact that S-phase human cells arrest for long periods 
of time after UV before proceeding with the cell cycle suggests that the presence of 
damage in S-phase cells is recognised and that the inhibition of DNA replication is 
actively controlled (Wang and Ellem, 1994). 
The arrest of replication-fork progression after UV irradiation has been shown to 
occur in vivo in chromosomal DNA by DNA-fibre autoradiography (Edenberg, 1976; 
Griffiths and Ling, 1989) and in SV40 minichromosomes by electron microscopy (Berger 
and Edenberg, 1986). However, the duration of the fork arrest, the mechanism of the 
recovery from the arrest and the detailed mechanism by which UV inhibits replication-
fork movement are not known. Just as an example, estimates for the duration of the 
fork arrest, range from 15 minutes (van Zeeland and Filon, 1982) to several hours 
(Griffiths and Ling, 1989; Griffiths et al., 1990; Lehmann et al., 1975; Park and Cleaver, 
1979). An account of the most recent advances in the understanding of the regulatory 
mechanisms behind the control of the cell cycle progression both through M and S, is 
presented in the Cell Cycle Control sections. 
1.5 Cell Cycle Control I: Progression through M 
Each time a cell needs to divide, the cellular machinery has to make a decision on 
whether to carry on with mitosis or not, and this decision is indeed under very tightly 
regulated mechanisms (Roberts et al., 1994). In order to decide, the cell has to take 
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into consideration a wide variety of signals that indicate when division is needed and 
appropriate. It is now known that these signals come from two different sources: signals 
that come from the extracellular environment (Graña and Reddy, 1995), and signals 
that come from intracellular checkpoint controls. Environmental signals provide the 
cell with information on the available nutrients, whether there is a need to divide, 
and whether there are overriding reasons not to begin a replicative cycle. Signals 
from internal checkpoints make sure that the preceding steps of the cell cycle have 
been successfully completed before the next stage of the cell cycle takes place (Murray, 
1994). Five cell cycle control checkpoints have been identified to date (Lees and Harlow, 
1995): 
A checkpoint that monitors for DNA damage and arrests cells in G2 
A checkpoint that monitors for DNA damage and arrests cells in Gi 
A checkpoint that signals that DNA synthesis has been completed before mitosis 
begins 
A checkpoint that monitors completion of mitosis before allowing entry into S 
phase 
A checkpoint that ensures that the chromosomes are correctly aligned at the 
metaphase plate prior to the initiation of the anaphase. 
Most of the regulatory mechanisms of cell cycle control act during the gap or G phases 
of the division cycle. Thus, the Gi phase between mitosis (M phase) and DNA synthesis 
(S phase) and the G2 phase between DNA synthesis and mitosis are the times in which 
the regulatory decisions of the cell cycle are made. In this section I will focus primarily 
on the regulation of M phase and the mechanisms underlying the G2/M transition as 
well as the regulatory connection between the S phase and the M phases of the cell 
cycle. In the next section I will deal with the regulation of the S phase in more detail. 
The current model of mitotic regulation in vertebrates is shown in Fig. 1.9 (Basi and 
Draetta, 1995). Briefiy,during interphase, cdkl (cyclin—dependent kinase 1) and cy-
din B associate and are phosphorylated on Thr14, Tyrl5 and Thrl6l. This inactive 
complex (preMPF) accumulates during S and G2. This complex becomes active by 
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the dephosphorylation of cdkl on Thrl4 and Tyr15, which is the rate-limiting step 
controlling entry into mitosis. Once this happens mitosis starts. Inactivation of MPF 
is brought about by the ubiquitination and subsequent degradation of cyclin B. Inacti-
vation of MPF is necessary for the exit from mitosis. After degradation, dephosphory-
lation of Tyrl61 takes place, which renders a monomeric, inactive (unphosphorylated) 
cdkl and the cycle starts again (Basi and Draetta, 1995; Coleman and Dunphy, 1994). 
preMPF 	 MPF 	 Transient form 
	
Monomeric CDK1 











Figure 1.9: Activation and deactivation of cdkl at mitosis. Dephosphorylation of cdkl 
on Thrl4 and Tyr15 promotes activation of the cdkl-cyclin B complex formed during 
interphase (preMPF) and is the rate-limiting step for mitotic initiation. The Thr161 
phosphate regulates positively the cdkl kinase and is also present in the active M-phase 
promoting factor (MPF). At the metaphase-anaphase transition, cyclin B is ubiqui-
tinated and subsequently degraded by an ubiquitin-dependent protease. Following 
degradation of cyclin B, cdkl is dephosphorylated on Thrl6l and MPF is inactivated. 
After formation of inactive monomeric cdkl, cells can exit from mitosis and start a 
new cycle. Adapted from Basi and Draetta, 1995. 
PCNA and p21 
The interaction between cell cycle regulators and other molecules that take part in 
repair processes, such as p21 and PCNA, is of special interest in the context of this 
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thesis. Several cdk-cyclin complexes are found to associate with PCNA and with 
small inhibitory peptides, which range in size from 14 to 27 kDa. In mammalian 
cells, the cdkl-cyclin B complex associates with PCNA and a 21 kDa protein (p21). 
Interestingly, this association is absent in transformed cells. As seen in the DNA 
Replication section 1.2, PCNA is a cofactor of DNA polymerase 8, and it is required 
during DNA replication and repair (see Replication section 1.2 and Repair section 1.1 
for further information on PCNA). p21 gene was cloned simultaneously by 4 different 
groups (Graña and Reddy, 1995; Elledge and Harper, 1994), which named the protein 
in four different ways according to the approach they used to clone it. The first group 
was working on the isolation of proteins that interacted with cdk2 and named the 
gene CIP1 (cdk2-interacting protein-1). The second group were screening for genes 
induced by p53 and named it WAF1 (wild type p53-activated fragment-1). A third 
group, which was cloning genes specifically activated during senescence, called this 
gene SDI1 (senescent cell-derived inhibitor-1). The fourth group microsequenced a 21 
kDa protein that co-immunoprecipitated with cyclin D. p21 was capable of inhibiting 
the catalytic activity of all the cdk-cyclin complexes tested in vitro. It is interesting 
to note that, in vitro, the cdkl-cyclin B complex is inhibited by p21 less efficiently 
than the cdk2-cyclin A complex (Basi and Draetta, 1995). p21  also inhibits the cdk2-
cyclin E complexes necessary for the early events in DNA replication (Jackson et al., 
1995; Hartwell and Kastan, 1994). Structural studies of the p21 protein have provided 
an explanation based on conformational changes for the mechanism that regulate the 
binding diversity of p21 (Kriwacki et al., 1996). 
The presence of PCNA in the cdkl-cyclin complex is not well understood. It has been 
proposed that the function of PCNA may be to signal the presence of DNA damage 
or other signals. The fact that this complex of PCNA, p21 and cdkl-cyclin B does 
not exist in transformed cells where S and M are still coupled, may indicate that it 
plays an important role in the process of cell transformation, but that it is probably 
not essential for the regulation of MPF (Basi and Draetta, 1995). 
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1.5.1 The dependence of mitosis on S phase 
The succession of the different cell cycle phases is regulated in eukaryotes by the cell 
cycle checkpoints. Checkpoints are molecular controls which act at specific points of 
the cell cycle and prevent entry into the subsequent phases of the cell cycle if the 
preceding phase has not been properly completed. Thus, in order to proceed into 
mitosis, a checkpoint control monitors that S phase has been completed. If DNA 
damage is present, for example, entry into mitosis is delayed until the DNA has been 
repaired or DNA replication has been completed. However, little is known about the 
precise mechanisms which monitor the presence of unreplicated or damaged DNA, and 
how this signal is then transmitted to the cell cycle regulation machinery (Basi and 
Draetta, 1995). 
In a normal cell cycle, a type-2A phosphatase, regulating the cdc25 and the weel 
activities, is gradually inactivated during the G2 phase (Basi and Draetta, 1995). Due 
to the balance between the activity of kinases and phosphatases, the inhibition of the 
type-2A phosphatase results in the inactivation of weel and the activation of cdc25. 
cdc25 then induces the dephosphorylation of cdkl (Coleman and Dunphy, 1994), which 
brings about the activation of preMPF and entry into mitosis. If DNA synthesis is 
inhibited, a feedback control mechanism blocks inactivation of the type-2A phosphatase 
until DNA replication is completed (Basi and Draetta, 1995). Another checkpoint 
could be in charge of controlling the activity of weel by regulating the kinase which 
phosphorylates and inactivates weel (Coleman and Dunphy, 1994). Furthermore, it has 
been suggested that it is possible that other checkpoints exist which are independent 
of the regulation of cdkl on tyrosine. In this model, PCNA and p21 could function as 
signalling molecules detecting DNA damage (Basi and Draetta, 1995). 
G21M DNA damage checkpoint 
The G2/M checkpoint monitors completion of DNA synthesis and the presence of 
DNA damage. This is a replication—dependent checkpoint which prevents mitosis by 
inactivating cdkl (Lees and Harlow, 1995). Delay in passage through G2 results in 
a postponement of mitosis and cell division, and has been observed in all eukaryotic 
organisms examined, including ciliates, fungi, algae, flowering plants, slime moulds, 
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sea urchins, insects and mammals (Rowley, 1998). 
Early studies of G2 delay in mammalian cells resulted in the accumulation of a number 
of data that can be summarised as follows (Rowley, 1998): 
• Irradiation of growing cells results in a delay in entering mitosis, which depends 
on the radiation dose (55 min delay/Gy in Chinese hamster ovary cells), the 
degree of cellular differentiation (mouse intestinal crypt cells) and the phase of 
the cell cycle (V79 hamster and HeLa cells). 
From experiments with HeLa cells it was seen that once the cell has entered 
mitosis, it is no longer delayed in that cell cycle. 
• Studies carried out with CHO cells to pinpoint the precise position of the G2 
arrest in the cell cycle have shown that G2 delay happens 49 minutes before 
completion of cell division, 17 minutes before metaphase and 18 minutes after 
cycloheximide transition point (the point in the cell cycle after which this protein 
synthesis inhibitor cannot delay entry into mitosis). 
The first attempts to characterise the molecular mechanisms behind the G2 arrest 
showed that G2 delay required protein and mRNA synthesis (Rowley, 1998). Studies 
performed using caffeine (which was known to sensitise bacteria to UV—induced dam-
age) showed that mammalian cells were also sensitised to radiation upon treatment 
with caffeine, and CHO cells exposed to it immediately after irradiation are not de-
layed in G2 (Rowley, 1998). What is more, if caffeine is administered to CHO cells 
immediately after irradiation and then removed after an interval of as long as 12 hours, 
a period of delay follows that is identical in length to that observed in cells that have 
not been treated with caffeine. It seems that caffeine not only blocks the expression of 
the delay, but also preserves the damage that gives rise to it, allowing the expression of 
delay on caffeine removal. Caffeine may be sensitising these cells to DNA damage at 
two levels: indirect inhibition of repair via abolition of checkpoint controls and direct 
inhibition of repair functions, perhaps by binding sites of damage, as hypothesised for 
UV—irradiated bacteria (Rowley, 1998). 
No mammalian cell mutant has yet been identified that is defective for G2 delay alone, 
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so additional drug treatments and other manipulations are required for the determina-
tion of the effects of losing the G2 checkpoint. When caffeine treatment is combined 
with the method of mitotic selection (mammalian cells usually round up upon entry 
into mitosis, so it is usually possible to select for mitotic cell subpopulations by shaking 
the culture flask and selectively detaching cells in M) it is possible to measure survival 
after irradiation of those cells that were treated in G2 and delayed or failed to delay 
at G2. Cells that received caffeine immediately and continuously after irradiation (X-
rays) were radiosensitive to killing and showed the same radiosensitivity as mitotic cells. 
These cells also showed increased number of achromatic gaps, deletions and exchanges. 
However, if an interval was allowed before the addition of caffeine, permitting a period 
of delay, aberration frequencies declined with the length of the interval (Rowley, 1998). 
Assuming that chromosome aberrations result from DNA double-strand breaks, and 
because caffeine prevents the repair of chromosomal aberrations, the caffeine should 
reduce the rate of DSB repair. This seems to suggest that the G2 checkpoint, DNA 
damage repair and chromosomal integrity are intimately related. Indeed, it has been 
shown that DNA damage itself, i.e., the induction of a single DSB in the genome of the 
budding yeast, is sufficient to induce a cell cycle delay, arguing for the fact that DNA 
damage does initiate the G2 arrest and that the delay provides time for the repair of 
DNA damage, prior to chromosome segregation (Rowley, 19981. Consistent with this 
result, Chinese hamster cells deficient in the repair of DSBs suffer abnormally long 
delays in G2 (Rowley, 1998). 
The proteins involved in the G2 delay biochemical pathway are likely to include cdc25, 
cdkl itself, or the tyrosine kinase weel. PCNA and p21 may also exert an additional 
regulatory role on cdkl, but this still remains a hypothesis and the pathway that 
PCNA/p21 use to regulate cdkl also remains uncharacterised. The fact that these two 
factors play a key role in the S phase regulation, makes their possible involvement in 
the coupling of S and M a plausible option (see Replication, section 1.2 and Cell Cycle 
Control II, section 1.6). Studies of specific overexpression of p21 in mouse liver, where 
hepatocytes overexpressing p21 showed a phenotype that included increased levels of 
polyploidisation, led Wu et al. to postulate that the p21-overexpressing hepatocytes 
may be arrested at G2 and that p21 may be playing a role in the mechanism of this delay 
(Wu et al., 1996). The fact that the phenotype of the liver of the p21-overexpressing 
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mice closely resembles that of the ERCC1—deficient mice may also provide an additional 
link between p21, DNA repair (NER) and control of the cell cycle at G2. 
1.6 Cell Cycle Control II: Progression through S 
1.6.1 Initiation events within S phase 
It is possible that replication might be controlled in the cell cycle by limiting the 
availability of the factors required at the replication fork. However, most replication 
factors are present in the cell throughout the cell cycle. This is due in part to the fact 
that many of the factors involved in replication are also involved in other processes, 
such as DNA repair. This probably means that replication must be controlled by a 
relatively small number of S phase—inducers whose function is to regulate when and 
where initiation of replication takes place 8 . 
Through fusion studies it was possible to determine that S phase—inducers can only act 
on Gi nuclei and cannot induce G2 nuclei to undergo another round of DNA replication. 
In S phase/G2 and G1/G2 HeLa cell fusions the G2 nuclei did not replicate until 
after passage through mitosis, which suggested that the absence of DNA replication in 
normal G2 cells is not due to the presence of diffusive inhibitors in the G2 cytoplasm 
and that there were specific mechanisms for the prevention of re—replication of the G2 
nuclei (Blow, 1995)(see below). 
Gi and S phase nuclei in G2 cytoplasm replicated normally. This suggests that pro-
gression of events in S phase does not require cytoplasmic factors to proceed in an 
ordered fashion. What is more, fusion of Gi and late S cells caused the Gi nuclei to 
enter S phase prematurely, with replication patterns of nuclei in early S phase, rather 
than in late S phase (Blow, 1995). This suggested that the S phase—inducers present 
in the cytoplasm induce responsive nuclei to undergo the normal sequence of S phase 
event, but are not themselves responsible for dictating the stage of replication the 
nucleus should undergo. 
8  For a complete review on the subject of cell cycle control, it is recommended to read Cell Cycle 
Control, Hutchinson and Glover editors, 1995. The data for this section have been taken from Blow, 
1995. 
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In summary, replication control can be divided in two distinct components: the DNA 
template in the nucleus (see Replication section 1.2), and activities in the cytoplasm 
which act on this nuclear template. The nucleus can be in two different states: respon-
sive or not responsive to the S phase-inducers by undergoing DNA replication. Also, 
the cytoplasm provides two types of activity, one that induces a responsive (Gi) nu-
cleus to undergo S phase (S phase-inducers), and another (related to passage through 
mitosis) that changes a refractory G2 nucleus into a responsive Gi nucleus (Blow, 
1995). Once replication is initiated, the S phase proceeds through the different stages 
of DNA replication (including initiation at early- and late-firing origins) without the 
need for specific signals from the cytoplasm. 
1.6.2 Prevention of re—replication in a single S phase 
As mentioned before, fusion experiments on HeLa cells showed that only G 1 nuclei 
can initiate DNA replication in response to cytoplasmic signals. G2 nuclei on the 
other hand must go through mitosis in order to regain responsiveness to these sig-
nals. However, if G2 nuclei, in a Xenopus cell-free system, were allowed to progress 
into mitosis and undergo subsequent nuclear envelope breakdown and chromosome 
condensation, they were then capable of undergoing a further round of replication. 
Some metaphase function therefore permitted G2 nuclei to revert to the responsive Gi 
state (Blow, 1995). What is more, agents that caused nuclear envelope permeabilisa-
tion, such as lysolecithin or phospholipase, rendered the G2 nuclei responsive to the S 
phase-inducers and capable of re-replication in fresh extract (Blow, 1995). 
A model has been put forward that explains these results (Blow, 1995; Blow, 1993). 
An essential replication factor called 'Licensing Factor', can bind to the DNA during 
late mitosis or early interphase before nuclear assembly has occurred. Since Licensing 
Factor cannot cross the nuclear envelope, once the nuclear assembly is complete it is 
only present in the nucleus where bound to DNA. On entry into S phase, each molecule 
of Licensing Factor supports a replication initiation event after which it is destroyed or 
inactivated. Therefore, in G2 there is no active Licensing Factor present in the nucleus, 
and the nuclear envelope has to be transiently permeabilised to allow a further round 
of DNA to happen. 
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Experiments using Xenopus extracts have also shown that Licensing Factor activity 
can be inhibited by the addition of the protein kinase inhibitor 6-dimethylaminopurine 
(6-DMAP) prior to exit from metaphase, resulting in a block of the initiation of repli-
cation (Blow, 1995; Blow, 1993). Licensing Factor levels are low during the early 
stages of mitosis and they rise suddenly shortly after the metaphase-anaphase tran-
sition, allowing the decondensing telophase chromosomes to become licensed before 
completion of nuclear assembly. This abrupt appearance of Licensing Factor does not 
require protein synthesis, so it has been proposed that Licensing Factor is in fact a 
post-translational modification of a protein that is already present (Blow, 1995). This 
post-translationally modified protein is probably the real target of 6-DMAP (Blow, 
1993). Licensing Factor that remains cytoplasmic and has not bound DNA probably 
becomes unstable and is degraded by mid-S phase, where it has disappeared. 
However, there is little evidence on the molecular mechanisms of DNA re-replication 
control. Studies with drugs that induce chromosome replication in the absence of 
intervening mitosis, such as trichostatin A, leptomycin B and staurosporine-analogue 
protein kinase inhibitors, have provided one line of experimental evidence on this mech-
anism in mammalian cells. Uncoupled cell cycle without mitosis has been reported to 
occur through the action of a chemical that inhibits protein kinase activity, K-252a 
(Usui et al., 1991). Treatment of rat diploid fibroblasts with K-252a results in the ac-
cumulation of cells with high ploidy values (8C and higher, depending on the cell line 
used), and concomitant with this, although weak cdkl activity is seen during 5, cdkl 
activity is not detected during M. Thus, it appears that cdkl-cyclin B and cdkl-cyclin 
A complexes may play a role in the control of the re-replication process (Kearsey et al., 
1996), and indeed, there have suggestions that cdkl may be the responsible factor for 
what has been termed 'G2 memory' (Usui et al., 1991). Briefly, G2 memory is what 
tells cells that replication (S phase) has taken place and that, in the absence of mitosis, 
should not happen again. These observations are supported by genetic experiments in 
fission yeast which have shown that cdkl-cyclin B complexes mark the cell in the G2 
state (O'Connell and Nurse, 1994). Temperature sensitive mutations in cdc13 (a B-
type cyclin) or cdkl cause increase in ploidy resulting from multiple S phases without 
mitosis (O'Connell and Nurse, 1994). Deletions of the cdc13 gene cause the cells to 
accumulate with grossly enlarged nuclei containing up to a 32C DNA content (Hayles 
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et al., 1994). 
Cyclin G and p21 have also been implicated in the regulation of G2/M transition 
in primary cultured and immortalised rat fibroblasts in response to DNA damage 
(Shimizu et al., 1998). What is more, there is increasing evidence that p21, along 
with the mitotic kinases cdk2 and cdkl-cyclin B complexes, plays a role in the control 
of re-replication (Bates et al., 1998; Guadagno and Newport, 1996). Absence of p21 
has been shown to cause diploid cell lines derived from the human colorectal cancer 
cell line HCT116 to undergo re-replication in the presence of DNA damage (Waldman 
et al., 1996). These cells acquire grossly deformed, polyploid nuclei and subsequently 
die through apoptosis (Waldman et al., 1996). Paradoxically, overexpression of p21 in 
liver (Wu et al., 1996) seems to have the same effect on mouse hepatocytes in that 
hepatocytes overexpressing p21 seem to undergo polyploidisation (Wu et al., 1996). In 
addition, pRb (the retinoblastoma protein), as part of the p21 regulatory pathway, has 
recently been implicated in preventing endoreduplication in human cells (Niculescu III 
et al., 1998). The exact role of p21 and the precise mechanisms involved in this process 
remain unknown. 
Polyploidisation in mammalian liver 
Although re-replication of DNA in the absence of mitosis to give rise to polyploid nu-
clei is something that in most cells does not occur, polyploidisation in the parenchymal 
cells of the livers of adult mammals has long been recognised. However, the physiolog-
ical significance of this process is still a matter of speculation (see Chapter 3, section 
3.3 for additional information) and the biochemical bases of polyploidisation remain 
a mystery. It is generally assumed that polyploidisation is a hormonally regulated, 
age-related process which varies according to the mammalian species under study 
(Medvedev, 1986). The patterns of polyploidisation in rat and human liver are similar 
but they differ from that of the mouse. In fact, the periods of polyploidisation in hu-
man liver are restricted to the periods of active growth and development and, contrary 
to the situation in mouse liver, polyploidisation of human hepatocytes at the end of 
the growth period does not attain as high levels as in the mouse (Kudryavtsev et al., 
1993). In addition, unlike the situation in mouse liver, a rapid increase in the number 
of binucleate cells and accumulation of high ploidy levels in hepatocytes are not typ- 
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ical of the human liver during the postnatal liver growth period (Kudryavtsev et al., 
1993). In rat the polyploidisation pattern of hepatocytes is progressive only until 12-14 
months of age and does not continue into senescence. There are no further changes 
in the polyploidisation of rat hepatocytes between 14 and 27 months of age where 
the average DNA content corresponds to that of tetraploidy. Overall, the polyploidi-
sat ion patterns of rat and human livers are very similar and differ significantly from 
the pattern followed by hepatocytes from the mouse liver, where the accumulation of 
hepatocytes with increasing ploidy continues even during senescence. The senescence 
period in mice (age between 14 and 28 months) also coincides with the accumulation 
of 8C, 16C and 32C nuclei. Even during the later stages of senescence (28-33 months 
of age) when the liver biomass starts to decline there is a continuing accumulation of 
highly polyploid 32C and 64C hepatocyte nuclei (Medvedev, 1986). 
1.6.3 G1/S damage checkpoint 
S phase delay 
It has already been discussed in the Replication section 1.4 that cells that have been 
irradiated in S show a temporary inhibition of replication and 'that the degree and 
duration of the delay are dose—dependent. It has been observed in normal human 
diploid fibroblasts that the radiation dose—response curve is biphasic and that doses 
of 10 Gy and below inhibit uptake of tritiated thymidine more effectively than doses 
above 10 Gy (Rowley, 1998). If the incorporation of radioactivity into the newly 
synthesised DNA was measured in these cells 30 minutes after irradiation (5 and 20 Gy), 
a strong inhibition was observed in irradiated cells, suggesting that the inhibition occurs 
preferentially at the initiation of replication. It is possible that the biphasic nature of 
the dose—response curve arises from the differential radiosensitivity of initiation vs 
elongation of the daughter DNA molecule. 
Is this suppression of initiation, elongation or both the result of a checkpoint? Muta-
tions in the ATM gene (this gene is found mutated in AT patients), alters the shape 
of the radiation—response curve for inhibition of replication. In fact, it has been shown 
that in AT cells, inhibition of DNA replicon initiation does not occur. The existence 
of this mutant argues in favor of a checkpoint—mediated mechanism for the inhibition 
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of replicon initiation (Rowley, 1998). 
As with G2 delay, S phase or replicon initiation delay in HeLa and V79 cells, is abolished 
by continuous caffeine treatment and postponed by finite treatments. Thus, elongation 
of daughter DNA continues after irradiation, as observed for AT cells. The mechanisms 
involved in this caffeine effect are not well understood (Rowley, 1998). 
As with the G2 checkpoint, no mammalian cell mutant is known that is defective for 
the replicon initiation checkpoint only, and nothing is known of the consequences of this 
particular checkpoint defect. It has been speculated, however, that the role of replicon 
initiation delay is to allow repair of DNA lesions before replication is initiated. This 
repair would be relatively error—free as opposed to post—replication repair of chromatid 
breaks (see Replication section 1.2). 
Painter has suggested that a single DNA DSB in a replicon cluster may result in the 
deformation of the chromatin structure in that domain and that this acts to signal the 
DNA synthesis delay (Painter, 1986), but the actual nature of this arrest still remains 
speculative. The molecular mechanisms responsible for this delay are not yet known 
either. In mammalian cells, the only gene known that is required for the S phase 
checkpoint control is ATM, but very little is known about this gene or its function, 
apart from the fact that p53 stabilisation in response to ionizing radiation in AT cells 
is impaired. 
Gi delay 
In normal cells there are at least two pathways that are used as regulation points where 
DNA damage leads to arrest. On of them, the G2/M checkpoint has been discussed in 
the Cell Cycle Control I section 1.5. Whereas the G2/M checkpoint is best understood 
in yeast, the Gi checkpoint is best understood in mammals. 
Recent work has implicated the tumour suppressor gene p53 as a key player in the Gi 
cell cycle checkpoint in mammalian cells. Levels of p53 protein are elevated in response 
to DNA damage induced by a number of agents (Lees and Harlow, 1995). Tumour 
cells lacking p53, or having a dominant mutation in p53, are defective in their cell 
cycle progression delay at Gi in response to ionizing radiation. By restoring wild type 
p53 function in these cells the delay is also restored, and addition of dominant mutant 
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p53 to wild type cells prevents delay. The mechanism of p53 action is not completely 
understood, but at least it is known the chromosomal breaks lead to increased levels of 
p53. It appears that the point in Gi at which cells are delayed by the p53-dependent 
checkpoint control coincides with the restriction point, that is, the point in the cell cycle 
beyond which the cell commits to division and loses the potential to differentiate, or 
enter a state of quiescence. This is based on observations that the activities of cdk4 
and cdk6 can be modulated by p53 (see below). These two cdks associate with D-
type cyclins and they appear to be part of a restriction point since their expression 
influences the duration of G1 and the cellular dependence on mitogens (Rowley, 1998). 
In addition it has been shown that tyrosine phosphorylation of cdk4 is required to 
block cells in Gi after UV irradiation. 
Apparently the p53-dependent delay in Gi following DNA damage can be abolished 
by caffeine, but the effective concentration seems to be cell-line-independent (Rowley, 
1998). If this is true, it means that there is a caffeine susceptible checkpoint-control 
component that mediates delays in all three phases of interphase (see previous sections). 
As explained and discussed in the Replication section 1.2, treatment of cells with 
cycloheximide , which inhibits cell progression, before cells are irradiated , results in 
an increase of cell survival with increasing time to release from the cycloheximide-
induced arrest. This suggests that if cells are given time before progress into S phase, 
the cells are capable of repairing the damage. Surprisingly, loss of G1 checkpoint control 
does not seem to result in an increase of radiation induced killing. This paradox has 
an explanation in the fact that cells that fail to arrest in Gi go on to delay longer 
at subsequent checkpoints in S phase or G2, allowing for repair to take place then. 
A p53-deficient MCF-7 cell population has been shown to arrest at G2 with higher 
frequency (cells are arrested at G2 at 16 hours after 6.3 Gy) than the p53 wild-type 
population (Fan et al., 1995). 
Failure to delay in G1 increases the frequency of gene amplification in irradiated cells 
(Rowley, 1998). Gene amplification occurs at a rate of 10 5-10 3 in cells without 
a functional p53-dependent checkpoint control and at an undetectable rate in normal 
diploid fibroblasts (Rowley, 1998). It has been proposed that failure to delay in Gi after 
DNA damage leaves insufficient time for repair of chromosome breaks. Such breaks may 
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then be replicated upon passage through S phase, by joining sister chromatids, with 
consequent bridge formation in mitosis, non-disjunction and the unequal segregation 
of specific genes. Repetition of this process leads to gene amplification. Therefore, 
repair in Gi is relatively error-free compared to repair in G2, when the break has 
already been replicated. Mice lacking both copies of p53 develop relatively normally, 
but they develop tumours by 6 months of age, which confirms the relationship between 
increased genomic instability and predisposition to cancer. p53 mutations are found in 
50% of all known human tumours. A number of cancer-prone syndromes exist, i.e., Li-
Fraumeni syndrome, Fanconi's anaemia, Werner's syndrome, Bloom's syndrome and 
ataxia-telangiectasia (AT)(also see Premature ageing section 1.1.5 and Chapter 6), 
that provide evidence that links genetic instability to DNA damage repair mechanisms, 
DNA damage recognition pathways and cell cycle control regulation. In particular, 
AT points directly towards a direct role of p53 in these processes. AT is caused by 
a recessive mutation that inactivates the feedback mechanisms that regulate DNA 
replication in irradiated cells. Cells from these patients are unable to induce p53 
stabilisation in response to ionizing radiation. These results point towards a defect in 
the signal transduction pathway that involves p53 and that controls cell cycle arrest 
following DNA damage. 
G1 delay is observed after irradiation (either UV or ionizing), treatment with topoiso-
merase II inhibitors, a DNA restriction enzyme, alkylating agents, depleted medium, 
heat or hypoxia. Thus, Gi delay seems to be induced by a wide variety of factors, in-
cluding DNA damage. p53 in particular is induced by agents that either induce DNA 
damage directly (ionizing radiation) or initiate processes such as repair or replication, 
which lead to the formation of DNA strand breaks (Nelson and Kastan, 1994). 
Most theories support the idea that the Gi arrest consist of two major components: 
a detector of DNA damage and an effector of progression arrest. The effector for the 
induction of the Gi delay in response to DNA damage is most likely to be a cdk. The 
detector remains unknown, but there are candidate proteins such as the Ku protein 
and the associated double-stranded DNA-dependent protein kinase (DNA-PK). Signal 
transduction factors may include p53 and also the ATM gene. 
Various reports support the idea that levels of p53 protein increase after DNA damage 
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in a variety of cells (Abrahams et al., 1995; Reinke and Lozano, 1997; Poon and Hunter, 
1998; Li et al., 1996; Nelson and Kastan, 1994; Lu and Lane, 1993; Dumaz et al., 1998; 
Maltzman and Czyzyk, 1984). The DNA damage-induced stabilisation of p53 seems 
to be brought about by blocking a ubiquitin-dependent p53 degradation pathway. 
p53 regulation is defective in AT cells, suggesting that ATM protein Kinase regulates 
p53 levels. A total of 10 phosphorylation sites have been identified in rat p53 (Rowley, 
1998). MAP kinase, casein kinase I, casein kinase II (CKII) and cdkl can phosphorylate 
p53. Mutation of the CKII site results in loss of growth suppression by p53, and both 
DNA-PK and CKII can promote tetramerisation of p53, a conformation required for 
DNA binding, although defects in DNA-PK do not seem to affect p53 stability, since 
p53 function is normal in SCID mouse fibroblasts (deficient in DNA-PK function). 
Phosphorylation of serine-12 by cdkl modulates the nuclear localisation signal of p53 
(Rowley, 1998). 
Downstream effectors of p53 function are better characterised. p53 is a transcription 
factor, and its stabilisation results in the transcriptional activation of key regulatory 
genes, which in turn play a direct role in the arrest of cell cycle progression. One of 
the best understood p53-induced genes is p21. As mentioned before, p21 physically 
associates with cdk-cyclin complexes whereby inactivating the kinase activity of these 
cdk-cyclin complexes. The direct involvement of p53 in the transcriptional induction 
of p21, brought about by the existence of p53-responsive elements in the p21 promoter 
region, links p53 directly to the cell cycle. p53 is therefore a key 'connector' between 
DNA damage and inhibitory regulation of the cell cycle at the GuS transition. 
If the Gi delay provides time for repair of DNA damage, then a system to coordinate 
repair and progression seems likely to exist. As shown before, in normal mammalian 
cells p21 is found complexed with a cyclin, a cdk and most importantly in the context 
of DNA repair, with PCNA. PCNA, apart from being an essential component of the 
repair machinery (see Replication section 1.2) and being found at sites of replication, 
can also be found at putative sites of DNA repair following irradiation (Rowley, 1998). 
p21 directly blocks PCNA-dependent DNA synthesis and activation of polymerase-8 
(Waga et al., 1994) and Li et al. showed that although p21 blocks replicative DNA 
synthesis, it allows PCNA to function in DNA repair (Li et al., 1994b). Each type of 
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p21 inhibitory function requires different domains in the p21 protein, i.e., inhibition of 
cdk activity by p21 required the amino-terminal, whereas inhibition of PCNA function 
required the carboxy-terminal residues of p21 (Chen et al., 1995). Like p21, GADD45 
is induced by ionizing radiation in a p53-dependent manner and associates with PCNA 
(Rowley, 1998). When GADD45 was removed from an in vitro excision repair reaction, 
by immunodepletion, the rate of repair was decreased (Smith et al., 1994). However, 
the precise role of GADD45 is not known, but it is likely that it interacts with and 
inactivates a form of PCNA required for DNA replication, thus blocking entry to 
S phase while simultaneously stimulating repair (Rowley, 1998). GADD45 can be 
induced by UV or MMS, but not ionizing radiation, in the absence of a functional p53 
protein (Rowley, 1998). 
1.7 Aims 
The aim of this thesis is to use histology, cytology and biochemistry to find a model that 
links cellular processes such as DNA repair, cell cycle control and cellular differentiation 
and senescence in order to explain the phenotype seen in the livers of ERCC 1-deficient 
mice. In order to do so a number of different approaches have been brought together, 
from liver morphology, immunohistochemistry and immunocytochemistry studies, to 
in vitro biochemical studies of different UV-induced damage responses in primary and 
transformed fibroblasts. A subsidiary aim of this thesis is to investigate the possibility 
of the existence of a human disease related to a defect in ERCC1. The human disease 
chosen for this study has been the premature ageing syndrome Hutchinson-Gilford 
progeria. The ERCC1 status in the progeria fibroblasts as well as the response of 
progeria cells to DNA damage have been assessed. 
Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Suppliers of laboratory reagents 
Restriction endonucleases and other nucleic acid modifying enzymes 
• Boehringer Mannheim PLC. 
• GIBCO BRL Life Technologies. 
New England Biolabs Inc. 
Pharmacia LKB Biotechnology. 
Standard laboratory reagents 
• BDH Chemicals Ltd. 
• Fisons Chemicals. 
• GIBCO BRL Life Technologies. 
• ICN Flow Ltd. 
• Sigma Chemical Co. 
• New England Biolabs Inc. 
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Reagents for cell culture 
. GIBCO BRL Life Technologies. 
• ICN Flow Ltd. 
. Sera-lab Ltd. 
• Sigma Chemical Co. 
Radioactive reagents 
• [a _32  p] dCTP 3000 Ci/mmol, Amersham Redivue 
• [methyl - H] Thymidine 25 Ci/mmol, Amersham Life Science 
Antibiotics 
• Penicillin G, Sigma Chemical Co. 
• Streptomycin, Sigma Chemical Co. 
Primer synthesis 
• Perkin-Elmer Ltd. 
• Oswel DNA service 
Antisera 
Primary antibodies 
1. Anti ERCC1 antibodies. These antisera were kindly donated by Dr. Richard 
Wood, ICRF, Clare Hall laboratories. 
• RW09: rabbit polyclonal against a synthetic ERCC1 peptide (aa282-aa294) (R. 
Wood personal communication). 
• RWO17: rabbit polyclonal against the whole human protein expressed in E. 
coli (R. Wood personal communication). 
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XPF (ERCC4) antibody. This antiserum was kindly donated by Dr. Richard 
Wood, Clare Hall laboratories. 
• RA1: rabbit polyclonal raised against the C-terminal half of XPF (ex-
pressed in E. eoli)(R. Wood, personal communication). 
Anti p53 antibody 
Ab-7: sheep polyclonal raised against human p53 (expressed in E. coli) (Oncogene 
Research Products) 
Anti ligase antibodies were kindly provided by Dr. Tomas Lindahl and co-
workers, ICRF, Clare Hall laboratories. 
• TL6: rabbit polyclonal raised against a conserved peptide in the C-terminus 
of Ligase I (Tomkinson et al., 1990). 
• TL18: rabbit polyclonal antibody raised against a peptide in the C-terminus 
of Ligase IV (Tomas Lindahi, personal communication). 
• TL25: rabbit polyclonal antibody against recombinant full length human 
DNA ligase III (Tomas Lindahi, personal communication). 
Vimentin antibody. Vimentin is an intermediate filament protein (MW 57 kDa) 
of mesenchymal cells. It is used as a fibroblast marker. 
• Vim3B4: mouse monoclonal against the whole purified bovine protein (Bradsure 
Biologicals Ltd.). 
Anti BrdU antibody, 
• MAS250: rat monoclonal; clone BU1/75 (Harlan, SeraLab) 
Anti Ki67 antibody, 
• MI131: rabbit polyclonal; clone MIB-1 (Immunotech) 
Centromeric staining antibodies: These 3 antibodies were kindly donated by 
Prof. William Earnshaw, Edinburgh University. 
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• NR: Antiserum obtained from a patient with scieroderma. NR recognises 
the centromeric proteins Cenp A, B and C. NR stands for the name of the 
rheumathologist who supplied the serum, Naomi Rothfleld (Earnshaw and 
Rothfield, 1985). 
• Biotin-conjugated anti-human IgG. 
• Streptavidin-conjugated Texas Red tertiary antibody. 
Secondary antibodies 
Biotinylated rabbit anti-sheep IgG: Calbiochem (Oncogene Research Products) 
Biotinylated goat anti-rabbit IgG: Calbiochem (Oncogene Research Products) 
Biotinylated swine anti-rabbit IgG: DAKO Ltd. 
Tertiary reagents 
Streptavidin: as part of the StreptABComplex/HRP kit (DAKO Ltd.) 
Biotinylated Horseradish Peroxidase: as part of the StreptABComplex/HRP kit 
(DAKO Ltd.) 
2.1.2 Standard buffers and solutions 
• 20x SSC: 3 M NaCl; 0.3 M tn-sodium citrate, pH 7.0 
• lOx TBE: 0.9 M 'flis-HCl; 0.9 M boric acid, 20 mM EDTA,pH 8.0 
• TE: 10 mM Tris-HC1, 0.1 mM EDTA, pH 8.0 
• PBS: 8 mM K2HPO4, 1.5 mM KH2PO4, 150 mM NaCl 
• TBS: 12.5 mM Tris.HC1, pH7.6, 150 mM NaCl 
• TBST: 12.5 mM Tnis.HC1, pH7.6, 150 mM NaCl, 0.01-0.5% (v/v) Tween 20 
• lOx MOPS: 200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA, pH 7.0 
• Lysis Buffer (Protein Extraction): 125 mM Tnis pH7, 33 mM DTT, 2% SDS, 2 
mM PMSF, 2mM EDTA, pH 8. 
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• Denaturing Buffer: 0.5 M NaOH, 1.5 M NaCl 
• Neutralising buffer: 3 M NaCl, 0.5 M Tris.HC1, pH 7.0 
. Scintillation Fluid: 2.5 ltr Toluene, 15 g PPO (2,5-Diphenyloxazole), 0.4 g 
POPOP (1 ,4-bis[5-Phenyl-2-oxazolyl]benzene; 2,2'-p--Phenylene-bis[phenyloxazole]) 
PCA: 25 parts redistilled phenol, 24 parts chloroform, 1 part isoamyl alcohol 
. CA: 24 parts chloroform, 1 part isoamyl alcohol 
• Tail buffer: 300 M sodium acetate, 10 mM Tris-HC1, 1 mM EDTA, 1% SDS 
• 1 xProtein electrophoresis buffer: 20 mM Tris, 192 mM Glycine, 0.1% SDS, pH 
8.3 
. 10xPCR buffer: 50 mM KC1, 1.5 MM M902, 10 mM Tris-HC1 pH 8.3, 0.01% 
(w/v) gelatin, 0.45% (v/v) Triton X-100, 0.45% (v/v) Tween 20 
2.1.3 Cell culture media and cell lines 
Fibroblast culture medium 
• Normal fibroblast culture medium: 10% (v/v) Foetal Calf Serum (FCS) or 20% 
(v/v) FCS in the case of AG08466 primary fibroblasts, 1 x non-essential amino 
acids, 25 U/ml penicillin, 1 mM sodium pyruvate, 25 Mg/ml streptomycin. 
• GMEM Serum-free fibroblast culture medium: 1 x non-essential amino acids, 25 
U/mi penicillin, 1 mM sodium pyruvate, 25 fig/ml streptomycin, in GMEM. 
Freezing medium for long term storage of cells 
This medium consisted of the appropriate supplemented culture medium with addi- 
tional DMSO and FCS to final concentrations of 10% (v/v) and 20% (v/v) respectively. 
Cell lines 
• 46BR.1G1: SV40 transformed human fibroblast cell line with aberrant DNA 
iigase I activity (Webster et al., 1992). 
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• MRC5V1: SV40 transformed wild-type human fibroblast cell line (Huschtscha 
and Holliday, 1983). 
o PF20: Spontaneously immortalised wild type mouse embryonic fibroblast cell 
line (Melton et al., 1998). 
PF24: Spontaneously immortalised ERCC1-deficient/HPRT-deficient mouse em-
bryonic fibroblast cell line (Melton et al., 1998). 
• CH09: Immortalised wild type Chinese hamster ovary cell line, which is a sub-
clone of the CHO-KK cell line (Burki et al., 1980). The cells used in the repli-
cation experiments carried out in Cambridge (see Methods below), were kindly 
donated by S. Squires and R. Johnson, Zoology Dept., Cambridge University. 
The cells used in Edinburgh were kindly donated by Richard Wood, ICRF, Clare 
Hall. 
• CHO 43-3B: Immortalised ERCC1-deficient Chinese hamster ovary cell line, de-
rived from the parental CH09 cell line (Wood et al., 1982). The cells used in 
the replication experiments carried out in Cambridge (see Methods below), were 
kindly donated by S. Squires and R. Johnson, Zoology Dept., Cambridge Univer-
sity. The cells used in Edinburgh were kindly donated by Richard Wood, ICRF, 
Clare Hall. 
• CHO AA8: Immortalised wild type Chinese hamster ovary cell line (Thompson 
et al., 1980). Kindly donated by S. Squires and R. Johnson, Zoology Dept., 
Cambridge University. 
• CHO UV5: Immortalised ERCC2-deficient Chinese hamster ovary cell line, de-
rived from the parental CHO AA8 cell line (Thompson et al., 1981). Kindly 
donated by S. Squires and R. Johnson, Zoology Dept., Cambridge University. 
• A2780: Human ovarian adenocarcinoma cell line. Epithelial morphology (Behrens 
et al., 1987). 
• AG08466: Human primary skin fibroblast isolated from a patient diagnosed with 
Hutchinson-Gilford syndrome. Obtained form the N.I.A. ageing cell culture 
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repository, Coriell Institute for Medical Research, 401 Haddon Ave., Camden, 
NJ 08103. 
2.1.4 Miscellaneous 
Proteinase K (PK): 5 mg/ml in d.11 2 0 (Boehringer Mannheim), stored at 4°C. 
• Trypsin: 0.025% (w/v) trypsin (ICN Flow, Cat No. 043-5090), 1 mM EDTA, 
1%(v/v) chicken serum (ICN Flow Cat No.29-501-49) in lx PBS. 
50x DAB (3,3' Diaminobenzidine): 125 mg in 5 ml d.H2 0, aliquoted in 100 Ml 
aliquots and stored at -20°C. 
2.2 Methods 
2.2.1 Isolation of primary embryonic fibroblasts 
Dissection of conceptuses 
Plugged females were killed on the required day of embryonic development, and the 
uteri were dissected out of the body cavity. The muscle layer of the uterus was removed, 
along with the Reichert's membrane and placenta, to leave the embryo and visceral 
yolk sac. Embryos were incubated in trypsin and disaggregated for embryonic fibroblast 
isolation. 
Isolation of mouse embryonic fibroblast cultures 
Primary fibroblasts were isolated from E10.5 or E11.5 embryos. Following dissection, 
embryos were incubated in 0.5 ml trypsin for 30 minutes at 37°C. 15 mls of medium 
were added, the embryo mechanically disaggregated with a pipette, and cells plated 
out into 90 mm dishes. 
Growth of mammalian fibroblasts 
Cells were maintained in supplemented GMEM at 37°C in a 5% CO2 atmosphere in a 
humidified tissue culture incubator (Forma Scientific). To passage cells, the medium 
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was aspirated, the bottom of the flask rinsed with 1-2 mis of trypsin, then a further 
1-2 mis of trypsin added and incubated at 37°C until the cells had become detached. 
Thereupon 5 volumes of medium were added, and the cells pelleted by 5 minutes 
centrifugation at 1,300 rpm. The supernatant was discarded, and the cells resuspended 
in an appropriate volume of medium, and an aliquot transferred into a 90 mm dish. 
For long term storage, cells were kept in liquid nitrogen. Cultures to be frozen were 
trypsinised, spun down, the supernatant removed, and cells resuspended in ice cold 
freezing medium. 1 ml aliquots were placed at -20°C for 2 hours, then transferred to 
-70°C overnight, before removal into liquid nitrogen. Aliquots were thawed rapidly 
at 37°C and diluted in 9 mis of medium, before being pelleted by centrifugation at 
1,300 rpm for 5 minutes. The supernatant was discarded, the cells resuspended in an 
appropriate volume of medium, and transferred into a flask. 
2.2.2 Preparation of genomic DNA from cells 
High molecular weight cell genomic DNA, suitable for PCR amplification and Southern 
analysis was prepared from mouse tail samples, and fibroblasts by the same method. 
Cultured cells were harvested by scraping in ice cold PBS, and pelleted by centrifuga-
tion at 1,300 rpm for 5 minutes. Cell pellets were digested overnight at 37°C in 700 
pl tail buffer supplemented with proteinase K to a final concentration of 280 pg/mi. 
The supernatant was extracted twice with 700 p1 PCA and vigorous shaking, and sub-
sequently once with 700 pl CA to remove traces of phenol. Thereupon the DNA was 
precipitated for 10 minutes at room temperature by addition of 25 Al 3.0 M sodium 
acetate pH 5.0 and 700 p1 of isopropanol. Following 10 minutes centrifugation, the nu-
cleic acid pellet was washed twice with 70% (v/v) ethanol, vacuum dried, resuspended 
in 200 pl sterile distilled water and stored either at 4°C in the short term or at -20°C 
for longer periods. 
2.2.3 Preparation of RNA from cells and mouse tissues 
The following method is adapted from Chomczynski and Sacchi, 1987. Fresh cells or 
tissue were placed in a sterile polycarbonate centrifuge tube containing up to 7 ml of 
RNAzol solution (Biogenesis Ltd.) and homogenised. Subsequently, 0.1 volumes of 
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chloroform was added, the tube was shaken vigorously for 30 seconds and stored on ice 
for 5 minutes and then centrifuged for 15 minutes at 10,000 rpm in an HB4 rotor pre-
cooled to 4°C. The aqueous phase was transferred to a fresh centrifuge tube and RNA 
precipitated by the addition of 1 volume of isopropanol. The sample was stored at 4°C 
for at least 15 minutes before a 15 minute centrifugation as above. The RNA pellet 
was washed in 75% ethanol, centrifuged for 8 minutes at 5,000 rpm and resuspended 
in sterile d.H20 (Chomczynski and Sacchi, 1987). RNA was generally stored at -70°C. 
2.2.4 Quantification of nucleic acids 
Estimation of DNA concentration 
The DNA sample was diluted in 1 ml of distilled water and the OD of absorbance 
at wavelengths 260nm and 280nm was measured by a spectrophotometer (Perkin-
Elmer, Lambda 15, UV/VIS Spectrophotometer). An 0D 260 nm value of 1.0 represents 
a concentration of 50 mg/ml for DNA. The ratio OD260nm/OD 280nm provides an 
estimate for the purity of the nucleic acid. A value in excess of 1.8 indicates a pure 
preparation of DNA. 
Estimation of RNA concentration 
The RNA sample was diluted in TE and the OD of absorbance at wavelengths 260nm 
and 280nm was measured by a spectrophotometer (Perkin-Elmer, Lambda 15, UV/VIS 
Spectrophotometer). An 0D 260 nm value of 1.0 represents a concentration of 40 mg/ml 
for RNA. The ratio OD260nm/OD 280nm provides an estimate for the purity of the 
nucleic acid. A value in excess of 2.0 indicates a pure preparation of RNA. 
2.2.5 DNA manipulation 
Digestion of DNA with restriction endonucleases 
Most DNA restrictions were performed using BRL, Boehringer Mannheim or New Eng-
land Biolabs enzymes and buffers. DNA was digested with approximately 2-5 U of 
restriction endonuclease per jig of DNA using buffer and temperature conditions rec-
ommended by the manufacturer. For double digests involving enzymes with different 
/ 
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recommended buffers, the buffers were checked individually in double digests to deter-
mine which gave most efficient digestion. If the optimal digestion conditions varied for 
buffers, the DNA was digested with enzyme at lower salt concentration, the enzyme 
reaction stopped by heat denaturation or phenol extraction, the DNA precipitated and 
dissolved in a buffer appropriate for digestion by the next enzyme. Digestion reactions 
were terminated by addition of DNA sample buffer then heated for 10 minutes at 65°C 
prior to electrophoresis. 
2.2.6 Electrophoresis of nucleic acids 
Electrophoresis of DNA in agarose gels 
DNA was separated in 0.7-2.0% (w/v) electrophoresis grade agarose with 0.5 /.ig/ml 
ethidium bromide in lx TBE buffer (for Southern blotting and routine analytical gels). 
Prior to loading, DNA samples were mixed with 1/5 volume of 5x sample buffer (20% 
(v/v) glycerol, 100 mM EDTA, 0.1% bromophenol blue). Electrophoresis was carried 
out horizontally across a potential difference of 1-10 V/cm. Bacteriophage A DNA cut 
with Hindlil and q5X174 DNA cut with HaeIII were used as size markers. DNA was 
visualised by short wave UV illumination. Preparative gels were not exposed to short 
wave UV as this can result in thymidine dimerisation. Instead, the DNA in preparative 
gels was visualised by long wave UV from a hand held lamp. 
Electrophoresis of RNA in agarose gels 
RNA samples were electrophoresed through 1.4% (w/v) agarose gels made with lx 
MOPS, 0.66 M formaldehyde and 0.5pg/ml ethidium bromide. Samples were prepared 
by the addition of 30jtg of total RNA (in 20pl d.H20) to an equal volume of FSB 
(lOOjtl lOx MOPS, 200pl formamide, 1201 de-ionised 37%(w/v) formaldehyde) and 
one quarter volume of standard sample buffer (20% glycerol, 100 mM EDTA, 0.1% 
bromophenol blue) was also added and the sample heated for 5 minutes at 65°C then 
cooled on ice prior to electrophoresis for 3-4 hours at 100 V. 
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Recovery of DNA from agarose gels 
DNA was electrophoresed using low melting point agarose (LMPA) in lx TBE, 0.5 
zg/ml ethidium bromide, the desired fragment was visualised by long wave UV illu-
mination. The band of interest was excised and recovered from the agarose by phenol 
extraction. The gel slice volume was estimated then 0.5 volumes of TE, lit1  glycogen 
(Boehringer Mannheim) and 5yl 20% SDS was added to the gel slice and heated to 
70°C until the agarose melted (approx. 5 minutes). Liquified agarose was extracted 
three times with 1 volume of tris buffered phenol (pH 8.0) and once with 1 volume of 
chloroform. The aqueous phase was retained and DNA precipitated by the addition of 
0.1 volume 3 M sodium acetate and 1 volume of isopropanol. DNA was pelleted by a 
10 minute centrifugation at 13 Krpm and the DNA pellet resuspended in d.H20. 
2.2.7 Transfer of nucleic acids 
Transfer of DNA from agarose gels to membranes 
The Southern blot presented in this Thesis has been carried out by James Selfridge. 
Genomic DNA was digested with the appropriate restriction enzyme in a total volume 
of 50-100l overnight at 37°C and separated according to size on a 0.7-1% agarose 
gel (w/v) in lx TBE and 0.5 mg/ml ethidium bromide. Routinely, genomic DNA 
was electrophoresed for approx. 800Vhours then photographed. The gel was then 
soaked in denaturation buffer (0.5 M NaOH, 1.5 M NaC1) with gentle agitation for 15 
minutes. The DNA was transferred to Genescreen Plus nylon membrane (Du Pont; 
Stevenage, U.K.) by capillary action using denaturation buffer as the transfer medium 
(Reed and Mann, 1985). Transfer was performed for 12-24 hours then the membrane 
was neutralised and adherent agarose washed off by incubating for 10 min in 3 M NaCl, 
0.5 M 1ris-HC1 pH 7.0 on a rocking platform. Filters were air dried before use. 
RNA transfer 
Following electrophoresis, gels were washed three times for 20 minutes in lOx SSC at 
room temperature to remove formaldehyde and ethidium bromide. Transfer conditions 
were similar to DNA except that 10xSSC was used as the transfer buffer. On com- 
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pletion of transfer the membrane was washed in 2x SSC for 10 minutes then baked at 
80°C for 2 hours. 
2.2.8 Nucleic acid hybridisation 
Labelling DNA probes 
DNA labelled to high activities was obtained using the randomly primed DNA labelling 
method (Feinberg and Vogeistein, 1983). DNA probes were denatured, annealed to ran-
dom hexamer primers and extended by the Kienow fragment of E. coli DNA polymerase 
I in the presence of [c _32  P]dCTP. Oligonucleotide labelling buffer (OLB) containing 
nucleotides and random primers is required for this method. It is made by mixing 50 
ml Solution A (1.25 M Tris-HC1 pH 8.0, 0.125 M MgC12, 25 mM /3-mercaptoethanol, 
0.5 mM each of dGTP, dTTP and dATP), 125 ml Solution B (2 M HEPES buffer ad-
justed to pH 6.6 with NaOH) and 75 ml Solution C (random hexanucleotides 0D 260 nm 
= 90 in TE). Probes were labelled as follows: 100 ng of double-stranded DNA was 
made up to 321l with d.H 2 0 then denatured by boiling for 5 minutes and allowed to 
cool at 37°C for 10 minutes. The following reagents were then added: 10 tl of OLB, 
2pl of 10 mg/ml BSA, 5pl of [a _32  p] dCTP (3000Ci/mmol) and 10 units of Klenow 
enzyme. The reaction was incubated overnight at room temperature. 
DNA and RNA hybridisations 
Pre-hybridisations were performed in a hybridisation oven (Hybaid Limited) in a to-
tal volume not exceeding 30 ml of prehybridisation buffer (6x SSC, 1% SDS, 10% 
(w/v) dextran sulphate, 100 mg/ml of denatured herring sperm DNA). Blots were 
prehybridised for a minimum of 2 hours at 65°C for Southern transfer and at 60°C 
for northern transfer. DNA probes were heat denatured in 300l of 10 mg/ml herring 
sperm DNA and added to the prehybridisation solution after purifying them through 
a Nick Column, Sephadex G-50, DNA grade (Pharmacia Biotech). Following hybridi-
sation overnight at 65°C, the hybridisation solution was discarded and the blots were 
rinsed for 5 minutes in 2 x SSC at room temperature, followed by a 30 minute wash in 
2x SSC, 1% (w/v) SDS at 65°C then a 30 minute wash in 2xSSC, 1% (w/v) SDS at 
65°C. Membranes were sealed in a plastic bag and autoradiographed at -80°C, typically 
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overnight. Northern blots were hybridised and washed as above but at 60°C. 
Autoradiography 
Autoradiography was performed using Cronex X-ray film (DuPont) in a cassette with 
intensifying screens (Cronex Lightning Plus; Du Pont). Cassettes were exposed at 
-70'C to facilitate fluorographic enhancement. 
Stripping probes from membranes 
Radiolabelled probes were stripped from Southern blots by boiling in 0.1x SSC, 1% 
(w/v) SDS for 10 minutes with gentle shaking. The solution was decanted from the 
membrane, and the boiling procedure was repeated twice. Blots were autoradiographed 
to confirm that probe stripping was complete. The membrane was then incubated in 
pre—hybridisation solution and hybridised as above. Northern blots were stripped by 
washing them 4 times for 5 minutes in boiling 0.01x SSC, 0.01% (w/v) SDS. 
2.2.9 DNA sequencing 
The cDNA sequencing procedure presented in this Thesis was carried out by Dr. Nicola 
Redhead. 
Reverse Transcription of RNA 
Typically, lOpg of RNA in a volume of 101 were used per reaction as follows (Table 
2.1). 
The reaction mix was incubated at 43°C for 1 hour and after that time an additional 
0.5l RNasin and 1.51d of RTase were added per reaction. The samples were incubated 
at the same temperature for a further 1 hour. 
Samples were stored at 4°C after addition of 200pl TE. 
. 10xRT buffer: 500 mM Tris.HC1 pH 8.3, 60 MM  MgCl2 , 400 mM KC1, 10 mM 
DTT. Stored at -20°C. 
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Reagents +Rtase] —Rtase 
RNA 10i1 lOu! 
d.1120 3.5pl 5u1 
10xRT buffer (see below) 2pl 2pl 
RNasin (40 U/ui) 0 • 5ul 0.5pl 
25 mM dNTP hi! lpl 
Hexameres (0.1ig1p1) lpl lpl 
dT12_18(50pg/ml) 0•5u1 0.5pl 
RTase (20 U/ui) 1 • 5ul - 
Table 2.1: Reverse Transcription Reaction. Typical ingredients. 
PCR amplification of cDNA's 
201Ll of cDNA prepared as described in the previous section were used for amplification 
by the PCR method as follows. All PCR reactions were carried out in 501Ll volumes in 
1 x PCR buffer supplemented with EDTA and dNTPs, to a final concentration of 0.4 
mM and 0.1 mM respectively, and 2.5 units of Taq DNA poiymerase. Approximately 
lOOng of DNA was used per reaction, along with 1 ng of each primer (see Table 2.2). 
Cycle conditions varied for different primers pairs, but denaturation was generally 
carried out at 94°C for 1 minute, followed by 1 minute at an appropriate annealing 
temperature, and synthesis at 72°C for 1 to 2 minutes. 35-40 cycles were carried out 
for all PCR reactions. All experiments were carried out using an Omnigene thermal 
cycler (Hybaid Ltd.). 
PCR conditions for the amplification of ERCC1 cDNA: 
. 94°C for 1 minute 
. 68°C for 1 minute 
. 72°C for 1 minute 
Repeat for 35 cycles. 
The different PCR products obtained from the above PCR reactions were electrophoresed 
in a LMPA gel, the cDNA bands were extracted as explained elsewhere (see Recovery 
of DNA from agarose gels), and the cDNA's were subsequently sequenced (see below). 
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cDNA sequencing reactions 
Dye terminator cycle DNA sequencing was performed using an ABI PRISM dye termi-
nator cycle sequencing reaction ready kit (Perkin-Elmer Corporation), on an Omnigene 
thermal cycler (Hybaid Ltd.) and extension products separated on an ABI automated 
sequencer (Perkin-Elmer Corporation). 
Approximately 0.4pg of cDNA template was mixed with 3.2 pmoles of an appropriate 
primer and 8 p1 of terminator ready reaction mix in a final volume of 20pl. The mixture 
was overlaid with a drop of mineral oil, and subjected to thermal cycling (25 cycles) 
as follows: 
. 96°C for 30 seconds 
. 50°C for 15 seconds 
. 60°C for 4 minutes 
Extension products were purified away from unincorporated terminators by addition 
of 2.01l 3 M sodium acetate pH 4.8, 501Ll absolute ethanol, and incubation on ice for 
10 minutes followed by 15 minutes centrifugation. 
The resulting pellet was washed with 70% (v/v) ethanol, vacuum dried, and stored 
dry at -20°C. 
Name I Sequence (5'—+3')(Exon) I F/R Primer combination 
C8438 CCCTTGAGGCTCCAAGACCAGCAGG (El) F C8438-C8439 
A9568 GATGGACCCTGGGAAGGACAAAGAGG (E2) F A9568-A9570 
C8439 CCCTTGAGGCTCCAAGACCAGCAGG (E2) R C8439-C8438 
A9569 CCGTACTGAAGTTCGTGCGCAACG (E4) F A9569-A9570&A9571 
A9570 CCAAGGCGAAGTTCTTCCCCAGG (E5) R A9570-A9568&A9569 
A9571 TCATCAGGGTACTTTCAAGAAGGC (ElO) R A9571-A9569 
Table 2.2: Primers used in the PCR reaction for the amplification of the human ERCC1 
cDNA sequence. The polarity of the primer is represented by the letters F (forward) 
and R (reverse). The primer combination(s) each primer has been used in the PCR 
reaction is also shown. 




Sequence analysis was carried out on a UNIX mainframe computer using the Genetics 
Computer Group (GCG) package of programs, version 9. Alignment of nucleotide 
sequences was performed using the Bestfit, Lineup, and Pileup programs. 
2.2.10 PCR genotyping of mice 
In order to determine the genotype of an individual, PCR reactions were performed 
on genomic DNA samples extracted from tail. Cycle conditions employed for different 
primer pairs are outlined below (Table 2.3) 20iil of each reaction was subjected to 
agarose gel electrophoresis, and products visualised by ultra-violet illumination. 
2.2.11 Immunoassays 
Immunoblotting 
All proteins were detected by immunoblotting with crude liver or cell homogenates in 
conjunction with the appropriate antibody. Homogenates were prepared as follows: liv-
ers were dissected cleanly and homogenised in lysis buffer for protein extraction. Cells 
were scraped off their dishes and washed in PBS/0.01 M PMSF before homogenising 
in a sufficient volume of the same buffer. Total protein content was determined by the 
bicinchoninic acid method (BCA assay, Pierce). Samples were stored at -20°C prior to 
use. Homogenates and cell samples were boiled for 5 minutes with 1/2 volume of sam-
ple buffer before separation by electrophoresis in 1 x electrophoresis buffer, using 8 or 
12% SDS PAGE with a 3.3% stacking gel. NEB broad range pre-stained markers were 
run with all gels to assess separation and electrotransfer efficiency. Proteins were elec-
troblotted from acrylamide gels onto PVDF membrane (Immobilon P, Millipore) using 
a BioRad Transblot SD semi dry electroblotter at 12V for 2 hours. Membranes were 
blocked overnight at 4°C with 3-10% dried milk in TBST (0.01-0.5%(v/v) Tween 20) 
(Table 2.4), the blocking solution was discarded and incubated with the appropriate 
primary antiserum diluted optimally in TBST or dried milk/TBST for 1 hour at room 
temperature (Table 2.4). Membranes were washed twice for 10 minutes in TBST then 
the secondary antiserum added (Table 2.4) and incubated for 1 hour. Membranes were 
ND 
Name Sequence(5'-+ 3') Description PCR Conditions 
033M CCCGTGTTGAAGTTTGTGCG Erccl exon 4 (McWhir et al., 1993b) 
94°C 1', 68°C 1', 72°C 1' for 35 cycles 035M 	CGAAGGGCGAAGTTCTTCCC Erccl exon 5 (McWhir et al., 1993a) 
M4956 	GGTTCGAAATGCCGACCAAGCG Erccl neo cassette (D. Melton, personal communication)  
C1045 CAAAGAGCGTTGGGCATGTG p53 intron 7; A. Clarke, personal communication 
94°C 1', 62°C 1', 72°C 1' for 35 cycles C1046 	GTGGTGGTACCTTATGAGCC p53 exon 6; A. Clarke, personal communication 
-C1047 CATCGCCTTCTATCGCCTTC p53 neo cassette; A. Clarke, personal communication 
Table 2.3: ERCC1 arid p53 genotyping primers description 
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washed twice for 10 minutes in TBST, and then incubated in AB Complex (DAKO 
Ltd.) for 30 minutes at room temperature. Membranes were developed using a chro-
mogenic method with DAB (see below, Immunohistochemistry). 
Immunohistochemistry 
Most of the BrdU— and all of the Ki67—staining was carried out in the immunohisto-
chemistry section of the Pathology Department, Edinburgh University. 
Livers were removed and immersion fixed for 24 hours in Methacarn (Methanol: Chlo-
roform: Acetic Acid in a 4:2:1 ratio) followed by storage in 70%Ethanol. Livers were 
then dehydrated with alcohols and impregnated in wax during a 7 hour processing 
cycle. 3pm sections were mounted on slides which had been coated with poly-L-Lysine 
(PLL). 
Mounted sections were typically immunostained by the standard ABC method. Briefly, 
sections were dewaxed in xylene and rehydrated in descending grades of alcohol. For 
the BrdU antibody it was necessary to render the cells permeable by incubating the 
slides in iN HCl at 60°C for 1 hour. For Ki67 (MIB1) it was necessary to retrieve 
the antigen by microwaving the sections in citrate buffer (3.10 g citric acid/ litre of 
d.H20) for 5 minutes 3 times at high power. After either permeabilisation or antigen 
retrieval, the slides were washed in running water and subsequently rinsed in PBS for 5 
minutes. The sections were subsequently blocked for endogenous peroxidase activity in 
3% Hydrogen Peroxide for 10 minutes at room temperature and incubated a 1:5 dilution 
of Normal Goat Serum (SAPU) or Normal Rabbit Serum (SAPU) for 10 minutes. After 
this, the samples were incubated in an appropriate dilution of the primary antibody 
in Normal Serum in TBS for 30 minutes at room temperature, washed and incubated 
for 30 minutes in biotinylated secondary antibody diluted optimally in Normal Serum 
in TBS (Table 2.5). 
After washing the secondary antibody off, the slides were incubated in AB Complex 
(Streptavidin/Biotin, DAKO Ltd., in DAB/ABC buffer, see below) for 30 minutes at 
room temperature. AB Complex was washed and the positive nuclei were visualised in 







Antibody Blocking Solution Primary Ab Dilution Secondary Ab Dilution Antibodies Solution Washes 
Ab-7 3%M'/TBST(0.1%T 2 ) 1:2,500 1/50,000 0.5%M'/TBST(0.1%T) TBST(0.1%T2 ) 
RW09 10%M/TBST(0.025%T) 1:200 1/7,500 10%M/TBST(0.025%T) TBST(0.025%T) 
RWO17 10%M/TBST(0.01%T) 1:2,500 1/7,500 10%M/TBST(0.01%T) TBST(0.01%T) 
RA1 10%M/TBST(0.01%T) 1:1,500 1/7,500 10%M/TBST(0.01%T) TBST(0.01%T) 
TL6 3%M/TBST(0.05%T) 1:500 1/50,000 TBST(0.05%T) TBST(O.05%T) 
TL25 3%M/TBST(0.5%T) 1:500 1/50,000 TBST(0.5%T) TBST(0.5%T) 
TL 18 3%M/TBST(0.01%T) 1:500 1/50,000 TBST(0.01%T) TBST(0.01%T) 
Vim3B4 3%M/TBST(O.05%T) 1:500 1/50,000 TBST(0.05%T) TBST(0.05%T) 
Table 2.4: Summary of the conditions used for the different Westerns. 1 : 99% fat—free powder milk; 2:  Tween 
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Antibody jry Ab Dilution /Y Ab Dilution I Ab Solution 
BrdU(MAS250) 1:50 1:50 1:5 Normal Goat Serum in TBS] 
Ki67(MIB1) 1:100 1:400 1:5 Normal Rabbit Serum in TBS] 
Table 2.5: Immunohistochemistry conditions for BrdU and Ki67 staining of paraffin-
embedded liver sections. 
per 5 ml DAB/ABC buffer. This results in a final DAB concentration of 0.5 mg/mi. 
Finally, the slides were counterstained lightly in Haematoxylin and Scott's Tap water 
(see below), dehydrated and mounted. 
• DAB/ABC buffer: 50 mM Tris, 0.04N HCl 
• Scott's Tap Water: 1% (w/v) KHC0 4 , 10% (w/v) MgSO 4 . 
• Harris Haematoxylin (Sigma diagnostics): acidified before use with 16 ml of 
Glacial Acetic Acid per 350 ml stain. 
Controls were carried out using preimmune serum in place of primary antibody. 
Centromeric Staining of Hepatocytes 
Livers were obtained from wild type and ERCC1-deficient mice (18-20 days of age). 
After dissection, the fresh livers were gently pressed onto a glass coverslip. This method 
allows single hepatocytes to detach from the liver in a non-disruptive manner so that 
their nuclei remain intact. Liver cells prepared in this way were allowed to air dry for 
5 minutes and they were then fixed in 4% paraformaldehyde/PBS (see below). After 
washing in PBS the cells were permeabilised in KB buffer/0.1% Triton (see below), 
washed twice in PBS without Triton and incubated for 30 minutes at room temper-
ature in the primary antibody diluted optimally (NR antibody, 1:1000 in PBS/0.1% 
Triton/0.1% Sodium Azide). The coverslips were washed again twice in PBS/1% Tri-
ton/0.1% Sodium Azide and subsequently incubated in a 1:1000 dilution of the bi-
otinylated secondary antibody (anti-human IgG) in the same solution for 30 minutes 
at room temperature. After this, they were washed again and incubated for a further 
30 minutes in the tertiary antibody solution (Streptavidin/Texas Red-complex, 1:1000 
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dilution in PBS/0.1% Triton/0.1% Sodium Azide)at room temperature. Finally, the 
cells were washed and stained with DAPI(0.5 jig/ml in PBS) for 5 minutes, mounted 
on slides with Vectashield mounting medium and sealed with nail varnish. 
Red dots within the nucleus of the hepatocytes corresponding to the centromeres in the 
chromosomes were scored using a fluorescence microscope (Axioplan 2, Zeiss) using a 
100 x/NA 1.4 oil immersion objective lens. The images presented in this thesis were ac-
quired using a Sedat/Agard deconvolution microscope made by Applied Precision Inc. 
with an Olympus 1X70 inverted microscope, a 100x/NA 1.4 oil immersion objective 
lens and a PXL CCD camera from Photometrics. Deconvolution is a computational 
method that compensates for the effect of out of focus light, resulting from the use 
of fluorescence microscopes, by re-assigning the light to its correct point of origin in 
a three-dimensional stack of images (Davis, 1999). This process was performed us-
ing DeltaVision software running on a Silicon Graphics computer. All manipulations 
performed with this microscope were carried out by Prof. William Earnshaw, ICMB, 
Edinburgh University. All pictures were processed using the Adobe PhotoShop or 
Powerpoint packages. 
Buffers: 
. 10xPBS-azide: 100 mM NaPO4 pH 7.4, 1.5 M NaCl, 10 mM EGTA, 0.1 M 
NaN3. 
• 1OxKB: 100 mM tris.HC1 pH 7.7, 1.5 M NaCl, 1% BSA. 
• 1% Triton X-100: Made up in d.H20. 
• 4%CH20 in D-PBS: Made from paraformaldehyde. Dissolved by refluxing, then 
filtered through a 21Lm filter. 
2.2.12 Replication Assays 
Detailed Biochemical Assays: Repair/Stalling Experiments 
All the experiments described in this section were carried out in the University of 
Cambridge, Zoology Dept., under the supervision of Dr. Robert T. Johnson and Dr. 
Shoshana Squires. 
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Cells were plated out at the desired density (2 x 10 5 cells/90 mm dish)on a Friday and 
left to settle down for 5-8 hours. At the end of the day [ 14 C] TdR was added to a final 
concentration of 0.1 pCi/ml and left to label during the weekend until Tuesday 
[' 4 C] TdR medium was removed and the cells were allowed to grow in unlabelled 
medium for 16 hours. [3  HI TdR medium (to a final concentration of 1.0 pCi/ml)was 
added and cells were incubated at 37°C for 10 minutes. After that the labelled medium 
was removed and stored in a 50 ml Falcon tube at 37'C. 2 ml of pre-warmed PBS was 
added to the dishes and they were then UV-irradiated with a germicidal UVC lamp 
(emitting predominantly 254-nm) at the desired rate. 
After UV-irradiation the [3H] TdR medium was put back into the dishes and cells were 
allowed to incubate in it for a further 30 minutes and subsequently changed into normal 
unlabelled medium containing the four deoxyribonucleosides to a final concentration 
of 5 x 10-6  M. Samples were processed for DNA isolation either immediately (0 hours) 
or at various times after UV irradiation as described by Ryan et al. (Ryan et al., 
1991). Briefly, the cells were detached by incubating 1 minute at 37°C with 1 ml of 
Viokase. The cell suspension was then collected in 10 mls of medium and spun down 
for 5 minutes at 1300 rpm. 
The cell pellet was then resuspended in 400pl of 0.8%LMPA and the agarose+cell 
suspension was then sucked into a fine plastic tube (10-15 cm long x 3mm wide) with 
a syringe. The tubing was then put in ice for a few minutes until agarose had solidified. 
Each agarose worm was then pushed out of the tubing and cut into plugs (3-5 mm 
long). The plugs containing the cells were then put into vials and pre-equilibrated in 
2.5 ml of 0.5 M EDTA/1% Sarkosyl for a minimum of 2 hours. After 2 hours the plugs 
were incubated overnight at 50°C in the same buffer plus proteinase K (50jtg/ml). 
This allows gentle cell lysis without damaging their DNA. 
Plugs were washed the next day in 10 ml 50 mM EDTA/100 mM Tris and left to wash 
in the cold room five times over a period of three days to remove the lysis solution and 
proteinase K. This method yields plugs containing radiolabelled DNA equivalent to 1 
X  105 cells. 
After the plugs had been washed they were separated into 3 different vials. The first 
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vial contained approx. 1/2 the plugs. These were used as controls. The second vial 
contained approx. 1/4 of the plugs and was 'y-irradiated in 0.5 M EDTA/ 1% Sarkosyl 
(irradiations were performed with a Mainance 500C machine using a [137Cs] gamma 
ray source at a dose rate of 1 Gy/min) whilst the third vial containing the rest of the 
plugs was treated with DenV. 
The DenV treatment was performed as follows: 
Crude extracts of T4 endonuclease V (DenV) were prepared in R. Johnson's laboratory 
in Cambridge using the following method. The DenV was purified from an overpro-
ducing E.coli strain AB2480 transfected with the plasmid ptac-DenV. An overnight 
culture of the bacteria was diluted 100 times and grown at 37°C in fresh L broth with 
ampicillin to mid-log phase (OD 65o nm= 0.4-0.6). IPTG was then added to a final 
concentration of 0.75 mM, and the culture incubated for a further 4 hours at 30°C. 
Cells were then collected by centrifugation at 4,000 rpm at 4°C, sonicated in cold lysis 
buffer (10 mM Tris-HC1 pH 7.5, 1 mM glutathione reduced, 10% ethylene glycol, 2 
mM EDTA pH 8.0). Cellular debris was removed by centrifugation at 40,000 rpm for 
60 minutes at 10°C, and crude extract was partially purified by phase separation in 
20% w/w dextran T500, 30% w/w polyethylene glycol 600 (PEG), and about 40% 
w/v NaCl. The upper phase was carefully removed and dialysed using BRL dialysis 
membrane(MW cutoff=12-l4kDa) for 6 hours at 4°C (10 mM potassium phosphate 
pH 6.5, 10% (v/v) ethylene glycol, 10 mM /3-mercaptoethanol, 2 mM EDTA pH 8.0). 
Debris was removed by centrifugation at 10,000 rpm for 30 minutes at 4°C. Aliquots of 
the supernatant were stored at -20°C for several months. The extracts were tested for 
DenV and non-specific activities on a superhelical UV-irradiated plasmid, and were 
used at a dilution of at least 1:100. 
The DNA embedded in the agarose was treated or mock-treated with DenV to cleave 
the DNA at sites containing CPDs. Plugs were taken out of the washing solution and 
pre-equilibrated in lx DenV buffer (100 mM NaCl, 50 mM EDTA pH 8.0, 10 mM Tris 
pH 8.0, lpg/ml BSA) for 1 hour on ice and then in the presence or absence of DenV 
for 30 minutes to allow the enzyme to diffuse into the plugs. They were subsequently 
incubated at 37°C for 1 hour. The reaction was stopped by washing in storage buffer 
(100 mM Tris pH 7.5, 50 mM EDTA) and stored in the cold room. 
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Treated or mock-treated DNA was assayed for the presence of DSBs or SSBs by neutral 
pulse field or alkaline gel electrophoresis, respectively. 
1. Asymmetric Field Inversion Gel Electrophoresis (AFIGE) Technique. 
This technique is an adaptation of the gel electrophoresis technique developed by 
Denko et al. (Denko et al., 1989) and Stamato and Denko (Stamato and Denko, 
1990). 
The agarose plugs, treated or mock-treated with DenV, were loaded into the wells 
and electrophoresed in 1.5% agarose gels in TBE, 2% Ethidium Bromide for 6-8 
hours under the following conditions (Ryan et al., 1991): 
. 125 seconds at +150 V 
. 15 seconds at -300 V 
After a photograph was taken, the gels were then processed so that each lane 
that had been run was cut into two pieces. One that included the well (DNA 
that had not migrated into the gel) and another one that included the rest of the 
lane. 
Each gel wedge was put into a scintillation vial, 1 ml of 0.1N HCl was added and 
the gel was microwaved for 2-3 minutes until the agarose was melted. Subse-
quently 5 ml of scintillin was added and the [' 4 C] and [3H] counts were counted 
in a scintillation counter overnight and the results analysed as follows. 
Under the electrophoretic conditions described above, DNA that is smaller than 
1.6 Mb enters the gel, where it migrates as a discrete band independent of the 
range of molecular sizes. The amount of DNA that enters the gel is a measure 
of the DSBs formed, and is determined by calculating the fraction of radioactive 
counts that are released into the gel as a percentage of the total radioactivity 
(%FAR) in that sample. 
It has been shown that for a known dose of X-rays, the amount of DNA released 
from the plug is significantly reduced in S-phase cells relative to cells in other 
phases of the cell cycle (Iliakis et al., 1991). The DNA released varies linearly 
with the X-ray dose for both bulk and pulse-labelled nascent DNA, but the 
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FAR values for the replicating DNA ([ 3 H]-labelled) are several times lower than 
those of the bulk DNA ([' 4 C]-labelled) (Stamato and Denko, 1990), (Ryan et al., 
1991). With the AFIGE technique it is not possible to estimate the number of 
DSBs per unit of DNA directly, but it can be estimated indirectly by comparing 
the %FAR of the experimental DNA with that of the DNA exposed to a known 
dose of X-rays. The difference in the AFIGE assay in the response of replicating 
and bulk DNA to a given X-ray dose can vary in different cell strains and at 
various times after UV irradiation. In order to compare different samples and 
cell types the results are expressed as Gy equivalent DSBs and not as %FAR. 
The Gy equivalent of DSBs in the mock treated samples was subtracted from the 
values of the treated cells (for more detail see Chapter 4). 
2. Alkaline Gels 
The removal of cyclobutane dimers from the DNA replicating at the time of UV 
irradiation ([3 H]-labelled) and from the rest of the genome ([ 14 C]-labelled) was 
determined by measuring the SSB frequencies using the alkaline gel electrophore-
sis method. The method described here is an adaptation of the one developed 
by Freeman et al. (Freeman et al., 1986). 
The number of SSBs generated by DenV represent the number of incisions at CPD 
sites. DenV-treated or mock-treated DNA was denatured in alkaline loading 
buffer (300 mM NaOH, 6 mM EDTA, 18% Ficoll, 0.15% Bromocresol Green, 
0.25% Xylene Cyanol FF) for 1 hour and 20 minutes at 37°C. 
0.4% agarose denaturing gels were first made in neutral buffer (0.05 M NaCl, 
0.04 M EDTA) and allowed to soak in denaturing buffer (0.001 M EDTA, 0.02 
M NaOH) for 30 minutes. 
The gel was then run at 25 Vhour, 400 mAmps, 100 Watts overnight in denatur-
ing electrophoresis buffer (30 mM NaOH, 2 mM EDTA). Before visualising and 
processing for the scintillation counter the gel was neutralised for 1 hour (250 
mM Tris pH 7.5, 750 mM NaCl), stained in Ethidium Bromide (0.005% solution) 
for 1 hour and photographed. 
Each agarose track was then cut as follows starting from the well: 
CHAPTER 2. MATERIALS AND METHODS 
	
89 
. 8 x 0.5cm slices 
. 1 x 1.5cm slices 
. 3 x 2.0cm slices 
As markers the following samples were used. 
• 50 kb lambda concatemers 
• 1Kb ladder (0.5-12 kb fragments) 
• 170 kb T4 DNA 
• lambda digested with XhoI to give 15 and 33 Kb fragments 
A marker size versus distance of migration curve is constructed using these mark-
ers and the molecular weight of the DNA contained in each of the agarose wedges 
was calculated and each gel wedge was then processed for the scintillation counter 
as described before for the AFIGE gels. 
Inhibition of DNA replication by UV is determined from the sum of radiola-
belled counts measured in each alkaline gel track. The sum of [3 H]—thymidine 
radiolabelled counts, was normalised against the sum of [ 14 C]—thymidine counts 
incorporated to the uniformly labelled bulk DNA. The total [' 4C] radioactivity 
recovered from each gel track is used as a measure of the number of cells loaded 
per track. 
[3 H]:[ 14 C] ratio is taken as a measure of the amount of DNA synthesis in the cells 
during the radioactive pulse. 
The effect of UV irradiation on the molecular sizes of the daughter and parental 
DNA strands is estimated from the migration of the [3 H] and [ 14 C] radiolabelled 
DNA in alkaline gels. The average size of the parental DNA varies between 
different gel electrophoresis runs of the same material but the ratio between 
the average molecular size of the [3 H]—labelled and the [ 14 C]—labelled molecules 
remains constant. Therefore the changes in the average molecular size of the 
daughter strand after UV are expressed as changes in the ratio and not in the 
absolute measured molecular size values. 
The frequency of endonuclease sensitive sites (ESS) in replicating and bulk ge-
nomic DNA can also be calculated from the alkaline gels. 
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The number of incisions introduced in the UV-irradiated DNA by the DenV at 
a CPD is determined from the number of single strand breaks, which is in turn 
determined from the average molecular size number (M s). M is calculated from 
the radioactive profile of migration of the DNA on alkaline agarose gels. Using 
the two radiolabelled precursors, the relative amount, and hence the value of M, 
is determined for both the replicating and bulk DNA in each wedge. The method 
of calculation is a variation of the one used by Walker et al. (Walker, 1981) for 
calculating the average number of ESS from the alkaline sucrose sedimentation 
profiles. The distance of migration of the DNA molecules is dependent on size, 
and the relationship is not linear. As described above, for each gel a standard 
curve of migration of the size markers was calculated and the DNA size of the 
fragments in each gel wedge was determined. 
Rough Biochemical Assays: Replication Arrest Kinetics 
Cells were plated out at the appropriate density and were allowed to settle overnight in 
an incubator at 37°C. The following day they were put in isoleucine-deprived medium 
for at least 10 hours in order to arrest them in Gi phase of the cell cycle. The cells 
were released from the Gi block 6 hours before irradiation by putting them back into 
normal growth medium. After 6 hours the cultures, which were well into S phase, were 
mock-irradiated or irradiated with a hand-held UV lamp with the desired UV fluence. 
The cells were then processed immediately or put into normal medium and processed 
at different times after UV. 
Typically, cells were rinsed in serum-deprived medium and pulsed 15 minutes in 
[3H]thymidine-containing (2d/m1) serum-deprived medium at 37°C. After 15 minutes, 
the cells were rinsed in sterile PBS, lysed in a 1%SDS solution, and TCA precipitated 
with 1/2 volume of 20% (v/v) TCA pre-chilled at 4°C. Samples were kept at 4°C until 
needed. 
The samples were vacuum-filtered by passing them through 2.4 cm GF/C microfibre 
filters (Whatman). Each filter was put into a plastic scintillation vial and 2 mls of 
scintillation liquid was added to it. They were put into the scintillation counter and 
the [H] incorporation was measured as DPM counts. 
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2.2.13 Cytology: Morphometric Analysis 
Semiautomated System for Hepatocyte Nuclear Area Measurement 
Liver sections from ERCC1+/+ and ERCC1+/- aged animals were collected, fixed 
and embedded in paraffin. Sections (31Lm) were cut and these were stained with 
haematoxylin and eosin. In order to measure the size of each one of the hepatocyte 
nuclei present in a field, IBAS20 (Kontron Electronik GMBH, Munich; IBAS software 
v.2.0) was used. This system is a semiautomatic image analysis package available 
at the Imaging Unit in the Pathology department of Edinburgh University. Briefly, 
IBAS20 digitalises the image you desire (i.e., random field of a liver section), processes 
it and discriminates between the different structures on the section (i.e., hepatocyte 
nuclei, white blood cell nuclei, background connective tissue) through colour intensity 
differences in them. The computer produces a graphical representation of the mea-
surements per slide (approx. 15 fields) and works out the statistical parameters for 
the different values of the area, the minimum diameter (Dl) and the maximum diam-
eter (D2) of the nuclei. All images were acquired using a 100 x/NA 1.4 oil immersion 
objective lens. 
This system has the advantage of standardising any error that may occur as opposed 
to errors made during manual measurements which are non—reproducible such as bad 
visibility of nuclei due to imperfect staining, loss of accuracy in measurements, etc., 
and has the additional convenience of being much faster and giving out automatic 
statistical analysis of each slide separately. The results were analysed with the Sigma 
Plot package. 
Ax1oHOME Morphometric System 
This system was used to perform the study of Ki67, BrdU and area size distribution 
in young animals (up to 21 days of age). Contrary to the semiautomated system used 
before, the AxioHOME system (Zeiss) is not automatic and each measurement of the 
perimeter of the hepatocytes has to be done manually (Brugal, 1992). Basically, the 
software used, Basic Morphometry, allows the 'drawing' around the periphery of each 
nucleus in a field and the length of the perimeter is entered in the computer, which in 
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turn works out the area in pm's for each one of the measurements. 
Typically, 100x/NA 1.4 oil immersion objective lens was used for the measurements. 
10 fields, containing approx. 50-70 nuclei each, were measured for the Ki67 and 
BrdU—stained sections. For the area measurements and binucleate hepatocyte numbers 
(haematoxylin/eosin sections) all the nuclei in a field were measured and 5 fields were 
analysed per animal. The results were analysed with the Sigma Plot package. 
Chapter 3 
Liver Morphology and 
Immunocytology Studies 
3.1 Introduction 
p53 has been extensively studied in relation to its effect on cell cycle regulation. On 
the detection of DNA damage, p53 levels are elevated through an increase in the p53 
protein half-life. p53 is capable of inducing the transcription of downstream genes, such 
as p21 (Bates and Vousden, 1996), and this p53-mediated response to genotoxic stress 
is characterised by the arrest of cell cycle progression at both Gi and G2 checkpoints, 
and in some cell types it can also lead to apoptotic cell death 
p53 and p21 have also been implicated in cellular ageing (Harvey et al., 1993; Noda 
et al., 1994; Atadja et al., 1995; Bond et al., 1994; Bond et al., 1995). p53  levels 
accumulate as diploid fibroblasts age, with a corresponding increase in p21 levels, 
which in turn correlate with a slowing of cellular growth. 
The morphology of liver tissue in ERCC 1-deficient mice is already well characterised 
(McWhir et al., 1993a). Their liver presents characteristics that indicate premature 
ageing (i.e., elevated numbers of polyploid cells) as well as increased levels of p53 in 
hepatocytes. However, it is not clear what the role of p53 is, if any, in the process 
leading to the observed polyploidy and aneuploidy in the ERCC1-deficient liver. 
If the increase in the levels of p53 is responsible for ploidy changes in ERCC1-deficient 
liver, the possibility exists that the ERCC1-deficient liver phenotype might be rescued 
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in mice deficient in both ERCC1 and p53 (double null mice). 
In order to study this, a number of experiments were carried out using 3 week—old 
mice of the following genotypes: p53 wt/ERCC1 wt (wt/wt), p53 null/ERCC1 wt 
(p53hom/ERCC1wt), p53 wt/ERCC1 null (p53wt/ERCC1hom), p53 null/ERCC1 null 
(p53hom/ERCC1hom). The choice of age of the mice for this study is due to the severe 
phenotype of the ERCC1—deficient animals, which do not survive longer than 3 weeks 
(McWhir et al., 1993a). As will be discussed later, this is also the case for the double 
null animals. 
Ki67 (as a marker for cell proliferation), BrdU (as a marker for DNA synthesis) and 
morphological studies (both nuclear area measurements and binucleate cells count) in 
haematoxylin/eosin (h/e) liver sections were used to gain a better understanding of 
the cell cycle status of the hepatocytes. 
The morphology studies were mainly focused on the measurement of the nuclear area 
of the hepatocytes, since this feature is directly related to ploidy (Epstein, 1967a). 
The area of the hepatocyte nucleus becomes bigger as the nucleus acquires increasing 
degrees of ploidy, which in turn is related to the age of the animal (the older the mouse 
the higher the percentage of cells with larger/polyploid nuclei). The measurement of 
nuclear area for the determination of ploidy in hepatocytes and its relationship with the 
ageing process in several species has been studied extensively (Epstein, 1967a; Epstein, 
1967b; Brasch, 1980; Medvedev, 1986; Bohm and Noltemeyer, 1981; Kudryavtsev et al., 
1993). 
Following this line of thought, it was of interest to see if there was any correlation 
between the ERCC1 status and the ageing process in mice. Clearly, the fact that 
ERCC1—deficient animals died before weaning did not allow a study of the effect of 
a total ERCC1 deficiency at later stages in the mouse development. On the other 
hand, it was known that ERCC1+/- mice had a normal appearance and survived as 
long as their wild type counterparts. It was thus possible to address a related question 
by studying the effect of a partial deficiency of ERCC1 in the livers of aged animals. 
Is the effect of an ERCC1 deficiency cumulative? Is it therefore possible that aged 
ERCC1+/- animals show the same liver phenotype as the young ERCC1-/- ones? 
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In order to answer these questions a number of both ERCC1+/+ and ERCC1+/-
animals were collected at an advanced age (ranging from 15 to 31 months) and their 
liver morphology, i.e. the area of the hepatocyte nuclei, was compared. 
3.2 Results 
3.2.1 Aged ERCC1 heterozygote mice do not show any sign of aber-
rant liver morphology with increasing age 
Liver sections from ERCC1+/+ and ERCC1+/- aged animals were collected, fixed and 
embedded in paraffin. Sections (3pm) were cut and these were stained with haema-
toxylin and eosin before analysing them using the Semiautomated IBAS20 microscope 
system. Measurements of the area of each hepatocyte nucleus detected by this sys-
tem were taken and the results were analysed using the Sigma Plot package. For 
more details see Materials and Methods, section 2.2.13. The results of the study are 
summarised in Fig. 3.1. 
Enlargement of hepatocyte nuclei as a consequence of ageing is a common aspect of 
the liver physiology. As the liver ages the hepatocytes tend to the polyploidisation of 
their nuclei. It has been proposed that this is a defense mechanism against intrinsic 
DNA damage occurring in the liver (see Discussion). Since the liver is a an organ with 
low levels of cell proliferation, hepatocytes would instead replicate their DNA as a way 
of ensuring the sustainability of essential genes. This process would acquire a bigger 
significance with increasing age as the endogenous DNA damage would accumulate 
with time. 
As can be seen in the graph presented below there is no significant difference between 
the distribution of hepatocyte nuclear sizes in aged ERCC1+/+ and ERCC1+/- mice. 
These data suggest that the absence of only one copy of ERCC1 does not affect the 
liver morphology with time. A possible explanation for this is that the requirement for 
ERCC1 may be very small in the cells and a reduction in the production of ERCC1 
protein does not affect the function of NER in the hepatocytes. Only when ERCC1 is 
totally absent is NER disrupted and the aberrant morphology appears. 
Although this type of data analysis is different from the one used for the experiments 












0-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-100 101-110111-120121-130131-140141 -more 
Nuclear area (in pixels) 
Figure 3.1: Distribution of the size in pixels of hepatocyte nuclei belonging to 
ERCC1+/+ (animals sampled=23, 9 male+14 female) and ERCC1+/- (animals sam-
pled=34, 18 male+16 female) aged animals. Both genotypes presented an equivalent 
age distribution: ERCC1+/+ animals aged from 15-24 months=68.2%, ERCC1+/-
animals aged from 15-24 months=71.9%; ERCC1+/+ animals aged from 24-31 
months=31.8%, ERCC1+/- animals aged from 24-31 months=28.1%. 
described below, the general appearance of the profiles of nuclear area distribution can 
be compared. In fact, the profile displayed by the distribution of nuclear areas in both 
aged ERCC1+/- and ERCC1 wild type mice is similar to that displayed by the young 
ERCC1-/- deficient animals (see Fig. 3.3). All three present a high number of different 
size classes indicating a loss of the nuclear area uniformity, which is a characteristic 
of young wild type livers (see Fig. 3.3). What is more, both profiles belonging to the 
two aged categories and the ERCC1—deficient profile show a clear shift to the bigger 
area classes compared to the young wild type liver profile, indicative of an increase in 
polyploid hepatocyte nuclei (see sections below and Discussion). 
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3.2.2 The absence of p53 does not rescue the ERCC1-deficient phe-
notype 
It was clear from early observations of the survival of the different classes of mice 
that animals that were both ERCC1-deficient and p53-deficient did not survive longer 
than their ERCC1-deficient counterparts. This was the first clear indication that the 
absence of p53 did not rescue the overall phenotype associated with ERCC1 deficiency. 
Double null mice were also runted and died before weaning. It is important to note that 
the frequency at which this particular genotypic class was detected was extremely low. 
In the course of experiments that have lasted 4 years, where several hundred animals 
from crosses between double heterozygotes have been genotyped by tail cutting at 3 
weeks, double nulls have been detected at far less than the expected ratio of 1:16. Some 
of these have then died before liver samples could be collected. This has been the main 
reason for the low numbers of double null samples used in these experiments. 
In order to see if the liver phenotype was rescued, preliminary studies of h/e liver 
sections from these mice revealed that in fact, the appearance of the ERCC1 null and 
the double null livers was very similar (see Fig. 3.2 B and D). Indeed, the nuclear 
uniformity had been lost in p53wt/ERCC1h0m and p53hom/ERCC1h0m livers, with 
both showing enlarged nuclei in addition to the smaller size characteristic of wild type. 
This fact pointed towards a failure of p53 absence to rescue the ERCC 1-deficient liver 
phenotype. 
Binucleation was another morphological aspect that was investigated in these livers. 
Binucleation is a feature that has been related to normal liver development and ageing 
along with polyploidisation. In normal mouse liver development, the number of bin-
ucleate and polyploid cells increase with increasing age, concomitant with a decrease 
of mononucleate, diploid cells (Epstein, 1967a). Despite overall similarities in the ap-
pearance of the ERCC1 null and the double null livers there was a suggestion from 
initial observations that the number of binucleate cells was elevated in the double null 
livers compared to the ERCC1-deficient livers (see Fig. 3.2 B and D). 
Given the biological significance of binucleation and polyploidisation in the develop- 
ment of mouse liver, it was decided to carry out a more systematic study of these 
VO 
Figure 3.2: Morphology of the four different genotypic classes of liver from age matched 
mice (3 weeks old). Photographs of liver sections were taken from haematoxylin stained 
sections under the microscope using a 40 x magnification lens. A) wild type liver 
showing the typical uniform distribution of small nuclei seen in young animals. Note 
its similarity to the distribution seen in panel C. Eight-point star is situated next to 
a normal size binucleate cell. B) p53wt/ERCC1hom liver. This picture shows a wide 
distribution in nuclear areas. Arrow points towards a polyploid (giant) nucleus. C) 
p53hom/ERCC1wt liver showing a young wild type-like nuclear distribution. Eight-
point stars are situated next to normal size binucleate cells. D) p53hom/ERCC1hom 
liver. Note the abnormal distribution of nuclear sizes and its similarity to panel B. 
Arrow point towards a polyploid (giant) nucleus and star is situated next to a polyploid 
binucleate cell. 
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aspects and in order to do so, the size of the hepatocyte nuclei and the number of 
binucleate cells were determined for the haematoxylin/eosin sections of liver belonging 
to the four genotypes: p53wt/ERCC1wt (wt), p53hom/ERCC1wt, p53wt/ERCC1hom 
and p53hom/ERCC1hom. Only cells that appeared as unequivocally parenchymal in 
origin were counted, taking care to avoid the areas surrounding the portal veins, where 
there is an increased number of non—parenchymal cells. This section deals with the 
results obtained from the study of the hepatocyte nuclear area distribution in the afore-
mentioned livers and the next section deals with the incidence of binucleation in the 
same livers. 
The distribution of the nuclear area sizes is shown in Fig. 3.3. The wild type profile 
(top panel) shows a distribution of areas characterised by a mode of 20-30 pm 2 and a 
maximum area of 70 pm 2 . The number of nuclei that fall within the last two nuclear 
categories (from 50-70 pm 2 ) is so low (1% of the total nuclei number) that 50 pm 2 
is the cut-off area that was chosen in order to determine abnormal or big (polyploid) 
nuclei. This distribution coincides with the one that has already been reported by 
McWhir et al.(1993) and Weeda et al.(1997). 
Out of the four genotypes, only the p53hom/ERCC1wt livers present the same distri-
bution as the wild type ones (see figs.3.3 and 3.2). This suggests that p53 absence does 
not affect liver morphology and this is confirmed again by the observations made in 
the double null livers. 
In both the ERCC 1—deficient livers and the double null livers the size distribution 
profiles present a more spread-out shape, which indicates a shift of these hepatocytes 
towards the bigger nuclear areas. As similar pattern of nuclear area distribution in 
ERCC1 null mice is reported by Weeda et al. (1997). In fact, we observe that the mode 
in these two categories has increased from 20-30 to 30-40 pm2 , and the biggest nuclei 
reach up to 200 pm 2 . Also, the percentage of nuclei which are bigger than 50 pm 2 has 
increased for both the ERCC1—null and the double null genotypes (33.7% and 34.4%, 
respectively). This percentage remains low for the p53 null livers (5.36%). Overall, 
there is no clear difference in the distribution of nuclear areas in ERCC1 —deficient and 
the double null livers. What is more, both of them resemble the profiles expected for 
an aged liver (see Fig.3. 1). The implications of this observation are discussed below 
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Figure 3.3: Nuclear area size distribution in the four different genotypic classes of 
hepatocytes from 3 week-old mice. The areas were calculated as described in the Ma-
terials and Methods, section 2.2.13. The total number of nuclei counted per genotype 
is represented by n. 
(see Discussion and sections below). 
The results obtained here indicate that the absence of p53 does not rescue the ERCC1-
deficient phenotype. Therefore, the aberrant ploidy patterns seen in these hepatocytes 
are most likely created through a p53-independent mechanism. 
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3.2.3 Binucleation is inhibited in ERCC1-deficient hepatocytes 
As mentioned before, there have been previous studies of distribution of ploidy classes 
of hepatocytes in mouse livers (Swiss mouse) detailing the changes in ploidy with 
increasing age (Epstein, 1967a). One of the characteristics of such changes is the 
pattern of mononucleate and binucleate cells co-existing at a given time. The older 
the mouse the higher the percentage of high ploidy (4n, 8n) binucleate cells present 
and the lower the number of diploid (normal) cells. 
In order to study this aspect of liver cytology, binucleate cells were counted and divided 
into two categories: normal (area<50 pm2 ) and big/polyploid (area>50 pm2 ) (Fig.3.4). 
The basis behind this rationale has already been discussed in the previous section. 
From this graph it is clear that there is a decreased number of binucleate cells in the 
ERCC1 null livers compared to the other genotypes (see also Figs. 3.2 A, B, C and 
D). Both the wild type and the p53-/- ERCC1+/+ livers have similar percentages of 
binucleate hepatocytes (8% and 10% respectively). In these two genotypes there is no 
evidence of big (high ploidy) binucleate cells. In ERCC1-/- livers the percentage of 
total binucleate cells is the lowest of the four types (3%), with 44% of that number 
being comprised of high ploidy nuclei. In the case of the double null livers, the total 
number of binucleate cells is increased, being similar to that of the wild type or the 
p53 deficient tissues (7%), and a high percentage (61%) of those binucleate cells are 
polyploid. 
Thus, binucleation seems to be impaired in the absence of ERCC1 and this block is 
rescued by the absence of p53. The mechanism responsible for this ERCC1 effect 
remains to be determined. It is noteworthy however, that the levels of p53 are only 
elevated in the ERCC1-/- livers and that this seems to correlate with a decrease in 
binucleation. Since binucleation happens through repeated replication rounds in the 
absence of cell division and is the previous step to polyploidisation in the development 
and differentiation of the liver, this characteristic is of relevance to the liver phenotype 
observed in ERCC 1-deficient mice an a possible link between ERCC1, replication 
control and liver development. 
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Figure 3.4: Percentage of binucleate cells in the four different genotypic classes of 
liver from 3 week-old mice. Big nuclei (when present) are represented by the second 
(grey) bar in each genotype. wt/wt stands for p53wt/ERCC1wt; wt/horn stands for 
p53wt/ERCC1horn; hom/wt stands for p53hom/ERCC1wt and horn/horn stands for 
p53hom/ERCC1hom. Standard errors are shown. n indicates the number of animals 
sampled per category. 
3.2.4 The absence of p53 rescues the replication block in ERCC1 null 
livers 
Sections of liver were also stained with an anti-BrdU antibody in order to establish 
the replication index for each one of the genotypes. 
The results obtained for this study are summarised in the following graph (Fig. 3.5). 
Because ERCC 1-deficient and double null animals are runted, it was decided to use 
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rare runted wild type and p53 nulls as controls for this experiment. For comparison, 
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Figure 3.5: Percentage of BrdU—stained cells in the four different genotypic classes 
of liver from 3 week—old mice. Standard errors are shown. wt/wt stands 
for p53wt/ERCC1wt; wt/hom stands for p53wt/ERCC1hom; hom/wt stands for 
p53hom/ERCC1wt and hom/hom stands for p53hom/ERCC1hom. n indicates the 
number of animals sampled per category. 
Overall, the labelling index for the runted wt/wt, p53hom/ERCC1wt and p53wt/ERCC1 
horn livers is very low (less than 2%) (see Fig. 3.6). This can be explained by the fact 
that all animals participating in this study were runted and therefore suffer from an 
impairment of growth. As expected, the level of replication in normal—sized wild type 
animals was higher (4%). 
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Figure 3.6: Typical BrdU staining patterns for the four different genotypic classes of 
liver from age matched mice (3 weeks old). Photographs of liver sections were taken 
from BrdU-stained/haematoxylin counterstained sections under the microscope using 
a 40x magnification lens. A) wild type liver. Arrow points towards a normal size 
BrdU-stained nucleus. B) p53wt/ERCC1h0m liver. Arrow points towards a normal 
size BrdU-stained nucleus. Star is situated next to a BrdU-stained polyploid (giant) 
nucleus. C) p53hom/ERCC1wt liver. Arrow points towards a normal size BrdU-
stained nucleus. D) p53hom/ERCC1hom liver. Arrow points towards a normal size 
BrdU-stained nucleus. Star is situated next to a BrdU-stained polyploid (giant) nu-
cleus and eight-point star is situated next to a MU-stained polyploid binucleate 
cell. 
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Although replication levels in ERCC 1-deficient livers are less than in non-runted wild 
type animals, when compared to runted wild type animals there is no significant detri-
mental effect in terms of replication. In runted p53-/- livers the levels of replication 
are not rescued to normal wild type (non-runted) levels. It is possible that in these 
rare p53 null runted livers, the control of replication is carried out in the absence of 
p53. This suggests that under circumstances where there is efficient DNA-repair (no 
genotoxic stress), p53-independent pathways control the replication process. 
However, in the p53hom/ERCC1hom tissues the level of replication has doubled com-
pared to all other runted genotypic classes, reaching normal levels. This seems to 
indicate that double null hepatocytes proceed with the replication of their DNA in the 
absence of a proficient DNA repair mechanism. 
Once the difference in the replication index of the different liver classes was established, 
it was of interest to determine which subpopulation of hepatocytes, i.e., diploid, or 
polyploid, were responsible for the increase of BrdU incorporation in double null livers. 
In order to investigate this, studies to determine the size distribution of BrdU-positive 
nuclei were carried out (a summary graph is shown in Fig. 3.7). 
When the graphs corresponding to the BrdU-positive nuclei from the different geno-
typic classes are compared (Fig. 3.7) it can be seen that in the double null (p53hom/ 
ERCC1hom) livers the distribution of sizes of BrdU positive nuclei is shifted towards 
the bigger nuclei when compared with the other genotypes (see also Fig. 3.6 D). What 
is more, if the size distribution of BrdU-stained nuclei is compared to the general nu-
clear size distribution in the four different genotypic classes (Fig. 3.7) it is clear that 
although the distributions of BrdU-stained nuclei in both the wild type, the p53 null 
and the ERCC1 null livers correspond with the general area distribution for the same 
genotypic classes, this is not the case for the double null livers. 
In this latter case, it is apparent that the replicative potential of the liver lies within 
the polyploid subpopulation of hepatocytes (shown by a distribution of BrdU-stained 
nuclei that is shifted towards the bigger/polyploid nuclei) (see Fig. 3.7). If this is 
taken together with the fact that the percentage of BrdU-stained nuclei in these livers 
is higher than that seen in any of the other runted animals and has reached levels 
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Figure 3.7: Nuclear area size distribution of BrdU—stained nuclei in the four different 
genotypic classes of hepatocytes from 3 week—old mice (black bars). For comparison 
purposes, the general nuclear area size distribution of the hepatocytes corresponding to 
each genotypic class is also shown (grey bars). The areas were calculated as described 
in Materials and Methods, section 2.2.13. 
equivalent to that of normal wild type livers, it is reasonable to think that those nuclei 
that have 'gained' a replicative status are the polyploid nuclei. In addition, this 'gain 
of replicative function' effect is not seen in p53-/- ERCC1+/+ cells which reinforces 
the idea that in this system there is a link between NER and cell cycle regulation. 
Indeed, NER and cell cycle control can be brought together in the following model 
that would explain the observations in the double null livers: Hepatocytes are subject 
to high levels of endogenous damage. Although double null hepatocytes lack NER, 
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they probably escape the arrest at the G2 checkpoint of the cell cycle (see section 
3.2.6) due to their lack of p53. This allows these cells to go through additional rounds 
of replication, which results in the higher level of BrdU-labelling seen in these livers. 
3.2.5 The ratio of (G1+G2+M) cells to S cells is elevated in ERCC1-
deficient hepatocytes 
Ki67 staining was used to determine the amount of cycling cells in each one of these 
four categories of liver tissue. Scoring was performed in the same manner as for BrdU 
(see Materials and Methods). The results are shown in Fig.3.8. 
Although Ki67 has traditionally been reported to stain cycling cells only, it is important 
to note that recent studies indicate that cells that overexpress p21 or p53 remain 
positive for Ki67 staining even though they are arrested (vanOijen et al., 1998). Cells 
at GO are not stained by Ki67. 
As expected the percentage of cycling cells in the runted wild type mice is low (an 
average 2.36%), which is consistent with the runted phenotype and the cycling char-
acteristics of liver cells in general. This is in contrast with the other runted genotypes. 
In the case of p53 null livers, the percentage of cycling cells has increased compared 
to the wild type livers. In this particular genotype, Ki67 would be expected to stain 
only cycling cells and therefore, this seems to be a good reflection of what would be 
expected of cells that do not possess functional p53, i.e., poor regulation of cell cycle 
progression, which ties in with the observed increased frequency of cancers seen in 
these mice. 
In order to be able to discuss the results obtained for the rest of the genotypic classes 
studied it is important to take into account a number of considerations. 
• In these livers, both cycling and non-cycling cells (arrested cells) are stained by 
Ki67. 
• Cells in all stages of the cycle are stained. 
Since the results of the BrdU staining procedure allow us to know exactly how many of 
the cycling cells are in 5, it is possible to derive the percentage of cells that are either 
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Figure 3.8: Percentage of Ki67-stained cells in runted animals of the four different 
genotypic classes of liver from 3 week-old mice. Standard errors are shown. wt/wt 
stands for p53wt/ERCC1wt; wt/hom stands for p53wt/ERCC1hom; hom/wt stands 
for p53hom/ERCC1wt and hom/hom stands for p53hom/ERCC1hom. n indicates the 
number of animals sampled per category. 
in Gi, G2 or M using both sets of data. These percentages are calculated in Table 
3.1 and a graph showing the combined results from the BrdU and the Ki67 staining 
procedure is also shown below (see Fig. 3.9). 
In this analysis only the population of cells within the cell cycle, i.e., those cells that 
are either cycling (G1,S,G2 or M cells) or cells that are arrested, is considered. The 
GO population of hepatocytes is not included in the calculations. Both ERCC1 null 
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Figure 3.9: Percentages of Ki67— and BrdU—stained cells in the four different geno-
typic classes of livers from 3 week—old mice. Standard errors are shown. wt/wt 
stands for p53wt/ERCC1wt; wt/horn stands for p53wt/ERCC1horn; hom/wt stands 
for p53horn/ERCC1wt and horn/horn stands for p53hom/ERCC1horn. 
compared to the wild type controls. However, when the ratio of G1+G2+M cells to 
S cells is compared, it is clear that it is much higher in the ERCC1—deficient cells 
and it is closer to normal, wild type levels in the double null livers. Such a difference 
can be explained if we think that the increase in cells other than in S phase in the 
ERCC 1—deficient livers is due to all the hepatocytes that are arrested in G2 (see next 
section). In double nulls, due to the lack of p53, this arrest is not effective and the 
ratio of G1+G2+M cells to replicating cells is not affected. Again, this ratio is slightly 
elevated for p53—deficient livers, but in this case, since neither p21 nor p53 levels are 
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Genotype %BrdU] %Ki67 %(G1+G+M) I 106Y(G1+G+M)/%S1 
Wild type 0.7 3.06 2.36 3 
p53 wt/ERCC1 horn 1.96 13.45 11.49 6 
p53 hom/ERCC1 wt 1.70 8.5 6.8 4 
p53 hom/ERCC1 horn 4.99 17.45 12.46 2.5 
Table 3.1: Summary of the data obtained from the BrdU- and the Ki67- staining of 
liver sections from the four different genotypic classes of 3 week-old mice. %BrdU 
and %Ki67 represent the percentage of BrdU- and Ki67-positive cells; %(G1+G2+M) 
is the difference between the percentage of Ki67-positive cells and the percentage 
of BrdU-positive cells; %(G1+G2+M)/%S is the ratio of the percentage of cells in 
G1+G2+M to the percentage of cells in S. 
elevated, this increase in the ratio of G1+G2+M cells to S cells is only due to cells 
cycling out of control, with no contribution from arrested cells (see discussion above). 
When the distribution of the nuclear area sizes of the Ki67-positive nuclei is looked 
at (Figs. 3.10 and 3.11), it is noticeable that in the double null livers, those cells that 
are cycling show a tendency towards bigger sizes compared to the distribution shown 
for the general hepatocyte population. As it has already been discussed, this is also 
the case for the BrdU-positive nuclei in these double null livers where the effect was 
more pronounced. If this is taken into account, it is logical to think that the shift 
observed in the Ki67-positive double null cells is due to the bigger sizes of nuclei that 
are replicating (BrdU-positive nuclei). In the case of ERCC1-defective nuclei, both 
the Ki67-stained and the BrdU-stained nuclear populations show the same area size 
distribution as that of the general population. Since the percentage of BrdU-stained 
nuclei is so low in these ERCC 1-deficient livers (less than 2%) the vast majority of 
Ki67 cells belong to the non-replicating category (%(G1+G2+M)=11.49%) (see Table 
3.1; also see next section for further support for this argument), rather than S. 
3.2.6 ERCC1—deficient hepatocytes are arrested at G2 
In order to see what mechanisms lay behind this increase of the non-S hepatocyte 
population in the ERCC1-deficient livers, it was necessary to obtain direct proof of 
which point of the cell cycle these cells were at. This was achieved using centromeric 
staining of hepatocytes. Briefly, fresh liver cells were stained with a NR antibody 
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Figure 3.10: Nuclear area size distribution of Ki67—stained nuclei in the four different 
genotypic classes of hepatocytes from 3 week—old mice (black bars). For comparison 
purposes, the general nuclear area size distribution of the hepatocytes corresponding to 
each genotypic class is also shown (grey bars). The areas were calculated as described 
in Materials and Methods, section 2.2.13. 
which recognises all three cenpA, cenpB and cenpC antigens, counterstained with DAPI 
and analysed under a deconvolution microscope (see Materials and Methods, section 
2.2.11). The end result is the fluorescent staining of centromeres in the cells and the 
results obtained are presented in the following Figure. 
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Figure 3.11: Typical Ki67 staining patterns for the four different genotypic classes of 
liver from age matched mice (3 weeks old). Photographs of liver sections were taken 
from Ki67-atained/haematoxylin counterstained sections under the microscope using 
a 40x magnification lens. A) wild type liver. Arrow points towards a normal size 
Ki67-stained nucleus. B) p53wt/ERCC1hom liver. Arrow points towards a normal 
size Ki67-stained nucleus. Star is situated next to a Ki67-stained polyploid (giant) 
nucleus. C) p53hom/ERCC1wt liver. Arrow points towards a cluster of normal size 
Ki67-stained nuclei. D) p53hom/ERCC1hom liver. Arrow points towards a normal 
size Ki67-stained nucleus. Star is situated next to a Ki67-stained polyploid (giant) 
nucleus and eight-point star is situated next to a Ki67-stained polyploid binucleate 
cell. 
(a) Wild type nucleus 	 (b) Big (polyploid) ERCC1 null nucleus 
(C Small (diploid) ERCC1 null 
nucleus 
Figure 3.12: Centromere staining in wild type (a), polyploid null (b) and diploid null (c) 
hepatocytes. NR antibody was visualised by Texas Red. Each centromeric structure is 
represented by a red spot. The DNA is stained with DAPI and presents a blue color. 
The majority of the centromeric structures in (a) are single spots so this nucleus is 
considered to be in Gi. On the other hand the majority of the red dots in (b) and (c) 
are double spots so these nuclei are considered to be in G2. 
70% of the wild type hepatocytes examined. Only 30% of the wild type hepatocytes 
examined were at G2 (identified by a prominence of double centromeric structures). In 
the case of ERCC1 null hepatocytes belonging to an age-matched littermate, approx. 
75% of the hepatocytes were in G2. Figs. 3.12(b) and 3.12(c) represent such nuclei. It 
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is noteworthy that both diploid (small) and polyploid (big) nuclei were found to be at 
G2 as shown by a majority of doubled centromeric structures in these nuclei. This fact 
reinforces the suggestion presented in the previous section that the G2 arrest seen in 
the ERCC1-deficient hepatocytes is a phenomenon that affects the general hepatocyte 
population and not the polyploid cells only. 
It is now possible to answer the question that was presented in the previous section 
regarding the distribution of cell cycle phases in ERCC1-deficient hepatocytes. It 
follows from the results obtained with the centromeric staining studies that amongst 
the different populations of cells (G1, G2 and M) that could be responsible for the 
increased ratio of (Gl+G2+M) to S cells in the ERCC1-deficient hepatocytes (see 
previous section, Fig 3.10, Table 3.1), the most likely to be responsible, given its high 
incidence amongst the ERCC1-deficient cells, are cells arrested in G2. 
It would have been desirable to have performed this technique on double null hepato-
cytes. The prediction for these cells would be that since they escape the G2 arrest, 
they would not show the same pattern of centromeric staining as the ERCC1 null 
hepatocytes. Thus, we would be most likely to see the single-dot pattern seen in the 
wild-type cells. Unfortunately, this could not be done due to the lack of suitable ma-
terial. This technique is carried out using fresh tissue and it was not possible to obtain 
any double null live animals before the conclusion of this thesis. In an attempt to 
overcome this obstacle, centromeric staining of fixed material was attempted with no 
positive results. This particular experiment awaits the production of more double null 
stock to be suitably completed. This experiment will be carried out in David Melton's 
laboratory. 
3.2.7 p21  is a possible mediator of the G2 arrest seen in ERCC1 null 
livers 
p21 is involved in cell cycle arrest at the Gi checkpoint of the cell cycle as part of 
a p53-dependent pathway (Bates and Vousden, 1996). p21  null transgenic mice are 
viable, showing that p21 is not essential for development. They do not show the 
increased incidence of tumours associated with p53 absence. Fibroblasts from these 
animals, however, cannot arrest in Gi following DNA damage as expected (Brugarolas 
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et al., 1995; Deng et al., 1995), and what is more, human diploid fibroblasts and human 
tumour cell lines deficient in p21 show similar characteristics (Waldman et al., 1995; 
Polyak et al., 1996; Brown et al., 1997). 
From the studies of the latter cells another role for p21 has emerged. p21 has also been 
involved in both p53-mediated G2 arrest and coupling of DNA synthesis and mitosis 
(Waldman et al., 1996; Polyak et al., 1996). This notion has also been supported by 
the findings in another transgenic mouse model (Wu et al., 1996). According to Wu 
and collaborators, mice overexpressing p21 in their liver present a liver phenotype and. 
developmental characteristics very similar to the ones found in ERCC1-deficient mice. 
In his paper Wu proposes that a likely explanation for the phenotype he observes is 
the p21-mediated arrest of the hepatocyte cell cycle most probably at G2. 
To see if elevated levels of p21 could be associated with the cell cycle arrest seen 
in ERCC1 null mice, total RNA extracted from the four different types of liver was 
assayed for p21 mRNA levels. The graph below shows the overall results obtained 
from the northern analysis (Fig. 3.14). Pooled results from the analysis of a total 
of 11 non-runted wild type animals, 26 ERCC1-deficient animals, 3 non-runted p53-
deficient animals, and 3 double null animals are represented in this figure. The values 
represented in this graph correspond to the average p21 mRNA levels (expressed as 
p21/GAPDH signal values) corresponding to each phenotypic class. Figure 3.13 cor-
responds to a sample northern autoradiography of several liver mRNA's probed with 
both p21 and GAPDH. 
A number of conclusions can be derived from this experiment. Firstly, the basal level 
of p21 message in ERCC1-/- and p53-/-ERCC1-/- is double and 4.5 times that of the 
wild type livers, respectively. Weeda and co-workers also report elevated levels of p21 
in their ERCC1 k/o mouse model (Weeda et al., 1997).The fact that those are the 
two classes of liver tissue that present the aberrant polyploid phenotype ( similar to 
that reported in Wu's paper) indicates that p21 may indeed play an important role 
in the polyploidisation process as suggested by Wu et al. Secondly, the level of p21 
transcript in p53-/- is equivalent to that of the wild type samples. This aspect has 
interesting implications since the expression of p21 has been extensively reported to 
depend mainly on its transcriptional activation by p53. There are studies, however, 
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Figure 3.13: p21  northern autoradiography of total mRNA extracted from livers cor-
responding to the four different genotypes. All livers were extracted from 3 week-old 
animals. In order to obtain a loading control, the northern was reprobed with GAPDH 
and the ratio of p21/GAPDH signals was calculated using a phosphorimage analysis 
system. DN: double null; p53-/-: p53-/-ERCC1+/+; ERCC1-/-: p53+/+ERCC1-/-; 
WT: wild type 
that show that p21 activation can also be p53-independent (Wu and Levine, 1997; 
Michieli et al., 1994; Cox, 1997). In support of this latter view this study shows that 
in mouse liver, in vivo expression of p21 both in the presence and in the absence of 
proficient NER, is p53-independent. 
3.3 Discussion 
There is extensive evidence that the tumour suppressor p53 has a prominent role in 
cell cycle regulation and apoptosis in response to DNA damage (Dumaz et al., 1998; 
Haapajarvi et al., 1997; Kuwano et al., 1997; Reinke and Lozano, 1997; Selter and 
Montenarh, 1994; Smith et al., 1995; Sun et al., 1995; Wim et al., 1997; Wu et al., 1997; 
Ziegler et al., 1994). There is growing evidence that supports the notion that a tight 
regulation of the DNA repair process and cell cycle progression is necessary in order for 
the cell to cope with genotoxic stress (Brugarolas et al., 1995; Kaufmann and Paules, 
1996; Murray, 1994; Pellegata et al., 1996) and p21 (a major p53 effector) has been 
shown to play an important role in this process via p53-dependent and independent 
pathways (Chin et al., 1997; Kuwano et al., 1997; Li et al., 1994b; Li et al., 1996; 
McDonald et al., 1996; Sheikh et al., 1997). There is also growing evidence that p21 
plays an active role in the DNA repair process either directly or indirectly through 
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Figure 3.14: p21 levels in livers corresponding to the four different genotypes. All livers 
were extracted from 3 week-old animals. The bars show the means of the p21/GAPDH 
ratio for all the samples of a given genotype. Standard errors are shown. wt/wt 
stands for p53wt/ERCC1wt; wt/horn stands for p53wt/ERCC1horn; horn/wt stands 
for p53hom/ERCC1wt and horn/horn stands for p53hom/ERCC1horn. n represents 
the number of animals sampled per genotype. 
its interaction with PCNA (proliferating cell nuclear antigen) (Nakanishi et al., 1995; 
Savio et al., 1996; Zhang et al., 1994). 
The liver phenotype presented by the ERCC1-deficient mouse is a reflection of a pro-
found misregulation of the cell cycle in ERCC 1 null liver cells (McWhir et al., 1993a; 
Weeda et al., 1997). The fact that p53 levels had already been found to be elevated 
in ERCC1-deficient livers (McWhir et al., 1993a) makes the ERCC1-deficient mouse 
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a good model for the in vivo study of the relationship between p53, DNA-repair and 
cell cycle control. Weeda et al. also report deficiencies in the liver and spleen of their 
ERCC1 k/o mouse that we have not been able to see in our mice (see Conclusion 
section ?? for an extended discussion on this subject). 
Although the liver phenotype shown by the ERCC1 null mice is very severe, the absence 
of just one copy of this gene seems to have no effect on the mouse liver development. 
Indeed, ERCC1 +1- aged mice (15-31 months) present an aged wild type-like distribu-
tion of hepatocyte nuclear area. This distribution coincides with that of young 3 week 
old ERCC 1-deficient livers and adds proof to the idea that the phenotype presented by 
the young ERCC1-deficient mice is related somehow to premature ageing and severe 
cell cycle control misregulation. 
One way of looking at this was to carry out a systematic analysis of different aspects 
of the hepatocytes life cycle, such as polyploidisation and binucleation rates, which 
vary at different times of liver development and differentiate young from old livers, in 
combination with cell cycle regulation. In order to do this a number of mouse strains 
were established in collaboration with Dr. Alan Clarke (Department of Pathology, 
Edinburgh University). ERCC1 and p53 were chosen to be studied in conjunction and 
the genotypic classes used in this study were p53+/+ERCC1-/-, p53-/-ERCC1+/+, 
p53-/-ERCC1-/- and wild type mice. 
Binucleation 
When binucleation was studied, it was clear that the binucleation process in ERCC1 
deficient animals was impaired. ERCC1-/- deficient livers show a reduced percentage 
of binucleate cells compared to wild type. In contrast, wild type levels of binucleation 
are observed when p53 is not present in the ERCC1 null livers, which points towards a 
role for p53 in preventing binucleation when DNA repair does not occur in these cells. 
Under normal circumstances, however, p53 absence does not seem to affect binucle-
ation (see Fig. 3.4). This p53-dependent repression of binucleation in NER-defective 
cells makes sense in the context of the role of p53 as 'guardian of the genome'. It is 
not desirable for cells that cannot repair their DNA to proceed through replication 
(or binucleation, which involves a round of replication followed by an acytokinetic cell 
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division) in the presence of damaged DNA. This could lead to the perpetuation of pos-
sible lethal and carcinogenic mutations and the creation of chromosomal aberrations. 
p53 plays a crucial role in preventing this type of situation from occurring by arresting 
cells at G1/S before they replicate the damaged DNA. In the case of ERCC1-deficient 
cells, p53 would be playing a similar role, this time arresting the cells at G2, thus 
preventing the cells from going through mitosis and from becoming binucleated in the 
absence of a proficient DNA repair system. 
BrdU labelling index 
The effect of p53 absence can also be seen at the S cell cycle point as derived from 
the BrdU labelling data. All runted animals present lower percentages of cells in S 
phase than non-runted wild type animals which would be consistent with their intrinsic 
growth retardation. The values obtained for normal wild type animals are in agreement 
with results obtained by other groups (Soames et al., 1994; Sakata et al., 1996). These 
low runt-related levels in the ERCC 1-deficient animals are rescued back to normal, 
non-runt levels in the absence of p53, which again indicates a possible involvement of 
p53 in the control of progression through the G2 checkpoint. When p53 is not present, 
this checkpoint is not functional and the cells are allowed to go through additional 
rounds of replication, which would explain the higher levels of BrdU labelling in the 
double null livers. 
Ratio of (G1+G2+M) cells to S cells 
The difference seen in the regulation of the cell cycle in the four different types of 
hepatocytes is also reflected in the ratios of hepatocytes at different stages of the cell 
cycle in the different livers. Using both the BrdU- and the Ki67-staining results, it 
was possible to determine which percentage of the hepatocyte population was in either 
Gi, G2 or M and which percentage was in S. Not surprisingly, the (G1+G2+M) to 
S ratio in p53 deficient cells was slightly elevated compared to the normal, wild type 
ratio (4 and 3, respectively), which reflects the loss of cell cycle control due to the 
absence of p53 in these hepatocytes. 
This ratio was more highly elevated in ERCC 1-deficient livers (ratio=6), but was close 
to normal in double null hepatocytes (ratio=2.5). It is possible that the elevation in 
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the pool of cells in either Gi, G2 or M in ERCC1-deficient livers is due to the ac-
cumulation of G2 cells. Support for this view comes from the centromeric staining 
experiments discussed in previous sections. The logical conclusion regarding the situ-
ation in the double null livers is that, since these cells lack p53 and therefore bypass 
the G2 checkpoint, their G1+G2+M to S ratio would be close to the one seen in wild 
type hepatocytes. This is indeed the case. Double null livers have a G1+G2+M to S 
ratio of 2.5 compared to a ratio of 3 in wild types. Unfortunately, direct proof of the 
bypass of G2 arrest in double null cells using the centromeric staining technique could 
not be obtained. The expectation for the double null hepatocytes would be that they 
present the same pattern of centromeric staining as the wild type hepatocytes. This 
experiment will be carried out as soon as more double null mice are available. 
Despite all this, in the present work it has also been shown that, except for the binucle-
ation rate, the phenotype of the ERCC1-/- liver is not rescued by the absence of p53. 
It is possible that the increase in p53 protein levels seen in these cells is a response 
to endogenous damage but this p53 accumulation in itself is not an essential event in 
the process leading to the observed overall phenotype in terms of aberrant hepatocyte 
morphology and ploidy levels. It is more likely that a p53-independent pathway is 
involved in this process. 
p21 in liver 
A likely candidate to take part in such a pathway is p21. p21  has an already well 
established role in cell-cycle control and cell growth and overexpression of p21 in liver 
has also been linked to an ERCC1 null-like phenotype (Wu et al., 1996). Another line 
of evidence comes from studies performed in vitro using a human colorectal carcinoma 
cell line (DLD1). In this study a p53-independent role for p21 in cell growth and 
DNA repair (Sheikh et al., 1997) has been proposed. It is interesting to note that 
although the majority of the DLD1 cells overexpressing p21 grew slower and did not 
exhibit an apoptotic phenotype, a subset of these cells did undergo apoptotic death 
after becoming giant cells. 
The phenotype of the ERCC1-/- and double null livers is reminiscent of the one de- 
scribed for the DLD1 cells upon induction of p21. Whereas human cancerous cells in 
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vitro are committed to an apoptotic pathway if they become giant cells in response to 
p21—dependent growth inhibitory signals, mouse hepatocytes in vivo may arrest their 
progression through the cell cycle instead. The ERCC1 null mouse may be a useful tool 
in the understanding of the effect of p21—mediated growth arrest and its relationship 
with the DNA repair machinery in vivo. 
The mechanism by which p21 exerts its role, however, remains to be elucidated. p21 has 
been shown to play a role in the control of the initiation of mitosis (G2/M transition) 
through its effect on cdk2 and cdkl—cyclin B (Guadagno and Newport, 1996). p 21  has 
also been shown to bind and inhibit cdkl—cyclin A complexes, which play an important 
regulatory role in early mitosis (G2) (Basi and Draetta, 1995). Elevated levels of p21 
may be responsible for arresting the cell cycle progression in those hepatocytes that 
are deficient in ERCC1 at very early stages of the mouse development (for a possible 
additional role of p21 in double null livers, see below). Further experiments in this 
direction are required to fully elucidate the exact mechanism of p21 action in relation 
to growth control in mouse hepatocytes. 
Another aspect of these ERCC1 null livers is their elevated levels of polyploidisation at 
an early age. Polyploidisation of hepatocytes has a strong correlation with age and the 
levels of toxicity (either endogenous or exogenous damage) that the liver is subjected 
to. Because hepatocytes absorb some toxic products as part of their function, it is 
possible that liver cells accumulate genetic damage more rapidly than cells from other 
tissues. The absence of a special pool of non—differentiated stem cells able to produce 
more new hepatocytes makes the polyploidisation probably a safer way to compensate 
for cellular losses than mitosis which may result in a high incidence of chromosomal 
abnormalities (Medvedev, 1986). Somatic polyploidisation in liver and other tissues 
has been proposed to be a form of 'physiological regeneration' and this model for 
polyploidisation correlates well with the inverse correlation see between mitotic index 
in liver and the level of polyploidisation found in different species . Mouse liver for 
example, has a much lower mitotic index than rat liver and accordingly, mouse liver is 
the one that presents the highest level of polyploidisation. 
Apart from its role in protecting from the deleterious cellular effects of endogenous 
DNA damage, polyploidisation makes it possible for the liver to preserve its normal size 
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and the approximate volume of its functional capability without a risk of accumulation 
of a large proportion of aberrant, aneuploid cells, which may increase the level of 
cellular transformation. Nevertheless, the fact that polyploidisation starts at very 
early stages of the development of the mammalian liver (after birth) and at points of 
active growth, points towards a protective role of polyploidisation. Thus, this process 
would reduce the occurrence of mitoses which represent the most sensitive stage of 
the cell cycle and would decrease the accumulation of aberrant genomes, rather than 
providing an alternative way of repair and regeneration (Medvedev, 1986). 
There are several hypotheses that try to explain the possible mechanism by which 
polyploidisation exerts its protective role. 
By creation of redundant genetic information and reiteration of vital genes. 
By making the cell more resistant to toxins and carcinogens. 
By providing a morphogenetic strategy against ageing in specialised diploid sys-
tems. However, the polyploidisation of hepatocytes in later periods of life , par-
ticularly the progressive polyploidisation which is observed in mouse liver during 
senescence by formation of nuclei up to 32C in DNA content, is apparently an 
integral part of the ageing process, and more than representing a real protection 
against ageing it could well be a tissue—specific adaptation to the age—related 
cellular loss (Medvedev, 1986). 
By reducing the deleterious effects of chromosomal aberrations which might have 
higher frequency in liver resulting from its detoxification functions. 
The mechanism by which polyploidisation comes about involves continuous rounds of 
DNA replication in the absence of mitosis (a process known as endoreduplication). p21 
has also been reported to be involved in the regulation of the checkpoints which prevent 
endoreduplication, both using p21 null cells and p21 expressing cells lacking pRb in 
vitro (Bates et al., 1998; Niculescu III et al., 1998; Waldman et al., 1996). In this study 
endoreduplication is observed in the presence of elevated levels of p21, as opposed to 
its absence. The absence or presence of pRb has not been tested in these animals 
but there is no reason to believe that pRb would be modified or absent in otherwise 
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normal ERCC1-deficient cells. This possibility, however, can easily be tested in future 
experiments. It is proposed therefore that misregulation of the expression of p21 (either 
its absence or its overexpression) results in the loss of the 'knowledge' by the affected 
cell that it is in G2 (see 'G2 memory', Chapter 1, section 1.6) and this leads to repeated 
rounds of replication in the absence of mitosis. 
The other possibility is that elevated levels of p21, in response to non-repaired, ac-
cumulating damage, lead the hepatocytes towards a terminal (and also protective) 
differentiation pathway. p21 has been reported to play an important part in the 
differentiation process of several cell types (Elbendary et al., 1994; Jiang et al., 1994; 
Parker et al., 1995; Zhang et al., 1995). Since polyploidisation is the natural state 
of 'aged' hepatocytes the ERCC1 null phenotype could therefore be reminiscent of a 
premature ageing syndrome. This hypothesis will be tested in the context of a human 
premature ageing syndrome in Chapter 6. 
In summary, in the present in vivo study, in the absence of a proficient repair system 
(as happens when ERCC1 is not present), endogenous damage is accumulated fast in 
the liver which prompts the accumulation of p53 and p21. In this system, the induction 
of p21 seems to be p53-independent. p53 is likely to be involved in the control of the 
arrest that in hepatocytes occurs at the G2 checkpoint in the absence of proficient NER. 
When p53 is present, the G2 checkpoint is active and hepatocytes lacking ERCC1 are 
arrested at that point of their cell cycle. When neither ERCC1 nor p53 are present, 
as in the case of double null hepatocytes, cells apparently lack the G2 checkpoint and 
as a consequence they go through additional rounds of replication, as shown by the 
normal wild-type levels of BrdU incorporation in double null livers. Whether p53 is 
present or not, however, makes no difference as to the final effect of the NER absence 
in liver and hepatocytes undergo polyploidisation regardless of the p53 status. 
p21 may also have an active role in a p53-independent manner in the regulation of the 
G2/M checkpoint control, promoting G2 arrest, possibly after a previous deregulation 
of the S to G2/M transition, or/and in senescence. It is noteworthy that in double null 
hepatocytes, where p53 is not present and p21 mRNA levels are elevated, the arrest at 
the G2 checkpoint is nevertheless bypassed. This may suggest that the main role of p21 
in this particular system could be more likely related to the regulation of hepatocyte 
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differentiation and senescence. 
Hepatocytes lacking NER are more prone to accumulation of endogenous damage. 
The way this type of cell deals with this situation is by promoting polyploidisation, a 
process that involves both p53, in a manner that appears to be directly linked to cell 
cycle regulation at the G2 checkpoint, and p21, which in a p53—independent fashion 
(may be playing a more prominent role in the absence of p53) would probably promote 
the terminal differentiation of these cells. Both the p53—related and the p21—related 
mechanisms would have as an overall result the premature hepatic polyploidisation 
process seen in the ERCC1—deficient livers and their aged appearance. 
Chapter 4 
In Vitro Studies: Effect of UV 
on Replication in 
ERCC 1-Deficient Fibroblasts 
4.1 Introduction 
From the studies of the morphology and the cycling characteristics of the ERCC1-
deficient hepatocytes, it was clear that the absence of ERCC1 severely affects the reg-
ulation of the cell cycle in these cells. In the previous chapter it is argued that ERCC1-
deficient hepatocytes bypass the DNA damage-inducible G1/S checkpoint control and 
that they are subsequently arrested in G2 only if p53 is present. It was thus of in-
terest to study how ERCC1 null cells behave in terms of replication under conditions 
of damage. If the normal GuS checkpoint control is overridden in these cells under 
conditions of endogenous damage, does this mean that the expected arrest after UV 
damage is also affected? Do ERCC1-deficient cells show a different response to UV 
light compared to their wild type counterparts? 
This chapter deals with the experimental approach undertaken in an attempt to answer 
those questions. Therefore, in this chapter special attention is paid to the mechanisms 
of replication arrest under conditions of UV damage in excision repair-deficient and 
-proficient rodent cells. Extensive work has been carried out regarding this subject 
(for a review see Meneghini et al., 1981 and the Chapter 1, section 1.2 in this thesis), 
but it is not clear yet what the mechanisms of DNA inhibition by pyrimidine dimers 
are and what exactly happens in terms of the recovery from DNA synthesis arrest after 
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UV irradiation. 
It is known that after UV irradiation DNA synthesis is arrested and that after a 
certain period of time, it resumes again and replication proceeds as usual. Experiments 
carried out with human XP cells (deficient in NER) show that such recovery in DNA 
synthesis does not happen in the absence of NER (Lehmann, 1979). However, it is 
also known that NER is not enough to bring about such recovery, as is the case for 
human fibroblasts derived from patients with Cockayne's syndrome. These cells do not 
show recovery of DNA synthesis after UV but nevertheless they are able to carry out 
excision repair of dimers (Lehmann et al., 1979). The exact mechanisms behind this 
recovery are unknown, but there is a hint that it happens during S phase and protein 
synthesis is necessary for it to occur in human fibroblasts, as shown by experiments 
performed with protein and DNA synthesis inhibitors (Lehmann, 1979). Differences 
between rodent and human cells arise at this point. CHO cells seem to require DNA 
synthesis (passage through an S phase) to bypass the replication arrest (Meyn et al., 
1977). Also, only 25% of the dimers are eliminated in CHO cells after 5 J/m 2 , which 
seems to indicate that NER does not seem to account fully for the recovery in rodents 
(Meneghini et al., 1981). 
It has been suggested that the DNA recovery mechanism may be induced when DNA 
synthesis is inhibited. Specific proteins would be synthesised and a more effective 
DNA synthesis would be directed to the damaged template. This inducible process 
would resemble the bacterial SOS response (Meyn et al., 1977). It is also possible that 
the recovery mechanism is composed of NER and an inducible process dependent on 
de novo protein synthesis. This model would account for the behaviour of normal, 
XP variant, XP and rodent cells. The latter ones would be more dependent on the 
inducible process whereas the human cells would rely mainly on the NER mechanism 
(Meyn et al., 1977; Dahle et al., 1980). 
We wanted to study the behaviour of ERCC1-deficient rodent cells in terms of their 
capacity to recover from DNA synthesis arrest. In order to do so we used a method 
(described in the Materials and Methods, Chapter 2, section 2.2.12), that relies on 
the study of the number of double-strand breaks (DSBs) that can be detected after 
different periods of time post-UV irradiation. Briefly, a primary lesion in the DNA 
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(a single strand break) is converted to a DSB in the arrested replication fork by the 
enzymatic action of DenV and a decrease in the number of DenV—induced double strand 
breaks after UV irradiation is taken as an indication of the recovery from DNA synthesis 
arrest (fork progression arrest). Overall, the experimental procedure presented here 
allows us to correlate the rate of recovery from replication arrest with the extent of 
repair in the cell. 
In these experiments we used both CHO and transformed mouse cells. The choice 
of transformed cell lines was determined by the experimental procedures carried out, 
which involve great number of cells per experiment. Unfortunately, primary fibroblasts 
are difficult to grow and it was not possible to carry out all experiments with them. The 
preliminary results obtained with the transformed cell lines prompted the necessity to 
investigate further an aspect of DNA synthesis recovery that appeared to be different 
in ERCC1—deficient and NER proficient transformed cells. It was of vital importance 
then to find an experimental procedure that would allow a more flexible handling of 
the cells which if necessary, could also be used with primary fibroblast cell lines. 
The first part of this chapter deals with the former set of experiments up to the point 
where an apparent difference in recovery of DNA synthesis was identified (see section 
below, Theory). These experiments were carried out in Robert Johnson's laboratory 
in Cambridge under the supervision of Robert Johnson and Shoshana Squires (CRC 
Unit, Zoology Department, Cambridge). The rest of the experimental procedure was 
devised and carried out in Edinburgh and the results are presented in the second part 
of this chapter. 
The cell lines used for the experiments are C1109, CHO 43-3B (parental wild type 
transformed Chinese hamster cell line and ERCC1—mutant transformed Chinese ham-
ster cell line respectively), CHO AA8, CHO UV5 (parental wild type transformed 
Chinese hamster cell line and ERCC2—mutant transformed Chinese hamster cell line, 
respectively), PF20, PF24 (wild type transformed mouse cell line and ERCC1—mutant 
transformed mouse cell line, respectively) and PF+/+ and PF-/- (wild type and 
ERCC 1—deficient primary fibroblasts, respectively). All the CHO lines were kindly 
provided by R. Johnson. 
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Another aspect we wanted to investigate was the relationship between a possible mis-
regulation of the repair and the DNA synthesis processes in ERCC 1-deficient cells 
that would explain some of the phenotypic characteristics observed in the ERCC1-
deficient mice. It was clear from the morphology of the ERCC1 null livers (polyploidy, 
aneuploidy, aged appearance) that the cause of this phenotype had to do with cell 
cycle regulation defects. Since ERCC1 and replication protein A are known to interact 
and replication and DNA repair seem to have a tight interaction there was a possibil-
ity that the mutant phenotype was related to an ERCC 1-dependent misregulation of 
DNA replication. 
Studies of the relationship between DNA repair and replication of DNA have shown 
that the precise coordination of these two processes under genotoxic stress is of vital 
importance for the survival of the cell. Several genes and their corresponding prod-
ucts have been characterised as playing a role in this coordination process from the 
replication, the cell cycle and the DNA repair machineries. 
A key player in this process is PCNA (Jonsson et al., 1998). p21  is also known to inter-
act with PCNA (Li et al., 1994b) and to have an inhibitory effect on DNA replication 
(Chen et al., 1996a; Chen et al., 1996b; Jackson et al., 1995). Another protein that 
has been involved in the interaction between cell cycle control and replication is DNA 
polymerase € (Navas et al., 1995). RPA (replication protein A), a well characterised 
replication protein has a role both in replication and DNA repair and more specifically 
it has been characterised as conferring specificity to the ERCC 1 /XPF endonuclease 
activity (Matsunaga et al., 1996). 
The interaction between the above mentioned proteins indicates a fine balance and a 
careful and tightly regulated mechanism by which, under conditions of DNA damage, 
the cell cycle is arrested at the GuS checkpoint, before the onset of replication, so 
that the repair mechanisms can repair the damaged DNA before replication takes place 
and the damage is perpetuated. Another checkpoint at which arrest can take place is 
the G2 checkpoint. In this case, cells arrest entry into mitosis before damaged DNA is 
passed on to the daughter cells. This latter control mechanism is studied elsewhere in 
this thesis (Chapter 3). 
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Results obtained using the experimental procedures described here and experiments 
carried out by Melton and collaborators (Melton et al., 1998), have allowed the con-
struction of a model that explains the phenotype observed in these mice in terms of 
the way they deal with DNA damage and how they regulate the control of the cell 
cycle under conditions of UV damage. 
4.2 Theory 
4.2.1 Repair of cyclobutane pyrimidine dimers (CPDs) 
In order to study the removal of CPDs from the DNA replicating at the time of UV-
irradiation ([3 H]-labelled) and from the rest of the genome ([14  C]-labelled), analysis of 
DenV-induced SSBs in DNA extracted from these cells was carried out using alkaline 
gel electrophoresis. It is assumed that DenV cuts at all dimer sites present in the 
DNA. DenV incises at a dimer to give a single strand DNA break (Enzyme-sensitive 
site, ESS). Thus, the number of SSBs generated by the DenV action represents the 
number of incisions at CPD sites. It follows that the disappearance of ESS with 
incubation indicates the removal of dimers by the cellular repair machinery. 
Replicating DNA and bulk DNA can be differentially labelled with [3  H] TdR and ['4 C] 
TdR respectively. Once labelling is done, cells are irradiated and allowed to recover 
after injury. By plotting the number of remaining ESSs in [ 311] TdR and [' 4 C] TdR 
labelled DNA after the recovery time, the rate of repair in replicating and in bulk DNA 
can be deduced. 
The number of single strand breaks (SSBs) per unit DNA are calculated from the 
migration profiles of the alkaline gels, as stated in Materials and Methods, section 
2.2.12. The ESSs are defined as the breaks produced by the DenV acting on the 
UV-irradiated DNA. 
ESS= (Breaks per Mb induced by the DenV acting on UV (UV irradiated) DNA)-
(Breaks per Mb generated by the DenV acting on the unirradiated control). 
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4.2.2 Arrest of the replication machinery at the UV-induced dimers 
and the time course of the recovery from the stalling. 
These parameters can be studied from the results obtained from the pulse field gels 
(AFIGE) (Denko et al., 1989; Stamato and Denko, 1990). The presence of a single 
strand gap in the daughter strand opposite a pyrimidine dimer can be identified by 
the generation of Double Strand Breaks (DSBs) when the DNA embedded in agarose 
plugs is treated with DenV (see Materials and Methods, section 2.2.12). 
In this procedure, the amount of DNA that enters the gel is a measure of the number 
of DSBs formed and it is determined by calculating the fraction of radioactive counts 
that are released into the gels (any DNA fragment less than 1.6 Mbp long is released 
into the gel) as a percentage of the total radioactivity (%FAR) in that sample. 
It has been shown that the amount of DNA released into the gel varies linearly with 
the X-ray dose for both bulk and pulse-labelled nascent DNA, but the FAR values 
for the replicating DNA ([3 H]-labelled) are several times lower that those of the bulk 
DNA ([ 14 C]-labelled) (Stamato and Denko, 1990; Ryan et al., 1991). With the AFIGE 
it is not possible to calculate the number of DSBs per unit of DNA directly but it can 
be estimated indirectly by comparing the %FAR of the experimental DNA with that 
of DNA exposed to a known dose of X-rays. 
The different response of the replicating and bulk DNA to a given X-ray dose varies 
according to the cell strain used and the time allowed after irradiation. In order to 
compare different samples and cell types, the results are standardised as Gy equiv-
alent DSBs and not in %FAR. The following mathematical model is used for such 
calculations. 
Mathematical calculations 
FAR is calculated as: 
%FAR = 
CPM in track for 3H or 14 C - labelled DNA 
CPM in track + CPM in well (total CPM) 
(4.1) 
As 'y  irradiation induces both single and double strand breaks in the DNA which are 
equally distributed, and given the fact that the number of DSBs cannot be measured 
directly from the Pulse Field gels, the number of DSBs induced in the UV treated 
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samples is estimated from the %FAR of samples that have received a fixed dose of 'y 
irradiation (bOGy). 
In the -y irradiated samples the %FAR recorded is the sum of the release due to the 
fixed dose of bOGy plus the background levels of breaks, which are generated in the 
cell. 
For any given sample (S) and the same 'y  irradiated sample (G): 
the %FAR due to a dose of a lOOGy is A 
A=%FAR inG—%FAR in 	 (4.2) 
and therefore the DNA DSBs (Gy equivalent) are calculated as B. 
B = 100 x %FAR in S (UV or rnock)/%FAR of A (due to lOOGy) 	(4.3) 
Cellular DSBs induced by UV irradiation are: 
	
a=BofUV— BofUV 	 (4.4) 
DSBs induced after DenV treatment are: 
b = B of DenVUV - B of DenVUV 	 (4.5) 
b is the sum of cellular DSBs(a) and those that were generated by DenV due to stalling 
of the replication machinery. Thus the DenV associated DSBs (ESS DSBs)are (c): 
c(Gy equivalent) = b - a 	 (4.6) 
4.2.3 Arrest of the replication machinery after UV irradiation: Direct 
Assay 
In order to carry out a detailed study of the kinetics followed by the different cell 
types after UV it was necessary to devise a simpler assay that allowed the collection of 
specific data in an easy-to-analyse form. Thus, a short replication assay that allows us 
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to monitor the response at the level of replication in ERCC1—deficient and wild type 
cells after UV irradiation was devised. 
This assay has three major advantages over the previous experimental set up. 
• It only uses one type of radioactive isotope (tritiated thymidine). 
• It allows the synchronisation of the cells by isoleucine deprivation (G 1 arrest). 
• It is fast and the data is easily interpreted. 
Briefly, the cells are plated out at the desired density and they are allowed to settle 
overnight. The next day they are changed into an isoleucine—free medium for 16-18 
hours to obtain a Gi arrest. They are then released into S phase by changing their 
medium back to complete growth medium. The cells are then irradiated in S with a 
given UV dose after which they are pulsed with tritiated thymidine for 15 mm. The 
incorporation of radioactivity into their DNA is subsequently measured in a scintillation 
counter. All the data collected are in the form of DPM counts. 
Typically, a decrease in the incorporation levels (DPMs) relates to a decrease in repli-
cation. Likewise, an increase in the levels of replication will be reflected in a bigger 
tritiated thymidine uptake by the cell and higher radioactivity measurements. This 
allows us to see if there is a bypass of the arrest of the replication process after UV 
damage in the ERCC1 null cells. 
4.3 Results 
4.3.1 ERCC1—deficient transformed fibroblasts show impaired DNA 
repair activity. 
It has already been shown that cell lines defective in DNA repair (PF24, ERCC1-/-) 
are impaired in their capacity to repair DNA (Melton et al., 1998). Thus, it is logical to 
assume that PF24 cells cannot remove DenV—induced single—strand breaks from their 
genome after UV damage. In order to test this, the rate of removal of SSBs from the 
DNA of NER—deficient versus NER—proficient mouse transformed fibroblasts (PF24 
versus PF20) was assayed using the alkaline gel electrophoresis method. 
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Cells were prepared and treated as described in Materials and Methods and the results 
obtained are shown in Figure 4.1. This graph represents the number of ESS sites 
detected in both the bulk and the replicating DNA extracted from these cells after 
UV—irradiation (10J/m2 ). The number of ESS sites is plotted against time following 
UV irradiation. 
PF20 (ERCC1+/+) cells show a decrease of ESS sites with time in both bulk and 
replicative DNA. The decrease is noticeable 30 minutes after UV (14% less ESS than 
immediately after UV irradiation in the replicative DNA and 26% less ESS in the bulk 
DNA). The rate of loss of ESS sites is not rapid in either case, but this is in agreement 
with the low rate of repair that rodent cells exhibit after UV irradiation (Meneghini 
et al., 1981). In addition, the rate of decrease seems more rapid in the replicating 
DNA, which suggests that in mouse cells proficient in DNA repair, this repair takes 
place preferentially in the replicating DNA. 
As expected, FF24 cells show a different response. These cells seem to accumulate ESS 
sites at a higher rate than their wild type counterparts and these sites do not decrease 
with time below the starting level. This is likely to be a reflection of their inability to 
remove ESS (CPDs) after UV. 
In summary, NER seems to play a prominent role in the removal of SSBs in mouse cells. 
This removal seems to be preferentially directed towards replicating DNA and, when 
it happens, it is not very pronounced, which is in accordance with already published 
observations (Meneghini et al., 1981). 
4.3.2 NER—deficient rodent cells behave differently to NER—deficient 
(XPA) human cells in response to UV damage. 
As mentioned before, stalling of the replicating machinery can also be studied with this 
experimental approach. Calculations were carried out that provided information on 
stalling after UV in the different cell lines studied. Figure 4.2 shows the effect of UV 
in the mouse cells both in replicating and bulk DNA. This response is also compared 
to the response shown by a human XPA deficient cell line (data kindly provided by 
Shoshana Squires and Robert Johnson, Cambridge). 
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Figure 4.1: Repair capacity of PF20 (ERCC1 wild type) and PF24 (ERCC1-deficient) 
mouse transformed cell lines as indicated by the percentage of ESS sites remaining 
after UV. 
Briefly, any decrease in the number of DSBs as shown in any of these graphs is a 
reflection of the DNA-replicating machinery proceeding with replication after UV (see 
Introduction and Theory sections in this chapter, as well as Chapter 1 in this thesis). 
When both the replicating and the bulk DNA are studied by this method they show 
different behaviour in the way UV-induced damage affects them. Overall, the amount 
of DSBs induced in the bulk and replicating DNA differ in number (Fig. 4.2 top vs. 
bottom panel), which can be interpreted as replicating DNA being more sensitive to 
the formation of DSBs. This is an expected behaviour since replicating DNA is more 
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vulnerable to external damage than the protected, compact, supercoiled bulk DNA. 
Also, this may be an indication of the existence of gaps in the daughter strands of 
replicating DNA, which would make the number of DSBs higher. 
450 
400 
-- PE20 bulk DNA 
-v- PF24 bulk DNA 
MI.* 
	



























0 	180 	360 	540 	720 	900 	1080 	1260 	1440 
Minutes after UV irradiation 
Figure 4.2: Replication stalling as measured by the presence of DSBs in FF20 and 
FF24 cell lines. A human cell line deficient in XPA is also shown. The top panel 
represents the stalling in the genome overall. The bottom panel represents the stalling 
in the replicating DNA. 
As expected, the human cell line deficient in DNA repair, does not show a decrease in 
the number of DSBs after UV (both in the genome overall or the replicating DNA), 
which suggests that DNA synthesis remains stalled at the unrepaired lesions. This 
mechanism ensures that the cell does not replicate damaged and therefore potentially 
mutagenic DNA. 
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However, this is not the case for the mouse cell lines. Both PF20 and PF24, seem to 
continue with the replication of their DNA (shown by the rapid decrease in DSBs) re-
gardless of the damage inflicted upon their DNA. We know that damage is not removed 
efficiently (if at all) in these cell lines as shown with the alkaline gel electrophoresis 
procedure (see previous section). PF20 cells, which are capable of DNA repair, do not 
seem to remove SSBs very efficiently and PF24 cells, do not seen to do this at all. 
These kinetics of DSB removal are also shown with CHO cells (see Fig. 4.3). The 
number of DenV-induced DSBs in the replicating DNA from both CH09 and CHO 
43-313 cells decline rapidly soon after UV irradiation. By 3 hours after UV the number 
of DenV-induced DSBs has decreased to approximately 37 % of the initial number 
in CH09 cells and to approximately 15 % of the initial number in CHO 43-313 cells. 
Again this is an indication of rapid progression of fork movement after UV irradiation. 
In the case of CHO 43-313 cells this happens in the absence of lesion removal which, 
overall, seems to suggest that the existence of pyrimidine dimers is not an efficient 
blockage of fork progression in these cells and more importantly, NER does not seem 
to play a major role in the process of recovery from such arrest. 
This behaviour is in contrast with the human behaviour and could be an intrinsic 
difference in the way rodents and humans deal with their damaged DNA. It is likely 
that human cells rely on NER for the recovery of the arrest of fork progression, whereas 
hamster and mouse cells possess another mechanism, different from NER, that elicits 
a prompt recovery despite the presence of pyrimidine dimers and possible breaks in 
their DNA. This is supported by the fact that hamster cells seem to behave more like 
the mouse cells than human cells. 
There is an indication that ERCC1-deficient mouse cells (see Fig. 4.2) may arrest 
for a shorter time than their wild type counterparts. By 30 mm. after UV radiation 
DSBs have already diminished to approximately 55 % of the initial number in the 
mutant cell line whereas DSBs remain unaltered in the PF20 wild type cells. This 
apparent difference between ERCC1 wild type and ERCC1-deficient cells seen with 
this experimental method, prompted the following simpler and more flexible experi-
ments in which the main focus was to look in more detail into those first 30 mm. after 
UV-irradiation with an appropriate set of NER-deficient cells and their corresponding 
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Figure 4.3: Rate of disappearance of stalled replication sites with incubation time in 
CH09 (repair proficient) and CHO 43-313 (repair deficient) cell lines. 
wild type controls. 
4.3.3 Cells arrested in isoleucine—deprived medium and then released 
reach S—phase within 6 hours 
The experimental rationale behind this new set of experiments was to find a simple, fast 
method for studying the replication response of different sets of cells after UV. In order 
to see how UV affected progression through replication, cells had to be synchronised 
and irradiated in S—phase. It was important to get a good synchronisation in order to 
avoid background replication noise. 
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Isoleucine deprivation was chosen as the blocking method. Isoleucine deprivation causes 
the cells to arrest at G1. It was important therefore to know when the cells reached 
S—phase after the release from the block. The experiment described below allowed the 
estimation of the time of entry into S from a Gi arrest in the cells to be studied. 
A typical response curve of two transformed mouse cell lines is shown below (Fig.4.4). 
Cells were arrested in isoleucine-deprived medium for a minimum of 10 hours and the 
response in terms of tritiated thymidine uptake during short, 15 minutes, incubations 
in labelled medium (direct measurement of replication) was monitored at different 
intervals of time during their release into normal, complete medium for up to 8 hours. 
At 0 hours after release, the tritiated thymidine incorporation is at a minimum (cells 
are arrested efficiently) and subsequently it increases steadily as the cells enter into 
S-phase. By 6 hours after release cells were well into S phase. These results were 
taken as the basis for the time course chosen for subsequent experiments (see below). 
The UV dose chosen was 20 J/m 2 in order to make sure that high damage rates were 
obtained and to increase the probability of obtaining a clear arrest in the replication 
progression in the different cells. 
4.3.4 There is no difference in the DNA replication behaviour of 
ERCC1+/+ and ERCC1-/- mouse cells in the first two hours 
after UV. 
As mentioned before, the previous experimental setup was very informative in terms of 
looking at the differential behaviour of replicating versus bulk DNA after UV damage 
and provided good data regarding the repair capacity of ERCC1+/+ versus ERCC1-/-
deficient cells. However, given technical difficulties with the timing and work load in-
volved in the preparation of the samples to be examined, it was impossible to use this 
same assay to follow replication arrest in the first 2 hours after UV with sufficient de-
tail. This period was of interest because there was a hint that ERCC1-/- transformed 
fibroblasts had a shorter arrest after UV damage than ERCC1+/+ transformed fibrob-
lasts (see section 4.3.2). 
With the method presented here, the amount of handling involved was reduced consid- 
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Figure 4.4: Tritiated thymidine incorporation (measured as total DPM counts) in 
two cultures of transformed mouse fibroblasts (PF20 and FF24) after release from an 
isoleucine block (10 hours). 
idea of the behaviour of the transformed cell lines after UV. If the results obtained 
with the transformed cell lines showed a significant difference between the ERCC1-
deficient and the ERCC1 wild type cell lines, this method was also flexible enough to 
allow working with the more sensitive primary fibroblasts cell lines. 
If ERCC 1-deficient cells had a shorter arrest of replication after UV it should be pos- 
sible to detect this using this method. It would be expected that a shorter arrest 
time would result in a faster increase in the uptake of tritiated thymidine after UV 
by the mutant cell line. The experiment was performed with transformed mouse fi- 
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broblasts (PF20, PF24; ERCC1+/+ and ERCC1-/- respectively), transformed CR0 
cells (CH09, CHO 43-3B; ERCC1+/+ and ERCC1-/- respectively) and also mouse 
primary fibroblasts (PF +1+, PF  -/-; ERCC1+/+ and ERCC1-/- respectively) and 
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Figure 4.5: Tritiated thymidine incorporation (measured as %DPM counts relative to 
the mock samples) in PF20 (ERCC1+/+), PF24 (ERCC1-/-); CR09 (ERCC1+/+), 
CHO 43-3B (ERCC1 mutant); PF +1+ (ERCC1+/+), PF -/- (ERCC1-/-) after release 
from isoleucine block (10 hours) and UV irradiation (20J/m 2 ). Each point belonging 
to a single experiment represents two duplicate measurements. For the primary fibrob-
lasts one experiment is reported. For the transformed cell lines two experiments are 
reported. The error bars represent the mean standard error. 
This graph shows the incorporation of [3 H]Thymidine by the different synchronised cell 
lines after a dose of 20 J/m 2 . For the mouse primary fibroblasts only one experiment 
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was carried out (each point represents the average of duplicate samples) and for the 
transformed cell lines two separate experiments are shown (the error bars represent 
the mean standard error). 
In order to make sure that there were no major differences in the behaviour of the 
primary and the transformed mouse cell lines, a preliminary, shorter, experiment was 
set up that has been included in this graph. The time course studied with the primary 
fibroblasts covers only the first two hours after UV irradiation ('critical' time). The 
results obtained suggest that both primary and transformed mouse fibroblasts behave 
in essentially the same manner. Both transformed and primary wild type mouse cells 
show an equivalent reduction in the [3H]Thymidine uptake 2 hours after UV (-45 
% reduction in CH09 cells, -48 % reduction in PF20 cells and '-p65 % reduction in 
PF+/+ cells). In addition, there is not a significant difference in the incorporation 
of [3 H]Thymidine at the same time point after UV between the NER-proficient and 
the NER-deficient cell lines (-'59 % reduction in CHO 43-3Bcells, -p51 % reduction in 
PF24 cells and -p57 % reduction in PF-/- cells) which is in accordance with the results 
described in the previous sections. Thus, the rest of the longer, more demanding 
experiments were performed with the transformed cell lines, PF20 and PF24. 
It was also clear from this experiment that there was no significant differences in 
the trend followed by the CHO transformed cell lines, CH09 and CHO 43-313, when 
compared to their mouse counterparts, after the UV challenge. This similarity in 
the response of transformed CHO and mouse cell was used as the basis for the next 
experiment (see below). 
The trend followed by all the cell lines used in this experiment is the same. They all 
reduce their tritiated thymidine uptake after UV irradiation as would be expected. This 
decrease reaches a minimum between 2 and 4 hours after UV-irradiation as previously 
reported for rodent cells (Meneghini et al., 1981). In order to see if this decline in 
the incorporation of tritiated thymidine was maintained at later time points and to 
investigate the possibility that other NER mutants may behave differently, further 
experiments were set up that are reported in the next section. 
In summary, these results differ from the expectations derived from the previous studies 
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carried out on replication fork stalling (DenV-induced DSBs measurement after UV 
damage), from which there was an apparent difference in the kinetics of replication 
arrest recovery between NER-deficient and wild type transformed mouse fibroblasts. 
Under this experimental procedure there was no indication of a different response of the 
ERCC1-/- transformed mouse cell lines when compared to their wild type counterparts 
in the first minutes after irradiation. This was also confirmed by the other experiments 
carried out and presented in the next section. 
4.3.5 The kinetics of recovery from UV irradiation-induced arrest 
are equivalent in cells from different ERCC complementation 
groups (ERCC1 and ERCC2). 
This experiment was designed to investigate whether the recovery from UV irradiation-
induced replication arrest differed in ERCC1 mutants when compared to wild type or 
mutants from another ERCC group. Four different CHO cell lines, CH09, CHO 43-
3B, CHO AA8 (wild type) and UV5 (ERCC2-deficient) were used. Chinese Hamster 
Ovary cells (CHO) were used mainly due to the fact that ready access to ERCC1 and 
ERCC2 null cell lines was available which was not the case for mouse. 
The following graph shows the results of the experimental work with the above men-
tioned cell lines (Fig.4.6). The two mutant cell lines are deficient in DNA repair and 
show increased susceptibility to UV irradiation. The wild type cell lines are the cor-
responding parental lines for each one of the mutants. This graph shows the kinetics 
of replication after UV irradiation in each one of these cell lines. Each cell line was 
arrested at @1 in isoleucine-free medium for a period of 10 hours, released into nor-
mal medium and UV irradiated with a dose of 20 J/m 2 . Each time point in each of 
the experiments was carried out in duplicate and there was also a duplicate for each 
corresponding mock-irradiated control. In the case of the ERCC1 cell lines, each point 
depicts the mean from two separate experiments with error bars. For the ERCC2 cell 
lines each point represents the mean of three experiments. 
The Y-axis represents the tritiated thymidine incorporation (DPM counts) as a per-
centage of the values for the unirradiated controls. The X-axis represents the time 
points at which each sample was collected after UV (or mock) irradiation. 
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Figure 4.6: Tritiated thymidine incorporation (measured as %DPM counts of unirra-
diated controls) after UV irradiation in C1109 , CHO 43-313, CHOAA8 and UV5 
There is a difference in the way parental lines behave when compared to NER deficient 
ones. This difference however, is not at the early time points as suggested by the 
previous set of experiments (Fig. 4.2), but at the later time points. Both parental lines 
decrease their tritiated thymidine incorporation to about 40% of controls by 4 hours 
after irradiation. After that, they start recovering and go back to 100% incorporation 
by 8-10 hours. This is in accordance with results obtained using different experimental 
procedures with rodent cells (Meneghini et al., 1981). The UV—sensitive cell lines show 
a decrease to 20 % after 4 hours but, as would be expected after such high UV doses, 
do not recover after that time. In fact most cells from both cell lines, UV5 and 43-3B, 
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had died by 10 hours after UV irradiation. 
This recovery in the rate of DNA synthesis as measured by this method seen in the 
NER-proficient cell lines has been reported previously for rodent cells (Meneghini et al., 
1981). In our experiment, cells that are not proficient in NER (CHO 43-3B and CHO 
UV5) do not seem to undergo such a recovery. It is likely that NER is needed under 
these circumstances to overcome the DNA synthesis arrest. 
This seems to be in disagreement with the results obtained in the previous sections 
(see section 4.3.2) in which these same NER-deficient cells seem to proceed through 
replication irrespective of their NER status. However, there is a major difference 
between these experimental procedures. The experiments described in the previous 
section were performed under moderate UV doses (10J/m 2 ) whereas the experimental 
procedure presented in this section was carried out at high fluences (20J/m 2 ). It is 
possible, as it has been already suggested that the mechanisms acting under these 
circumstances differ from one another. It could be argued that under low to medium 
UV doses, NER does not play an essential role in the way DNA synthesis progresses. 
Under these circumstances, in NER-deficient cells, fork progression (as shown by the 
decrease in the number of DenV-induced DSBs after UV) would proceed even in the 
presence of unrepaired DNA. A tolerance mechanism would be operational in these 
cells, different from NER (see Chapter 1, section 1.2). At high UV doses, it would be 
logical to assume that the damage is too big for the alternative DNA lesion-tolerance 
mechanism and NER would then be required to repair the damage. In this case, cells 
that cannot repair their DNA are not capable of proceeding with the replication process 
(as shown by a rapid and sustained decline in the uptake of tritiated thymidine) and 
ultimately, they die. 
Overall, this behaviour of wild type rodent cells is in contrast with the way normal 
human skin fibroblasts subjected to DNA injury react under equivalent conditions. In 
human cells recovery of DNA synthetic rate, as measured by cell autoradiography after 
a dose of 5 J/m2 , is initiated between 3 and 6 hours and reaches a maximum value 65-75 
% that of unirradiated control by 12 hours after irradiation which is maintained for up 
to 24 hours without increasing further (Rude and Friedberg, 1977). This is concomitant 
with a marked G2 arrest and a prolonged delay of entry into mitosis shown by these 
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cells after UV (normal human diploid fibroblasts delay entry into mitosis for up to 32 
hours if irradiated in S) (Wang and Ellem, 1994). Apparently, this delay is required for 
the DNA to be repaired before the cell proceeds safely into mitosis. A human cell line 
deficient in NER would not recover from this arrest and indeed this is in accordance 
with the detailed biochemical study performed on the human XPA—deficient cells (see 
previous section). 
Both wild type CHO cell lines seem to recover an unirradiated—like rate of DNA syn-
thesis in a very short period of time (8-10 hours after UV) and presumably, this means 
that they are ready to proceed with the following phase of the cell cycle, mitosis. Given 
the short time of arrest the DNA—repair process is probably not completed and they 
proceed on a partially damaged template. We know this because the rate of repair in 
these cells is very low (Meneghini et al., 1981) and according to the studies described 
in the previous section (see section 4.3.1), the burden of ESSs that these cells carry at 
the time that the recovery from arrest is seen (10 hours) is still very high. The UV dose 
used in the experiment described in section 4.3.1, as has been discussed previously, is 
lower than that used in the tritiated thymidine incorporation experiments described 
in sections 4.3.4 and 4.3.5, but it would be logical to assume that the number of unre-
paired CPDs in the latter experiments would be even higher, which reinforces the idea 
that the bypass mechanism is of great importance in rodent cells. The mechanism that 
these cells use to bypass this arrest is not known. 
4.4 Discussion 
DNA damage leads to a rapid and dose—dependent inhibition of replication. This 
damage—induced arrest of DNA synthesis has at least two components. One is the 
actual blockage of replication by the damage (Edenberg, 1976; Berger and Edenberg, 
1986; Moore et al., 1981) and is due to delay in fork progression (Lehmann, 1972; Dahle 
et al., 1980; Meneghini et al., 1981; Meneghini and de Mello Filho, 1983; Painter, 1985). 
The other is the blockage of replicon initiation (Doniger, 1978; Kaufmann et al., 1980; 
Cleaver et al., 1983). Ultraviolet light damage affects mainly DNA—fork progression 
(Edenberg, 1976; Berger and Edenberg, 1986) although some reduction of replicon 
initiation can be seen, especially at low doses (Cleaver et al., 1983; Painter, 1985). 
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From in vitro studies it is known that elongation can be blocked or slowed when the 
polymerase is unable to find an appropriate matching nucleotide for an altered, missing 
or misaligned base (Moore et al., 1981). On the other hand, the block to replicon 
initiation appears to affect initiation in an entire replicon cluster (Painter and Young, 
1976; Kaufmann et al., 1980). Inhibition of initiation of replication and inability to 
bypass lesions are finally overcome by unknown mechanisms (Painter, 1985; Griffiths 
and Ling, 1987; Bierne and Michel, 1994). 
In general, after DNA-damage is inflicted, repair takes place and replication is in-
hibited. If the repair mechanism that deals with the type of damage inflicted is not 
present, it is possible to think that replication would ensue. This is indeed the case 
in human cells derived from AT (ataxia telangiectasia) patients (Shiloh et al., 1985). 
This reflects a deficiency of AT cells in the repair of DNA damage which is coupled to 
replication (Hanawalt and Painter, 1985). 
The relative recovery of DNA synthesis after damage (UV irradiation) also varies de-
pending on the animal species under study. Rodent cells recover DNA replication and 
progress through the cell cycle much faster than human cells. When hamster cells in S 
are irradiated with UV, they arrive at mitosis within 15 hours of exposure, with many 
chromatid type aberrations. By contrast, the entry of human cells is delayed by '30 
hours (Wang and Ellem, 1994). After UV the long-lived DSBs retard the progression 
of the S-phase human cells through the cycle, and if the DSBs are not repaired (as 
happens in XPA cells) the cells arrest in G2. Rodent cells either repair or bypass the 
UV induced lesions, but do not generate DSBs, which enables the cells to reach the 
first mitosis (Shoshana Squires and Robert Johnson, Cambridge, personal communi-
cation). Wild type human cells show significant blockage of replication after exposure 
to 5 J/m2 but not to 2.5 J/m2 and this arrest has been shown to last for 5 hours 
after which replication continues as shown by DNA fibre autoradiography (Griffiths 
and Ling, 1989). Excision repair deficient human cells show significant blockage both 
immediately and 5 hours after irradiation even at lower UV doses (2.5 J/m 2 ) (Griffiths 
and Ling, 1989). In the case of CHO cells (V-79 CHO) dimers have been shown to 
constitute a block of fork displacement during the first 5 hours after exposure. This 
chain growth arrest is bypassed within 10 hours after irradiation (Dahle et al., 1980). 
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Most of the work in this area has been carried out using human and Chinese hamster 
cells and it was of interest to investigate the behaviour of mouse cells. 
In the present work, we have investigated the capacity of DNA-replication arrest of 
Chinese hamster and mouse cells after UV as well as the capacity of these cells to 
recover from such arrest and we have looked into the possible role of ERCC1 in this 
process. 
First, it has been possible to confirm that wild type mouse cells (NER proficient) repair 
replicating DNA preferentially, as shown by their ability to remove DenV-induced SSBs 
more rapidly from replicating DNA than from the bulk DNA. On the other hand, as 
expected, ERCC1-defective mouse cells do not repair DNA and the number of UV-
inflicted SSBs remain high both in the bulk and replicating DNA. This repair in wild 
type rodent cells is nevertheless moderate. 
Second, it has been shown that the arrest that both wild type and ERCC1-deficient 
mouse and CHO cell lines show after UV is shorter than the arrest shown by a hu-
man cell line that cannot repair its DNA (XPA). This has also been reported before 
(Meneghini et al., 1981). In both mouse cell lines (PF20 and PF24), nearly all the 
DenV-associated DSBs disappear by 3 hours. This indicates that after a period of 
stalling, the DNA-polymerases start to bypass the pyrimidine dimers without leaving 
a gap in the daughter strand, and/or that the blocking pyrimidine dimers have been 
repaired (in the case of PF20 cells only) before replication is resumed. In the case of 
CHO cells, however, the period of stalling is longer (about 6 hours). Overall, there 
does not seem to be a requirement for functional NER in order for rodent cells to 
bypass fork progression arrest due to UV damage as shown by the fact that, in both 
the mouse and the CHO cells, both the NER-proficient and the NER-deficient cell 
strains show the same behaviour. 
Third, there was an indication that ERCC 1-deficient cells arrest fork-progression for 
even shorter times than their wild type counterparts. In order to investigate this latter 
point, experiments were designed that allowed us to look into this particular aspect in 
more detail. Using this technique it was possible to determine the cell cycle response 
of rodent cells to UV irradiation. There was no indication that ERCC1 null mouse 
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cells behave differently to the wild type cells in terms of arrest of [3H]Thymidine in-
corporation in the first hours after UV damage. By 4-6 hours all the wild type cell 
types studied start recovering from the reduction in [3 H]Thymidine incorporation. By 
10 hours the levels of incorporation in CHO wild type cells go back to pre—UV lev-
els, indicating that the cells have recovered and can progress through the cell cycle. 
This recovery of DNA synthesis has been reported before in normal human and Chi-
nese hamster cells for low UV fluences (Rude and Friedberg, 1977; Dahle et al., 1980; 
Ventura and Meneghini, 1984). No recovery was seen in ERCC1 null cells, which is 
in accordance with the fact that these cells cannot repair UV—induced DNA damage 
and therefore are highly sensitive to UV—induced cell killing. Experiments with un-
synchronised CH09 and CHO 43-3B cells have been published that support the data 
presented here in terms of the kinetics of recovery from UV—induced DNA synthesis 
inhibition (Wood et al., 1982). In their study, Wood et al. also show that at low UV 
doses (0.5 J/m2 ) CH09 and CHO 43-313 cells show the same response to UV irradi-
ation in terms of DNA synthesis inhibition. At higher UV doses, CHO 43-3B cells 
show an impairment in their recovery from UV as shown by their kinetics of recovery 
from DNA synthesis after higher irradiation fluences (1.0 and 2.5 J/m 2) (Wood et al., 
1982) in a manner equivalent to that reported here with the 20 J/m 2 dose. A failure 
to recover DNA synthesis after UV irradiation (5 J/m 2 ) has been shown to occur with 
XPA cells (Rude and Friedberg, 1977). However, at lower UV fluences (1 J/m 2 ), XP 
cells can bypass the replication arrest (Kaufmann and Cleaver, 1981). 
When the response seen in our thymidine incorporation experiments is correlated with 
the results obtained from the previous set of experiments, some facts to be taken into 
account. In the case of the NER—proficient cells it is clear that the data obtained 
from the AFIGE analysis and the data obtained from the tritiated thymidine incorpo-
ration experiments can be easily reconciled. Fork progression (as determined by the 
AFIGE procedure) is restored in the wild type cells approximately 3-6 hours after UV 
irradiation (10 J/m 2 ). This has already been shown for V-79 CHO cells which only 
show arrest of fork progression during the first 5 hours after UV irradiation (Dahie 
et al., 1980). DNA synthesis (as measured by tritiated thymidine incorporation lev-
els) reaches unirradiated control levels 10 hours after UV (20 J/m 2 ) in the same cells. 
Dahle et al. also report total recovery of chain growth by 10 hours after UV exposure. 
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One explanation for the lagged response in terms of the recovery of DNA synthesis 
levels could be that since the latter experiments were performed under more damaging 
conditions, the cells need more time to bypass the arrest. Another explanation is that 
although fork progression is fully restored earlier, DNA synthesis takes a bit longer to 
go up to normal levels, because the synthesis of DNA that takes place only starts after 
the fork movement is restored. It is interesting to note that DNA synthesis levels start 
to go up precisely at 4 hours post—irradiation, when fork progression is fully restored. 
In the case of the NER—deficient cells (both mouse and CR0) the two experimental 
procedures seem to give contradictory results. Although both CHO 43-313 and PF24 
cell strains seem to behave in an equivalent manner to their respective parental cell 
lines in terms of fork progression arrest as shown by the AFIGE technique, they present 
a different response in terms of DNA synthesis rate recovery. These NER—deficient 
cell lines bypass fork progression arrest, but they show a permanent arrest of DNA 
synthesis. Wood et al. also report no recovery in DNA synthesis in CHO 43-313 
cells after 1 and 2.5 J/m 2 (Wood et al., 1982), which supports the results obtained 
with the [3H]thymidine uptake procedure. One explanation for this discrepancy in 
the results could be the difference in the UV fluences used for both experimental 
procedures. For the fork progression assessment experiments, the UV dose used was 
lower than that used for the DNA synthesis rate recovery experiments. In the former 
case, it is possible that the cells, even though they cannot repair their DNA, manage 
to escape the arrest somehow, through a yet unidentified bypass mechanism. When 
the UV dose is higher and the damage inflicted increases, the bypass mechanism is not 
enough anymore and NER is then required in order to achieve recovery from arrest. 
The other possibility is that after low UV fluences, NER—deficient cells still possess 
a residual capacity for repair of UV—induced lesions that is overwhelmed at higher 
UV doses (higher number of lesions) (Wood et al., 1982). Under these circumstances, 
and if NER is absent, further progression into the following phase of the cell cycle is 
prevented and the arrest is therefore permanent. This checkpoint probably takes place 
in G2 and prevents the occurrence of mitosis in the presence of damaged DNA. Another 
possible explanation for the conflicting results is that, given the complexity of the 
first experimental procedure, the interpretation of the data obtained by this method is 
dependent on too many parameters (such as DNA conformation and migration patterns 
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on the gel, distribution of UV-induced lesions along the bulk or replicating DNA, very 
complicated mathematical calculations) and it is difficult to interpret straightforwardly. 
This would make the results obtained in this way unreliable. 
ERCC1 does not seem to play a significant role in the process of replication arrest as 
indicated by the fact that CHO cells defective in ERCC2 (UV5) behave in the same 
way as cells defective in ERCC1 (43-313). From this study it can only be said that 
in the presence of UV-damage, the absence of a proficient DNA repair mechanism in 
rodent cells does not seem to be a stringent factor in the progression of fork movement. 
However, it seems that NER-deficient cells manage to halt cell cycle progression and 
ultimately they prevent gross abnormalities from being passed on to the daughter 
cells. However, this does not explain why ERCC1-deficient cells (and in particular 
hepatic cells) and not ERCC2-deficient cells show such an aberrant phenotype. A 
plausible explanation for this difference comes from studies performed by Melton et 
al. (Melton et al., 1998) that show that ERCC1 has a unique, albeit indirect, role in 
the mechanisms that determine progression into the next phase of the cell cycle. This 
is not new since ERCC1 has been implicated in recombination and other eukaryotic 
ERCC1-homologues have been shown to be involved in an array of different functions 
from mating-type switch in yeast to meiotic recombination in D. rnelanogaster (see 
Introduction, section 1.1 and Conclusion). 
As has been shown before, in the presence of UV damage, rodent cells seem to bypass 
a key checkpoint (S-checkpoint) and proceed through replication despite the fact that 
repair is incomplete, and the gaps created after UV are still present and represent a 
serious risk for the rodent DNA integrity (see Introduction, section 1.4). This is also 
the case for rodent cells defective in NER, i.e., ERCC2-deficient cells. In fact, rodent 
cells possess a mechanism that ensures that the DNA integrity is somehow restored so 
that it is possible to go through replication in the absence of 'properly'-repaired DNA. 
Such a system is called 'illegitimate recombination'. 
Studies carried out by Melton and co-workers suggest that cells that lack ERCC1 are 
deficient in 'illegitimate recombination' and are therefore more prone to carry through 
the UV-induced gaps in their DNA into the next phase of the cell cycle (Melton et al., 
1998). Although the resulting product is DNA that has breaks in it, the cell is allowed 
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to proceed through replication and damage is carried through to the G2 phase of the cell 
cycle where the strong arrest occurs. This would result in cells going through normal, 
non-stringent rounds of replication in the absence of cell division, which would explain 
the observed polyploidy and aneuploidy in the ERC61-deficient hepatocytes. In the 
case of ERCC2-deficient cells the DNA would be recombined, and the progression 
through the cellular cycle would continue normally with normal rounds of mitosis and 
no aberrant nuclear phenotype. 
In summary, rodent cells, as opposed to human cells, accept unrepaired DNA damage, 
and are subsequently exposed to high rates of mutations. That they tolerate this is 
probably due to the fact that their generation time and their life span are short which 
allows them to reproduce successfully before the onset of lethal cancers and tumours. 
When the rough patch up mechanism they have evolved to quickly overcome gross 
DNA aberrations is not present, as in ERCC1-deficient mice, they do not even reach 
maturity. 
It is a fact that rodents show a very high incidence of cancers and tumours with in-
creasing age. A balance appears to exist between the necessity to repair DNA-damage 
in order to be able to successfully pass on the genetic pool to the next generation and 
the time, energy and resources that it takes to do so. In humans, who have longer life 
spans than rodents and lower reproductive success, it is therefore necessary to main-
tain a strict control of mutations and precise, stringent and tightly regulated cellular 
responses are a necessary 'investment'. 
Chapter 5 
In Vitro Studies: Effect of UV 
on the p53 and p21 Responses in 
ERCC 1—Deficient Primary 
Fibroblasts 
5.1 Introduction 
Human patients suffering from XP, a syndrome caused by defects in NER, show an 
increased incidence of skin cancer in sun-exposed skin areas. Consequently, there have 
been extensive studies on the response of cancer-related proteins, such as p53, to the 
effects of UV exposure in cells derived from these patients. As expected, studies of 
human cell lines defective in NER genes, such as XPD, show that defects in this DNA 
repair pathway make these primary fibroblasts more sensitive to the effect of UV light 
in terms of the p53 response, i.e. lower UV doses are needed to elicit a significant p53 
response in these cells (Dumaz et al., 1998). 
ERCC1 is essential for the NER process. The phenotype of the mice lacking ERCC1 
has no resemblance to any known human disease related to a defect in this DNA-
repair mechanism. The fact that these transgenic mice die so young makes the in vivo 
study of their response to UV impossible. Despite the interest in the study of the 
relationship between DNA damage, DNA repair, and cell cycle control, there are few 
published studies of p53 responses to UV damage in ERCC1-deficient cells (Melton 
et al., 1998). 
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This chapter presents a study of the response of both p53 and p21 to UV in primary 
fibroblasts from the already mentioned genotypes: wild type, p53+/+ERCC1-/-, p53 
-/-ERCC1+/+ and p53-/-ERCC1-/-. The culture of primary mouse fibroblasts pre-
sented some limitation. Growth of these cells required densities to be at least 70-80% 
confluence in order to maintain the cultures under proliferating conditions and even 
very slight reductions in these densities led the cells to arrest of cell growth and death. 
Another characteristic of these cultures is their rapid senescence. Since the studies that 
were going to be performed on them involved responses in terms of the induction of 
genes that have also been related to death—related pathways, it was important to carry 
out these experiments soon after their isolation from the embryos had taken place. All 
primary fibroblasts used in this study were used at a low passage number (passage 2 
when the density of cells allowed work at this stage and passage 3 when the initial 
density of cells was low). 
5.2 Results 
5.2.1 Low UV doses are sufficient to elicit a p53 response in ERCC1-
deficient primary fibroblasts. 
The kinetics of the p53 response to different UV doses was assessed in wild type and 
ERCC1-/- primary fibroblasts. Cells were irradiated with different UV doses (5, 20 
and 50 J/m2 ) and immunoblotting was carried out to show stabilisation of p53 at 
different time points after the UV irradiation (for details see Materials and Methods, 
section 2.2.11, subsection 2.2.11). 
Mouse wild type primary fibroblasts show no accumulation of p53 at low levels of UV 
irradiation (5 J/m 2 ) (see Fig.5.1 A). This is in accordance with studies carried out by 
Dumaz et al. in normal human and XPD primary fibroblasts (Dumaz et al., 1998). 
Dumaz et al. also report that XPD deficient cells are more sensitive to UV than their 
wild type counterparts in that, under the same low UV dose (5 J/m 2 ), they induce p53 
readily whereas the wild type human cells show no detectable response. This is also 
seen in the ERCC1 null primary fibroblasts (see Fig.5.1 A). The stabilisation of p53 
after 5 J/m 2 is detectable 2 hours after UV irradiation and is maintained for at least 
30 hours. This long p53 accumulation is also seen in XPD fibroblasts, described by 
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Figure 5.1: Stabilisation kinetics of p53 after varying doses of UV in wild type (left hand 
panels) and ERCC1-/- (right hand panels) mouse primary fibroblasts. A) 5 J/m 2 ; B) 
20 J/m2 ; C) 50 J/m 2 . The level of p53 protein was determined in unirradiated controls 
(Con), and at different intervals after UV (1, 2, 4, 6, 18 and 30 hours). 
Dumaz and co-workers, which show sustained p53 stabilisation up to 120 hours after 
low doses of UV irradiation. 
When mouse primary fibroblasts are challenged with a dose of 20 or 50 J/m 2 (see 
Fig.5.1 B and C), both the wild type and the ERCC1-deficient cells behave in the 
same way and follow the same kinetics. They accumulate p53 from as soon as 2 hours 
post-irradiation and the response is maintained for at least 30 hours. This mouse wild 
type response is in contrast with the one described for the human wild type cells as 
reported by Dumaz et al. Normal human fibroblasts show a decrease in the amount 
of p53 protein back to normal levels 24 hours post-irradiation (20 J/m 2 ). This may 
reflect a difference in the way human and mouse fibroblasts deal with DNA damage. 
Human cells tend to completely repair their DNA before proceeding with their cell 
cycle, whereas rodent cells can progress through theirs with damaged DNA, which 
would result in more prolonged p53 responses. 
In general, the kinetics of induction of p53 under these conditions are also supported 
by the findings of Lu and Lane (Lu and Lane, 1993). In their work, Lu and Lane report 
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that after a dose of either 10 or 50 J/m 2 , mouse prostate cells show stabilisation of 
p53 after a lag time of 2 hours and its levels remain high for at least 30 hours. 
We do not see a difference in the basal unirradiated levels of p53 amongst the different 
genotypes studied here. In both wild type and ERCC1-deficient there were barely 
detectable levels of p53 in unirradiated fibroblasts and in no case was an increase seen 
in the ERCC1 deficient cells. p53 has been implicated in the transcriptional activation 
of p21 on many occasions (El-Deiry et al., 1993; El-Deiry et al., 1994; Cox, 1997; Isaacs 
et al., 1997; Shigemasa et al., 1997; Takahashi and Suzuki, 1994; Waldman et al., 
1995), but p21 has also been shown to be transcriptionally activated in a manner 
independent of p53 (Cox, 1997; Janson et al., 1997; Johnson et al., 1994; Michieli 
et al., 1994). In order to assess the situation regarding the relationship between p53 
and p21 in the mouse primary fibroblasts in response to UV irradiation we performed 
a number of experiments to study the induction of p21 under different UV doses in 
wild type, ERCC1-deficient and also p53-deficient and p53 and ERCC1 double null 
mouse primary fibroblasts. 
5.2.2 Basal levels of p21 are elevated in ERCC1-deficient primary 
fibroblasts. 
As shown in Fig. 5.2 the basal levels of p21 in ERCC 1-deficient primary fibroblasts is 
higher than that of the wild type cells (as has already been shown in liver). Therefore, 
p21 seems to be induced in these NER-deficient cells in the absence of exogenous DNA 
damage and in the absence of a detectable p53 stabilisation (see previous section). 
These permanently-induced basal levels of p21 may have consequences in the response 
of these cells to UV. In fact, we fail to see proper induction of p21 in these primary 
fibroblasts (see below). 
It is noteworthy that in the case of primary fibroblasts deficient in p53, both p53 -/-
ERCC1+/+ and double nulls, the basal levels of p21 are reduced to a tenth of those 
seen in the wild type cells. This observation is in contrast with the data obtained from 
the livers (Fig. 3.14, Chapter 3; for a summary see Table 5.1). 
It seems likely that p21 transcription in the absence of exogenous damage, as indicated 
by basal levels of p21 in vivo and in vitro have different p53 requirements. In hep- 
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Figure 5.2: p21  basal levels in primary fibroblasts corresponding to the four different 
genotypes. The bars show the means of the p21/GAPDH ratio for all the samples of 
a given genotype. An n value of 1 represents 2 determinations on independent dishes 
from a single embryonic fibroblast culture. Standard errors are shown. 
atocytes in vivo, transcription of p21 is p53—independent and in primary embryonic 
fibroblasts in vitro it is dependent on p53. This also supports previous in vitro findings 
(Reinke and Lozano, 1997) that p21 expression is dependent on p53 and reinforces the 
idea that, in vitro, p21 expression is p53 dependent and, in vivo, p21 regulation is p53 
independent, at least under the conditions observed here. 
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Genotype Primary Fibroblasts 
[ 
Liver] 
p53+/+ERCC1+/+ 1 1 
p53+/+ERCC1-/- 2 2 
p53-/-ERCC1+/+ 0.1 1 
p53-/-ERCC1-/- 0.1 2 
Table 5.1: Summary table of p21 basal transcript levels in primary fibroblasts and liver 
tissues. p21 levels are expressed as p21/GAPDH ratios. 
5.2.3 p21  induction is impaired after high UV doses in ERCC1-
deficient fibroblasts 
In light of the previous results, we were interested to see the response of the four 
different types of fibroblasts to UV damage. The induction kinetics of p21 after 
different doses of UV irradiation in each one of the primary fibroblast classes are 
shown in Fig. 5.3. 
The p21 response after low UV doses, 5 J/m 2 , (Fig. 5.3, 5 J/m2 ) is similar for all 
the genotypes studied although there is an indication of a higher p21 induction in 
p53hom/ERCC1hom primary fibroblasts at the longer time points (7 and 24 hours 
after UV). Briefly, p21 message levels are induced around two-fold three hours after 
UV and the induction is still maintained 7 hours after irradiation. In the wild type 
primary fibroblasts p21 transcript levels had gone back to control, unirradiated levels, 
whereas in the other three groups of cells it remained high. Reinke et al. (Reinke and 
Lozano, 1997) report a 10-fold induction of p21 transcript in rat embryo fibroblasts 6 
hours after a 10 J/m2 dose of UV which persists for at least 48 hours. We do not see 
such a prolonged induction of p21 after 5 J/m 2 but we see sustained induction after 
20 J/m2 (see below). The UV dose used by Reinke et al. is intermediate between our 
two UV doses and possibly reflects the minimal amount of UV damage required for a 
prolonged p21 induction. 
There is no evidence from this study that ERCC 1-deficient cells are defective in the 
p21 induction after low UV irradiation or that their p21 induction is more sensitive to 
UV than that of wild type or p53 deficient cells. Reinke and co-workers also report that 
this p21 induction is dependent on p53-binding sites being present in the p21 promoter, 
suggesting that p21 is activated via a p53-dependent mechanism. Their experiments 
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Figure 5.3: Induction of p21 in asynchronous mouse primary fibroblasts (wild type, 
ERCC1 null, p53 null and double null) collected at different time points (3,7 and 24 
hours) after varying doses of UV. All values refer to p21/GAPDH ratios within the 
same genotype. Standard errors are shown when possible. 
were based on an in vitro assay using a construct containing a p21 promoter and the 
reporter gene luciferase. Here we present in vitro evidence that suggests that p53 is 
not required for the transcriptional activation of p21 after UV damage, as shown by 
detectable p21 induction in double null primary fibroblasts 7 and 24 hours after UV 
irradiation. The discrepancy in these results may be due to differences in the responses 
to UV in mouse and rat primary fibroblasts or to the differences in the experimental 
approach. 
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When the UV dose of 20 J/m2 is considered, it becomes more evident that NER-
deficient cells are impaired in their p21 response (Fig. 5.3, 20 J/m2 ). Wild type cells 
noticeably induce p21 levels seven hours after UV (3 times unirradiated control levels) 
and this induction is maintained for at least 24 hours. At 7 hours post-irradiation none 
of the mutant cell lines show a clear increase in p21 transcript levels. However, 24 hours 
after irradiation all four cell types seem to reach similar levels of induction. High levels 
of p21 protein have been reported after a UV dose of 20 J/m2 in TTD/XPD human 
fibroblasts 24 hours after irradiation, which is consistent with these data (Dumaz et al., 
1998). This may reflect a delay in the response to UV damage in terms of p21 induction 
in cells lacking ERCC1. It is also noteworthy that both primary fibroblast cell lines 
lacking p53 show p21 induction 24 hours post-irradiation, although this has to be put 
in the context of low overall levels of p21 transcript in these cells (1/10 of that seen in 
wild type and ERCC1-/- primary fibroblasts) (see Fig. 5.2). 
The results for the highest UV dose (50 J/m2 ) are shown in Fig. 5.3, 50 J/m2 . For these 
experiments only wild type and ERCC1 -/- cells were considered. Wild type cells fail to 
induce p21 transcript levels at 3 and 7 hours post-irradiation. However, the induction 
in p21 message reaches a ten-fold increase 24 hours after UV damage. Similar results 
have been reported for human normal fibroblasts and rat embryo fibroblasts (Poon 
and Hunter, 1998; Reinke and Lozano, 1997). In their work, Poon and Hunter describe 
absence of induction of p21 protein levels 12 hours after high UV doses (60 J/m 2 ) 
despite apparent accumulation of p53 protein. At these high UV doses, they detected a 
faster mobility form of p21 (p21) which is mainly localised to the cytoplasm of the cell 
and which they propose may have a role in the deregulation of the cell cycle. However, 
they did not look at later time points and therefore the duration of the absence of p21 
induction they see cannot be determined. Due to the lack of appropriate anti-mouse 
p21 antibodies it was not possible for us to look at the protein expression of p21 in 
this work, but it would be interesting to see if p21i. is also expressed in these mouse 
fibroblasts. Reinke and Lozano also note the absence of p21 message induction after 
high doses of UV (50 J/m 2 ). They propose that the accumulation of damage after 
this UV dose is so great that it interferes with transcription and ultimately leads to 
apoptosis. 
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The fact that ERCC1-deficient primary fibroblasts fail to induce p21 24 hours after 
high UV doses (50 J/m2 ) seems to support this theory. After high UV doses, in the 
absence of a proficient NER mechanism, damage accumulates and remains unrepaired, 
which could explain the long-term inhibition of the p21-induction seen in these cells. 
In the case of wild type cells which can repair the damage it is possible that after a 
transient inhibition of transcription, the cells finally manage to overcome the damage 
and the cellular machinery recovers the ability to keep functioning. 
5.3 Discussion 
There is extensive evidence on the relationship between DNA damage, cancer-related 
genes such as p53 and p21 and cell-cycle regulators in different cell types both of rodent 
and human origin (Gadbois and Lehnert, 1997; Khan et al., 1997; Kuwano et al., 1997; 
Merlo et al., 1997; Rathmell et al., 1997; Smith et al., 1994; Smith et al., 1995; Smith 
and Fornace, 1996). These studies suggest that p53 and p21 are regulated differently 
according to both the cell type (Gadbois and Lehnert, 1997) and the type of agent 
that causes that damage (Janson et al., 1997). For example, p53 can be accumulated 
in cells without p21 being transcriptionally activated (Khan et al., 1997). Moreover, 
although p21 message has been shown to be induced by p53 (El-Deiry et al., 1993; 
El-Deiry et al., 1994; Cox, 1997; Isaacs et al., 1997; Shigemasa et al., 1997; Takahashi 
and Suzuki, 1994; Waldman et al., 1995), it has also been shown to be induced via p53-
independent pathways (Cox, 1997; Janson et al., 1997; Johnson et al., 1994; Michieli 
et al., 1994). The end result of these signalling and control pathways, that is, the 
response of the cells to the exogenous DNA damage also varies depending on the cell 
type. Either apoptosis (Merlo et al., 1997; Reinke and Lozano, 1997) or growth arrest 
(Smith and Fornace, 1996; Reinke and Lozano, 1997) have been reported as the end 
result of the p53-mediated response. 
A direct relationship between p53 and DNA repair has been proposed by Smith et 
al. (Smith et al., 1995). The authors present evidence from human colon carcinoma 
RKO cells, in which p53 function is abrogated, for reduced repair of UV-induced DNA 
damage. p21 has also been linked directly to DNA repair (Li et al., 1996; McDonald 
et al., 1996). Li and collaborators demonstrate by in situ experiments (quantitative 
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immunoblotting) on human W138 diploid fibroblasts, that the DNA repair capacity 
of the cells has a bearing on the expression of both PCNA and p21 proteins in the 
nucleus of these cells. Furthermore, they suggest that both PCNA and p21 have a 
role in linking DNA replication, DNA repair and cell cycle progression. McDonald et 
al. report that p21 function is required for DNA repair of a reporter plasmid that 
had been irradiated with UV and introduced in colon cancer cells. p2 l-/- cells show 
decreased reporter activity following transfection when compared to p2l+/+ cells. 
Overall, the dynamics of the interaction between DNA damage, its recognition path-
ways and the mechanisms involved in the cellular response to the injury (cell cycle 
regulation) are complex and generalisation is not easy. Literature is extensive in this 
area and the response of a number of different cell types to UV damage in terms of 
p53 and p21 activation has been studied in detail (see Table 5.2). In summary, all the 
cell types studied in the above experiments (see Table 5.2) respond to UV by inducing 
p53 and p21 with the end result being cell cycle arrest, and in the case of DNA repair 
proficient cell lines, their DNA being repaired if the damage is not extreme. When too 
much DNA damage occurs, the cell usually decides to 'commit suicide' (apoptose). In 
this case UV has been proposed to interfere with the transcription machinery (Reinke 
and Lozano, 1997), and although post—translational stabilisation of p53 occurs even af-
ter the highest UV doses (50 & 60 J/m2 )(Reinke and Lozano, 1997; Poon and Hunter, 
1998; Lu and Lane, 1993), p21  mRNA (Reinke and Lozano, 1997) and protein (Li 
et al., 1996; Poon and Hunter, 1998) are not induced. 
In general, the NER—defective cell lines are more sensitive to UV (they stabilise p53 
at very low UV doses: 2.5 J/m2 ) (Dumaz et al., 1998) but their response to higher 
UV doses in terms of the kinetics of the accumulation of p53 are similar to those 
seen in their normal counterparts (Lu and Lane, 1993). Apparently, the half—life of 
the p53 protein is elevated in non—irradiated XPA, XPB and TTD human fibroblasts 
(Abrahams et al., 1995). It is also interesting that two cell lines from Bloom's syndrome 
patients show no p53 response as reported by Lu and Lane. They also report that the 
p53 response is delayed in AT cell lines. 
All the studies that are presented in Table 5.2 which investigate the relationship be- 
tween the p53 and the p21 response (Reinke and Lozano, 1997; Poon and Hunter, 
Cell 7jpe j Challenge 	
] 
Response I Reference 
NHDSF' UV (10J/m 2 ) p53 stabilisation (Biphasic). Noticeable after lh. (Abrahams et al., 1995) 
__________ Sustained for up to 48 h.  
XPA2 ,XPB2 , TTD3 UV (10 J/m2 ) p53 stabilisation (Monophasic). 	Constitutive in- (Abrahams et al., 1995)  
crease _in_p53_half-life.  
REF  UV (10 and 50 J/m 2 ) p53 stabilisation. 	Detected after 6h. 	Sustained (Reinke and Lozano, 1997) 
for up to 24 h. Dose dependent.  
REF UV (10 and 50 J/m 2 ) p21 mRNA induction. Noticeable after 6h. Sus- (Reinke and Lozano, 1997) 
tamed for up to 24 h. Not detected after 50 J/m 2 . 
NHDF UV (30 and 60 JIm 2 ) p53 stabilisation. Noticeable at 12 h. (Poon and Hunter, 1998) 
NHDF, S3T3 MF6 , RF UV (30 and 60 J/m 2 ) p21 protein induction. Noticeable at 12 h. 	Not (Poon and Hunter, 1998) 
________________________  detected _after _60_J/m 2 . 
NHDF UV (12 JIm2 ) p21 protein stabilisation. 	Noticeable after 3h. (Li et al., 1996) 
Sustained for up to 24 h.  
NHDF UV (20 J/m2 ) p53 stabilisation. Noticeable at 3 h. (Nelson and Kastan, 1994) 
XPA UV (20J/m 2 ) p53 stabilisation. Noticeable at 3 h. (Nelson and Kastan, 1994) 
MPCS UV (10 and 50 J/m 2 ) p53 stabilisation. Noticeable after 2 h. Plateau at (Lu and Lane, 1993) 
12 h. Sustained for up to 30 h.  
XPA UV (50 J/m2 ) p53 stabilisation. Noticeable after 2 h. Plateau at (Lu and Lane, 1993) 
12 h._ Sustained _for _up_to_30_h.  
BS9 UV (50 J/m 2 ) No p53 stabilisation in 2 out of 11 BS cell lines. (Lu and Lane, 1993) 
AT'° UV (50 J/m2 ) p53 stabilisation. Appears at 3h. Increases signif- (Lu and Lane, 1993) 
icantly at 18 h. Similar to MRC5 NHDF.  
NHDF UV (various UV doses) p53 stabilisation only occurs at the higher UV (Dumaz et al., 1998) 
doses (10 and 20 J/m 2 ). Reaches a maximum at 
24 h. and declines after that.  
XPD, TTD/XPD UV (various UV doses) p53 stabilisation occurs at the lowest UV doses (Dumaz et al., 1998) 
(2.5 J/m2 ). At 5 J/m 2 appears at 4h. Sustained  
for 120 h.  
B3T3" UV (various UV doses) p53 stabilisation starts at 5 J/m 2 . 	Maximum (Maltzman and Czyzyk, 1984) 
stimulation at 10 J/m 2 . 	Less stimulation at 50 
J/m2 . Appears at Oh. Sustained for 6 h.  
Table 5.2: Some examples of p53 and p21 responses to UV irradiation in various cell types. 'NHDSF: Normal Human Diploid Skin Fibrob-
lasts; 2XP: Xeroderma Pigmentosum; 3 TTD: trichothiodistrophy; 4 REF: Rat Embryonic Fibroblasts; 5NHDF: Normal Human Diploid 
Fibroblasts; 6 53T3 MF: Swiss 3T3 Mouse Fibroblasts; TRF: Rat Fibroblasts; 8MPC: Mouse Prostate Cells; 9 BS: Bloom's Syndrome; 
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1998; Dumaz et al., 1998) point towards a direct role for p53 in the transcriptional 
activation of p21. This is also supported by other studies with other DNA damaging 
agents in which abrogation of p53 in NHDF, through expression of a dominant nega-
tive p53 mutant, results in the lack of induction of p21 after bleomycin-induced DNA 
damage (Wyllie et al., 1996). However, a p53-independent p21 response has been 
reported after treatment of p53-deficient embryonic mouse fibroblasts with butyrate 
(Janson et al., 1997). This may reflect differences in the behaviour of different cell 
lines to different DNA-damaging agents. We wanted to investigate this aspect of the 
relationship between p53 and p21 in the context of DNA repair and in order to do so 
we looked at the stabilisation kinetics of p53 in normal and ERCC 1-deficient mouse 
primary fibroblasts and also we have been able to look at the induction of p21 in these 
cells and in mouse cells defective in p53 and in cells lacking both p53 and ERCC1. 
p53 is not induced under low UV doses (5 J/m2 ) in wild type mouse primary fibroblasts 
as seen in the studies carried out in our laboratory (see Fig. 5.1 A). These results are 
supported by studies carried out using human primary fibroblasts (Dumaz et al., 1998). 
However, in contrast with observations by the same authors we do not see a reduction 
of p53 protein back to background levels in the mouse cells. In fact, at higher UV doses 
(20 and 50 J/m2 ) p53 stabilisation in mouse primary fibroblasts is seen as soon as 2 
hours after irradiation and is maintained for as long as 30 hours (see Fig. 5.1 B and 
C). The difference in the behaviour of the two cell types can be explained in view of 
the fact that human cells repair the DNA damage from their genome within 24 hours 
(Abrahams et al., 1995) and therefore p53 levels go down as DNA damage disappears. 
This is not the case for rodent cells which are capable of proceeding through their cell 
cycle with unrepaired DNA (they possess a high tolerance for the presence of CPDs in 
the non-transcriptionally active parts of their genome) (Orren et al., 1995). Orren et 
al. report that although CHO cells arrest the cell cycle progression in response to UV 
damage, cycling is not prevented. 
There are reports of p53 stabilisation after 5 J/m 2 in B3T3 cells (Maltzman and 
Czyzyk, 1984). We have constantly failed to see such an induction in wild type mouse 
primary fibroblasts after the same low UV-dose, but this difference may be due to 
the different origin of the cell lines used in these two studies. B3T3 cells are a non- 
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transformed immortalised cell line and the cells reported here are primary embryonic 
fibroblasts, which could explain the different p53-stabilisation kinetics seen in the two 
cell lines. As can be seen below, our results are in accordance with the studies carried 
out by Lu and Lane (Lu and Lane, 1993), who used a similar experimental approach 
to ours for the detection of p53. 
ERCC1-/- cells, on the other hand, accumulate p53 after 5 J/m 2 (see Fig. 5.1 A). This 
is in accordance with observations by Dumaz and co-workers (Dumaz et al., 1998) 
in human cells deficient in XPD. However, when ERCC1-deficient cells are irradiated 
with the higher UV doses, no difference between their behaviour and that of the wild 
type cells is seen. 
We do not see a delay or a defect in the induction of p53 as reported by Lu and Lane 
for BS cells (2 out of 11 primary fibroblast cultures derived from patients suffering 
from BS are reported to fail to accumulate p53 after UV irradiation, even 18 hours 
after exposure). Lu and Lane's report on the absence of p53 accumulation after UV 
irradiation in 2 BS primary fibroblast cell lines is the only one out of the studies 
discussed here that shows that a defect in the DNA damage repair pathway can lead to 
complete inactivation of the p53 response after UV irradiation. As will be seen in future 
chapters we have detected a similar defect in a cell line belonging to a patient with a 
premature ageing syndrome. The implications of this phenotype will be discussed in 
Chapter 6. 
The four genotypic classes of cells used in this experiment allowed us to look for the 
role of p53 in the expression of p21. We had seen before in liver tissue that the basal 
levels of p21 were elevated in ERCC1-/- livers even when p53 was not present. Also 
there was no reduction on the basal levels of p21 in DNA-repair proficient p53 null 
cells (see Table 5.1). We concluded that p21 expression in vivo in mouse liver is p53 
independent. This is in contrast with the results obtained with unirradiated cultured 
primary embryonic fibroblasts derived from the same animals. Under these conditions, 
p21 levels decrease 10-fold in p53-/- cells when compared to wild type levels. Thus, we 
conclude that under culture conditions primary fibroblasts exhibit a p53-dependent 
expression of p21. Although the overall levels of p21 message in these p53-deficient 
cells were very low we could still detect some induction of p21 transcript 24 hours after 
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UV irradiation (3 fold induction in p53 null primary fibroblasts after 20 J/m 2 ; 3 fold 
induction in double null primary fibroblasts after 5 J/m 2 and 20 J/m2 ). 
The induction of p21 message has also been looked at in these mouse primary fibrob-
lasts. In wild type cells irradiated with the lowest UV dose, p21 is induced 2-fold after 
UV as detected at 3 and 7 hours post-irradiation and its levels go back to normal after 
24 hours. This is in contrast with the lack of detectable induction of p53 at any time 
in these cells after the same UV dose (Fig. 5.3, 5 J/m 2 ). This result argues against 
a UV-induced p53-dependent p21 response in these cells as opposed to the situation 
in unirradiated fibroblasts. This dose resulted in a similar induction of p21 in all the 
different genotypic classes. There is also an indication of p21 being approximately 
3 fold elevated 24 hours after UV irradiation in cells lacking both p53 and ERCC1, 
although, given the fact that the experiments were only performed once, this could be 
due to variability in the measurements. 
With the dose of 20 J/m 2 , p21 was induced up to 3 fold in the wild type cells 7 hours 
after UV challenge, its levels remaining high throughout the experiment. This response 
is in accordance with the pattern of p53 expression seen in these cells irradiated with 
the same dose of UV and indicates a dose-dependent induction of p21. In the ERCC1-
deficient cells p21 was not induced after this UV dose in a significant manner (Fig. 5.3, 
20 J/m2 ) up until the last time point at which p21 mRNA levels were equivalent to 
those seen in the wild type cell. This is in contrast with the normal p53 response 
seen in these cells after this UV dose. This fact argues again against a UV-induced 
p53-dependent p21 induction. 
Bearing in mind that the basal levels of p21 are dramatically reduced in the p53-/-  and 
the double null fibroblasts, it is noteworthy that we can detect a 3-4 fold increase in p21 
transcript in these two types of cells over unirradiated control levels, 24 hours after UV 
irradiation, equivalent to that seen in p53+/+ cells. This points towards a mechanism 
of p21 induction which is p53 independent at the later time points. Moreover, the fact 
that the levels of p21 induction in p53+/+ ERCC1-/- cells seems to be equivalent to 
that of the p53-/- cells points towards an overall redundancy of p53 in the UV-induced 
transcriptional activation of p21 in this system. 
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Under the highest UV doses, there was a clear difference in the way wild type and 
ERCC1-/- cells behaved. Wild type cells failed to induce p21 at the first two time points 
(3 and 7 hours after UV) but the levels of p21 message had increased up to 10 fold 24 
hours after irradiation. On the other hand, ERCC 1—deficient cells showed an impaired 
induction of p21 even 24 hours post—irradiation when compared to their wild type 
counterparts. Absence of p21 induction after high UV doses has been reported before 
(Poon and Hunter, 1998; Reinke and Lozano, 1997). In the case of the studies carried 
out by Poon and collaborators, normal human diploid fibroblasts and rat fibroblasts 
show no induction of p21 at 12 hours post—irradiation (60 J/m2 ). However,they present 
no data for later time points. Reinke et al. looked at the expression of p21 up to 48 
hours after UV challenge (50 J/m2 ) and could not detect induction of p21 at that 
time. This is in contrast with our findings that p21 is in fact highly induced 24 
hours after UV—irradiation in wild type primary embryonic fibroblasts, but coincides 
with the p21 response we see in the ERCC1—deficient cells. They also report very 
high induction of p21 in normal rat embryo fibroblasts after the low UV dose (10 
J/m2 ) which again differs from the amount of induction we see in our mouse primary 
fibroblasts (a maximum of 3 to 4 fold induction over unirradiated p21 message levels). 
It is possible that the kinetics of the UV—induced activation of p21 transcription is 
significantly different in these two types of cells. 
It seems that the p21 response after high UV doses that we see in the ERCC 1—deficient 
mouse primary embryonic fibroblasts resembles that of normal cell lines from other 
species (human diploid fibroblasts, rat fibroblasts and rat embryonic fibroblasts) and 
differs from the normal p21 response seen in NER proficient mouse primary embryonic 
fibroblasts. It is possible that in mice, and rats and humans two pathways exist that 
deal with the response to high levels of UV damage. One of the pathways would involve 
the induction of p21 through an NER—related mechanism and it would be the main 
pathway in mice. The other pathway would play the most prominent role in humans 
and rats and would not depend on the induction of p21. It is possible that when ERCC1 
is absent in mice their main response mechanism is impaired (thus the poor p21 re-
sponse seen in ERCC1—deficient mouse primary embryonic fibroblasts) and mouse cells 
resort to the p21/NER—independent alternative pathway that is prominently active in 
rat and humans. 
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In summary, ERCC 1-deficient mouse fibroblasts are more sensitive to UV in terms of 
their p53 response than their wild type counterparts, and appear to be normal in terms 
of the kinetics of its accumulation. On the other hand, p21, which has extensively been 
proposed to be transcriptionally activated in a p53 dependent manner under conditions 
of DNA damage, seems to be induced by UV via a p53-independent pathway in these 
fibroblasts. On the other hand, the basal levels of p21 are elevated in the ERCC1-
deficient cells but they are drastically reduced (approximately a 10 fold reduction 
compared to wild-type levels) in those primary mouse fibroblasts deficient in p53 (both 
p53-/-ERCC1+/+ and double null cells) suggesting that under conditions of no DNA 
injury the amount of p21 message is likely to be under the control of p53. 
Chapter 6 
NER Studies on 
Hutchinson- Gilford Progeria 
Primary Fibroblasts 
6.1 Introduction 
No human disease has been associated with a defect in ERCC1. This could be because 
defects in ERCC1 are developmentally lethal or that an ERCC1 deficiency results in 
a pathology that differs totally from the expected defects in a NER-related syndrome 
and so has escaped identification up to now. On the other hand, some of the phenotypic 
characteristics of ERCC1-deficient mice are reminiscent of those of premature ageing, 
specially when the liver is considered. 
Certain human syndromes such as Werner's syndrome (WS; adult progeria), Cock-
ayne's syndrome (CS), Bloom's syndrome (BS) and ataxia telangiectasia (AT) have 
been studied as models for accelerated ageing'. Studies carried out using cells derived 
from patients suffering from these premature ageing syndromes (WS, BS and AT) have 
found common patterns of chromosomal instability. The defect in WS has been found 
to lie in a DNA helicase (Yu et al., 1996). The BS gene has also been found to encode 
a helicase (Ellis et al., 1995) and AT cells, defective in the ATM gene function, have 
been proposed to fail to monitor DNA damage and activate DNA repair (Meyn, 1995; 
Jeggo et al., 1998). CS has also been associated with abnormalities in NER (Nance 
For a review see Dyer and Sinclair, 1998 
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and Berry, 1992; Venema et al., 1990). Thus, many of these syndromes support the 
idea that, at the DNA level, ageing results, in part, from an imbalance between DNA 
damage and repair. 
Hutchinson-Gilford progeria is a very rare premature ageing human disease (1 affected 
individual born per 8 million people) of unknown aetiology (Dyer and Sinclair, 1998). 
Reports of patients suffering from this syndrome are scarce but the phenotypic de-
scription of some of the affected individuals and some studies performed on fibroblasts 
derived from them can be summarised as follows. 
• Progeria patients present precocious senility, very early death from coronary 
artery disease (cardiac failure), growth retardation and failure to thrive (Abdenur 
et al., 1991), absence of subcutaneous fat, aged face and alopecia. 
• At the molecular level, primary fibroblasts derived from some of these patients 
show increased elastin (Giro and Davidson, 1993; Colige et al., 1991b), fibronectin 
and collagen IV (Maquart et al., 1988; Colige et al., 1991b), altered response to 
EGF (Colige et al., 1991a), insulin resistance and hyperglycemia (Rosenbloom 
et al., 1983), high basal metabolic rates, low levels of insulin-like growth factor, 
high levels of hyaluronic acid (Zebrower et al., 1986; Brown, 1992), reduced 
insulin receptor protein levels, and most importantly in the context of the research 
carried out with ERCC1, decreased rate of DNA synthesis after UV irradiation 
(impaired capacity to repair DNA damage) (Sugita et al., 1995; Wang et al., 
1990; Wang et al., 1991). 
Some of the phenotypic aspects of the Hutchinson- Gilford patients are similar to those 
of the ERCC1-deficient mice (growth retardation, failure to thrive, premature death, 
absence of subcutaneous fat). Furthermore, at the cellular level the most interesting 
feature for us is the fact that these fibroblasts seem to have some impairment in their 
DNA repair capacity, which would be in accordance with a syndrome related to a 
DNA-repair deficiency. 
In order to investigate if progeria could be due to a defect in ERCC1 studies on a 
primary fibroblast cell line derived from a Hutchinson-Gilford patient, AG08466, have 
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been carried out. Due to the lack of a suitable human primary fibroblast cell line, 
the primary control fibroblasts used in the experiments of p21 and p53 induction after 
UV damage were fetal mouse fibroblasts. For the rest of the experimental work a 
transformed wild type human cell line, MRC5, was used as a control. 
6.2 Results 
6.2.1 ERCC1 mRNA and protein levels are reduced in AG08466 cells. 
To see if there were any major rearrangements in the genomic sequence of the ERCC1 
gene, or if the transcript, or the ERCC1 proteins levels were affected in the progeria 
fibroblasts, Southern analysis, northern analysis and western analysis were carried out 
using DNA, RNA and protein extracts from the progeria fibroblasts (for more detail 
on the methodology refer to Materials and Methods). Protein concentrations were 
matched using the BCA protein concentration detection method, DNA loadings were 
tested by reprobing the Southern gels with a PrP probe (1.1 Kb Smal/Ec0RT PrP exon 
3 probe (Moore et al., 1995)) and RNA loadings were also referred to a loading control, 
GAPDH. 
Based on the genomic restriction sites described by van Duin et al., a Southern blot 
was carried out using the following restriction enzymes: EcoRl, BamHI, BglII and SstI 
(van Duin et al., 1987) (see Fig. 6.1). Although it was clear from the first southern 
that there were no major rearrangements in the genomic sequence of ERCC1 in the 
progeria cells compared to the ERCC1 gene in the wild type MRC5 cells, there was an 
indication that the signal derived from the progeria DNA was weaker than that from 
the MRC5 DNA (see Fig. 6.1). 
In order to assess whether this effect was due to a loading difference between the DNAs 
or to an actual copy loss of the ERCC1 gene in the progeria cells, a loading control using 
a PrP probe was performed on the southern blot. When the phosphorimage signals 
from the different bands corresponding to the progeria and the MRC5 fibroblasts were 
compared to their respective PrP signals, it was found out that the apparent difference 
in the intensity of the ERCC1 signal was in fact a loading artifact. 
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Figure 6.1: Southern blot of progeria (AG08466) and wild type (MRC5) genomic DNA 
probed with an ERCC1 probe (exoni-10). Lanes 1, 3, 5 and 7 correspond to MRC5 
DNA. Lanes 2, 4, 6 and 8 correspond to progeria DNA. A schematic map corresponding 
to the exon-intron structure of the 15 Kb human ERCC1 gene with the approximate 
location of the cutting sites of the restriction enzymes used in this experiments is also 
shown. Exons are indicated by Roman numbers. Black boxes represent the coding 
exons and the shaded box is the differentially spliced exon VIII. This diagram has 
been adapted from van Duin et al., 1987. 
ERCC1 mRNA levels in the progeria fibroblasts were also determined by northern 
analysis. Again, MRC5 mRNA was used as a control, and a probe comprising ERCC1 
exons 1-10 was used to probe the membranes. Fig. 6.2 A shows a typical progeria 
northern. Two samples belonging to the same RNA preparation were loaded per cell 
line. The GAPDH reprobe signals are shown in the same figure. The value of 1 for 
ERCC1/GAPDH signal is given to the average of the ratio of ERCC1/GAPDH signal 
for the two different loadings of MRC5 RNA. ERCC1/GAPDH ratios for the progeria 
samples is calculated relative to the ratio of the MRC5 control. 
The results obtained using the northern analysis indicated that there were reduced 
levels of ERCC1 transcript in the progeria fibroblasts (approximately 1/2 of that in 
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wild type human fibroblasts). In order to confirm whether the levels of ERCC1 protein 
were reduced in the progeria cells, total protein was extracted from the AG08466 cells, 
as described in Materials and Methods, and 40 pg of each lysate were loaded onto 
denaturing protein gels. 
The western blots were probed with RWO17, an antibody raised against human ERCC1, 
which also recognises hamster ERCC 1 (see Materials and Methods, section 2.2.11, sub-
section 2.2.11 for details). Two CHO cell lines, one wild type (CH09) and one con-
taining mutant ERCC1 (CHO 43-313), were included in the experiment in order to test 
the specificity of the RWO17 antibody. It is known that due to the ERCC1 mutation 
in the CHO 43-313 cell line, the levels of ERCC1 are very low (barely detectable) in 
these cells (Hayashi et al., 1998). 
Indeed, RWO17 proved to be specific for ERCC1 in that it detected ERCC1 in hamster 
cells successfully (positive signal for CH09 cells and non—detectable levels of ERCC1 
protein in CHO 43-313 cells). When the human cell lines were used, a reduction in the 
ERCC 1 protein levels was detected in the progeria cell line, which supported the result 
obtained with the northern analysis. 
Since both the transcript levels and the protein levels of ERCC1 seemed to be at best 
only reduced in the progeria fibroblasts, and there was no sign of a major rearrangement 
in the genomic sequence of the gene, it was decided to look for possible mutations in 
the coding sequence of ERCC1. This was done by sequencing overlapping ERCC1 
PCR fragments obtained from total progeria cDNA. As a control, the same procedure 
was carried out using total MRC5 cDNA (see Material and Methods for more details). 
Table 6.1 shows the different primers used and the combinations they were used in to 
obtain the complete ERCC1 cDNA sequence. 
Once the different DNA sequences from each PCR reaction were obtained, they were 
manipulated using the GCG package. Overlapping stretches of DNA were identified 
and the sequences were edited. Once the whole cDNA sequence was obtained and 
edited for both MRC5 and progeria cells, they were compared to each other and to 
the existing GenBank human ERCC1 cDNA sequence, using the 'LineUp' program. 
The result obtained is presented in Table 6.2. When the ERCC1 coding sequence from 
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Figure 6.2: (A) ERCC1 mRNA levels in progeria and wild type transformed human 
fibroblasts. Two separate experiments are shown. Levels of ERCC1 message are ex-
pressed as ratios of ERCC1/GAPDH signal. (B) ERCC1 protein levels in progeria 
and human fibroblasts. As controls, to test the antibody (RWO17, see Materials and 
Methods) specificity, 2 CHO lines are shown. CHO 43-3B (ERCC1-mutant), levels of 
ERCC1 in this line range from very low to undetectable; wild type CH09, normal lev-
els of ERCC1. As controls for the ERCC1 protein levels in human fibroblasts, MRC5 
(wild type) and 46BR (Ligase 1-mutant). Human protein concentrations were matched 
to 40 Mg protein/lane (see Materials and Methods, section 2.2.11, subsection 2.2.11 for 
more detail). 
the progeria cells was compared to both the MRC5 ERCC1 coding sequence and the 
GenBank ERCC1 cDNA sequence, no mutations were found (see Table 6.2). 
In summary, there are no mutations in the coding sequence of ERCC1 in progeria cells 
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and no major rearrangements in its genomic sequence. However, there is a suggestion 
that ERCC1 transcript and protein levels are reduced in these cells compared to wild 
type human fibroblasts. 
Is this reduction in the ERCC1 protein levels something that is particular to the ERCC1 
protein in these cells or is it the case that these cells show reduced levels of other DNA 
repair-related proteins too? In order to answer this question and to see if progeria 
cells showed an ERCC1 protein-specific defect we devised the experiments detailed in 
the next section. 
6.2.2 Ligase I, III and IV protein levels are reduced in AG08466 cells 
but XPF protein levels are normal. 
Protein levels corresponding to a number of other proteins were investigated following 
the same procedure as the one detailed for the ERCC1 protein. The antibodies used 
were chosen firstly, because of their availability in the laboratory and secondly, they 
were chosen so that an array of repair-related proteins could be assayed in relation to 
a proper control protein whose expression should be normal in progeria fibroblasts. 
The chosen 'control' protein was Vimentin, an intermediate filament protein which is 
normally used as a marker for fibroblasts. The rest of the proteins studied were Ligases 
I, III and IV and XPF. 
We were interested in the expression of XPF because this protein forms a complex 
with ERCC1 to create a sequence-specific endonuclease and the levels of ERCC1 and 
Name I 	Sequence (5'-+3')(Exon) I FIR 
] 
Primer combination 
C8438 CCCTTGAGGCTCCAAGACCAGCAGG (El) F C8438-C8439 
A9568 GATGGACCCTGGGAAGGACAAAGAGG (E2) F A9568-A9570 
C8439 CCCTTGAGGCTCCAAGACCAGCAGG (E2) R C8439-C8438 
A9569 CCGTACTGAAGTTCGTGCGCAACG (E4) F A9569-A9570&A9571 
A9570 GCAAGGCGAAGTTCTTCCCCAGG (E5) R A9570-A9568&A9569 
A9571 I TCATCAGGGTACTTTCAAGAAGGG (ElO) R A9571-A9569 
Table 6.1: The primers in the table are listed in the same order as they are present 
on the cDNA sequence (Table 6.2). The polarity of the primer is represented by the 
letters F (forward) and R (reverse). The primer combination(s) that each primer has 
been used in is also shown. 
AGCCCTGGGC CACGCTGGCC GTGCTGGCAG 
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Table 6.2: ERCC1 cDNA sequence in progeria primary fibroblasts and transformed wild type MRC5 fibroblasts. The human ERCC1 
cDNA sequence hserccl was extracted from GenBank and used as a reference to check the obtained sequences. The total ERCC1 cDNA 
sequence from both fibroblast cell lines was obtained as stated in Materials and Methods, section 2.2.9. The position of PCR primers is 
shown on the sequence extracted from GenBank. Forward PCR primers are shown in blue; reverse primers are shown in green; START 
and STOP codons are shown in red. The consensus sequence obtained with the program LineUp (GCG package) is shown in slanted font. 
For a detailed account of the combinations of primers used in order to obtain the various PCR fragments necessary to cover the entire 
cDNA sequence see Table 6.1. 
cci 
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XPF have been shown to be related to one another, i.e., ERCC1 levels are reduced in 
XPF-deficient cells (Sijbers et al., 1996a). 
The Ligases offered an external control group in that they are involved in repair pro-
cesses, but also in replication and other cellular mechanisms, which allowed us to 
investigate the functional status of progeria cells in a number of cellular activities. 
DNA Ligase I is specifically involved in replication and it also participates in base ex-
cision repair. The DNA Ligase III-c isoform, which is ubiquitously expressed, forms a 
complex with the DNA single-strand break repair protein XRCC1 and the DNA ligase 
III-/3 isoform has been proposed to play a role in meiotic recombination (Tomkinson 
and Levin, 1997). Ligase IV has been shown to form a complex with XRCC4 and 
its role may be to carry out the final steps of V(D)J recombination and joining of 
DNA ends (Grawunder et al., 1997). Yeast DNA ligase IV has been shown to mediate 
non-homologous DNA end joining (Wilson et al., 1997). 
The results obtained are summarised in Figure 6.3. It was found that levels of Ligase 
I, Ligase III and Ligase IV proteins were reduced, although normal levels of XPF and 
Vimentin were present in these fibroblasts (see Fig. 6.3). This points towards a very 
complicated aetiology of the progeroid syndrome. It is possible that the levels of Ligase 
I are found to be reduced in these cells because their replicative capacity is extremely 
reduced, but no easy explanation is found for the fact that also Ligase III and Ligase 
IV levels are barely detectable using this assay. Ligase IV signal was also very weak 
in the control fibroblasts so it cannot be ruled out that the low levels of Ligase IV 
in progeria cells may be due to technical limitation of the immunoblotting procedure 
using the anti-Ligase IV antibody. 
It is interesting that Vimentin levels in progeria cells are equivalent to the levels de-
tected in wild type transformed MRC5 fibroblasts. This rules out the possibility that 
progeria cells, due to their general growth and reproductive impairment, present low 
levels of a wide range of molecules. 
The other protein that seems to maintain wild type-like levels in the progeria fibrob- 
lasts is XPF. This result is somehow unexpected since, as has been mentioned before, 
ERCC1 and XPF form a complex and levels of ERCC1 and XPF have been shown to 
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Figure 6.3: Different proteins levels in progeria and wild type transformed human 
fibroblasts (MRC5). Protein concentrations were matched to 40 pg protein/lane (see 
Materials and Methods, section 2.2.11 for more detail). For more information and the 
details concerning the origin and specificity of the antibodies refer to Materials and 
Methods, section 2.1.1. 
be correlated in XPF-deficient cells (van Vuuren et al., 1995; Yagi et al., 1997). It 
would be interesting to test the possibility that these cells are defective in some recom-
binational processes. However, the limitations imposed by the poor growth presented 
by these cells and their extremely long population doubling time, make it difficult to 
carry out demanding experimental procedures on these cells. 
6.2.3 AG08466 cells fail to induce p53 and p21 in response to UV 
irradiation. 
There are some reports in the literature that study the response of progeria fibrob-
lasts to UV. These reports show that some progeria cells have a reduced amount of 
unscheduled DNA synthesis after UV irradiation, which has led to the hypothesis that 
these cells may have a defect in the DNA damage-response mechanisms, and more 
specifically in the repair of UV excision damage (Sugita et al., 1995; Wang et al., 1990; 
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Wang et al., 1991). In addition to this, the experiments detailed above suggest that a 
wide range of metabolic functions may be compromised in these cells, from replication 
to DNA single—strand break repair. 
Another aspect of the cellular metabolism that could give an indication of the status 
of these cells in relation to the DNA damage repair mechanisms is the capacity of 
progeria fibroblasts to detect the damage inflicted to their DNA. p53 and p21 have 
been shown to be part of the DNA damage response machinery, and, in particular, a 
great deal of studies have shown that p53 protein is readily stabilised in response to 
UV (see Chapter 5), specially in cell lines with defects in their DNA repair machinery. 
In order to investigate the p53 and the p21 response of the progeria fibroblasts to UV 
damage, AG08466 cells were UV—irradiated with a dose of 20J/m 2 and/or 50J/m2 . The 
p53 and p21 response to UV was monitored using either immunoblotting to monitor 
p53 accumulation, or northern analysis, using a p21 PCR probe to detect transcrip-
tional induction of p21 message. Since no human wild type primary fibroblasts were 
available in the laboratory at the time the experiments were carried out, mouse wild 
type primary fibroblasts were used as controls for the induction of p53 stabilisation 
and p21 transcription after UV. 
A summary of the results obtained is shown in Figs. 6.4 A and B. In Fig. 6.4 A, three 
different transformed human cell lines were used as controls for the migration pattern 
of human p53 protein since there is a slight difference in the migration patterns of 
human and mouse p53. All the protein concentrations used for this experiment were 
matched to 40 pg per lane and the samples were taken 24-30 hours after UV irradiation, 
to allow for high p53 levels to be present in the cells and also to allow for a possible 
delay in the kinetics of p53 stabilisation in the progeria cells (the p53 response in 
human primary fibroblasts after high UV doses is known to remain elevated 24 hours 
after UV irradiation (Dumaz et al., 1998)). 
Overall, p53 levels in the unirradiated progeria and mouse primary fibroblasts were very 
low and barely detectable by this assay, which is to be expected in normal primary 
fibroblasts. However, after both doses of UV irradiation (20 and 50 J/m 2 ), we failed to 
see any sign of p53 stabilisation in the progeria fibroblasts. This is contrast with the 
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expected response in cells that seem to have a defect in the DNA—repair mechanism 
(Lu and Lane, 1993; Sanchez and Elledge, 1995). On the other hand, and as expected, 
wild type mouse primary fibroblasts show a prolonged p53 stabilisation (samples were 
taken 30 hours after UV irradiation with a dose of 20 J/m2 ). 
To see if p21 transcriptional induction was also compromised, we performed northern 
analysis of the levels of p21 transcript after a UV dose of 50 J/m 2 in the progeria 
fibroblasts and compared this response to the response of mouse primary fibroblasts 
after a UV dose of 20 J/m2 . Both human and mouse RNA samples were collected 
24-30 hours after UV—irradiation. The results from this experiment are shown in Fig. 
6.4 B. 
It is apparent from this experiment that mouse primary fibroblasts show the predicted 
response to UV damage, i.e., they have a 3—fold induction of p21 transcript 30 hours 
after UV—irradiation compared to the unirradiated mouse controls. Contrary to this, 
progeria primary fibroblasts do not show a significant induction of p21 message levels 
even after a more dramatic UV challenge (50 J/m 2 compared to 20 J/m 2 in the case 
of the mouse cells). It is also noticeable that the levels of p21 transcript detected 
in unirradiated mouse primary fibroblasts are twice those seen in the unirradiated 
progeria fibroblasts (see Discussion). 
Despite this apparent difference in the p53 and p21 responses of these two cell lines, 
it has to be taken into account that mouse and human cells respond differently to UV 
damage, both in terms of the mechanisms that deal with the overcoming of the DNA 
damage—induced cell cycle arrest and in the kinetics of DNA damage removal (see 
Chapter 4). Mice are less efficient in the removal of UV—induced DNA damage, which 
makes them more tolerant to the presence of unrepaired DNA, and in turn makes the 
DNA damage recognition mechanisms more prone to suffer long term induction. This 
would explain the prolonged p53 stabilisation and long term induction of p21 mRNA 
transcription. 
However, these differences between mouse and human cells do not account for the lack 
of any apparent UV—induced response in the progeria cells in terms of p53 accumulation 
or p21 transcriptional activation. Human cells are known to arrest cell cycle progression 
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Figure 6.4: A) p53 stabilisation in progeria fibroblasts after UV (20 and 50 J/m 2 ). 1) 
MRC5, transformed human fibroblasts; 2)46BR, transformed human fibroblasts, Ligase 
I-deficient; 3) A2780, human ovarian carcinoma cell line; 4) progeria unirradiated; 5) 
progeria irradiated (20 J/m 2 ); 6) progeria unirradiated; 7) progeria irradiated (50 
J/m2 ); 8) MPF (mouse primary fibroblasts) unirradiated; 9) MPF (mouse primary 
fibroblasts) irradiated (20 J/m 2 ). B) p21 induction after UV irradiation in progeria 
and wild type primary mouse fibroblasts. p21 levels are expressed as p21/GAPDH 
ratios. 1) progeria unirradiated; 2) progeria irradiated (50 J/m 2); 3) MPF (mouse 
primary fibroblasts) wild type unirradiated; 4) MPF (mouse primary fibroblasts) wild 
type irradiated (20 J/m2 ). The top p21/GAPDH ratio has been calculated taking each 
unirradiated control as a separate value of 1, to indicate induction of p21 in each of 
the primary fibroblast cell lines. The bottom p21/GAPDH ratio has been calculated 
taking the p21 mRNA levels in unirradiated progeria fibroblasts alone as 1, to indicate 
differences in the levels of basal p21 message between unirradiated mouse and progeria 
primary fibroblasts. 
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after UV irradiation in order to allow DNA repair to take place (Sanchez and Elledge, 
1995). This arrest is known to be prolonged and p53 has been implicated in this 
mechanism. 
p21 is an effector of p53 and accordingly, its mRNA levels are elevated through its 
transcriptional activation by p53. p21  is known to be involved in the arrest of the 
cell cycle that is seen in human cells after UV. It would be expected that after UV 
damage has occurred, both p53 and p21 responses would be activated in the irradiated 
cells. Reports exist, however, that p21 protein induction is inhibited in normal human 
diploid fibroblasts after high UV doses (60 J/m2) despite accumulation of p53 protein 
levels (Reinke and Lozano, 1997). Reinke and Lozano suggest that after such high 
UV doses the levels of DNA damage are so high that even transcription processes are 
arrested. This could also be the case for the progeria fibroblasts but, as discussed in 
the previous chapter, these authors looked at the p21 response up to 12 hours after UV 
irradiation and the extent of the inhibition of the p21 response cannot be determined 
for longer periods of time post-irradiation. 
Overall, it seems that AG08466 progeria cells fail to detect DNA damage and thus they 
fail to respond to it, at least in a way that involves a p53 and, possibly, a subsequent 
p21 response. 
6.3 Discussion 
DNA repair defects have been proposed to have an effect on the ageing process of 
organisms through their involvement in the processing of DNA damage, and their role 
in preventing genetic instability (Dyer and Sinclair, 1998; Kirkwood, 1989). Conversely, 
ageing in humans is associated with decreasing ability of cultured skin and blood cells 
to process new UV-induced DNA damage (Moriwaki et al., 1996). 
The ERCC1 knock-out model presents some characteristics reminiscent of premature 
ageing, and since there has not been a human disease associated with a defect in this 
gene, it seemed logical to investigate the possibility of it being involved in the aetiology 
of a premature ageing syndrome. Defects in two different helicases and different genes 
involved in DNA repair have been shown to be responsible for some premature ageing 
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diseases such as Werner's syndrome, Bloom's syndrome, Cockayne's syndrome and 
ataxia telangiectasia. There is however, another extremely rare premature ageing 
disease whose aetiology has not been identified, Hutchinson-Gilford neonatal progeria. 
Cells derived from patients suffering from this disease have already been shown to 
have impaired DNA repair capacity (Sugita et al., 1995; Wang et al., 1990; Wang 
et al., 1991) and defects in the timing of the DNA repair process relative to replication 
(Lipman et al., 1989). 
The progeria cell line AG08466 has been used in this work in order to assess the status 
of the ERCC1 gene and some other DNA repair-related proteins. ERCC1 protein and 
mRNA levels are reduced in these cells, although no major gene rearrangements as 
shown by Southern blot have been found. Also, no mutations in the ERCC1 cDNA of 
these cells have been detected. 
XPF and Vimentin proteins are found in levels equivalent to wild type. Since XPF 
and ERCC1 form a complex that functions as a structure-specific endonuclease it 
seems of interest that the levels of ERCC1 are reduced in progeria cells while XPF 
levels are apparently normal. Indeed, XPF has a prominent role in the stabilisation 
of ERCC1 protein as found by mutation studies of ERCC1 that affect the domain 
of XPF-ERCC1 interaction. Any mutation, either in XPF or ERCC1, that impedes 
the interaction between these two proteins decreases the half-life of ERCC1 protein 
in the cell, resulting in reduced ERCC1 protein amounts in the affected cells (Sijbers 
et al., 1996a). No mutations have been found in the ERCC1 cDNA in progeria cells 
but the possibility remains that XPF may be mutated in these cells. However, it has 
been reported that XPF protein levels are reduced to 5% of those in normal cells in 
XPF-deficient fibroblasts (Brockman et al., 1996; Yagi et al., 1997). Therefore, the 
fact that XPF levels appear to be normal in progeria cells argues against a mutation 
in this gene. 
The levels of other proteins such as Ligases I, III and IV are also reduced. Reduced 
levels of Ligase I can be explained by the fact that this protein is present in lower 
quantities in slow growing cells (Lindahl and Barnes, 1992). The absence of detectable 
levels of the other ligases may have some implications for the aetiology of progeroid 
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cells. As mentioned in the previous section, Ligase IV seems to be involved in non-
homologous DNA end joining (Wilson et al., 1997) and the Ligase III-c isoform seems 
to play an important role in DNA single-strand break repair, along with XRCC1, with 
which it forms a complex. The possible defects that would be derived from an impaired 
expression of these proteins, would have serious repercussions in the DNA metabolism 
of the cell. However, these reduced levels of ligases are more likely to be the effect of 
the progeroid syndrome rather than its cause. 
The response of these progeria cells to UV-induced damage was also studied by mea-
suring the induction of both p53 protein stabilisation (after 20 and 50 J/m 2 ) and p21 
mRNA transcription (after 50J/m 2 ). No obvious induction of either was found to oc-
cur in the progeroid cells, which points to a defect in this cell line in the recognition 
of DNA damage. It has been observed previously that human cells are particularly 
proficient at inducing p53 and p21 in response to DNA damage. This induction is 
both fast and prolonged in order to allow the DNA to be repaired before replication 
takes place (Sanchez and Elledge, 1995; Lu and Lane, 1993). Lipman et al., 1989, 
suggest that temporal control of DNA repair (which in part is regulated by p53 and 
p21) is impaired in progeria cells, which supports the findings presented here. If this 
regulatory mechanism is missing in these cells it is reasonable to speculate that the 
acceleration of age-associated changes observed in progeria may relate to an inability 
of the cells to optimally repair DNA damage before the onset of DNA synthesis. It 
is also of interest to note that 2 out of 11 cell lines derived from Bloom's syndrome 
patients have been reported to show no p53 accumulation after UV irradiation (Lu 
and Lane, 1993). These cells also show an aberrant response following X-ray. We have 
not performed any X-ray irradiation experiments with these cells but the experiment 
should prove of interest. 
The basal levels of p21 mRNA were also found to be reduced when compared to 
mouse p21 transcript basal levels. One possible explanation for this is that the p21 
mouse probe recognises the human p21 mRNA with less specificity than the mouse 
GAPDH probe recognises human GAPDH, hence the difference in the p21/GAPDH 
ratios observed between human cell and mouse cells. However, this piece of data must 
be taken cautiously since the appropriate human primary fibroblast cell line was not 
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available in the laboratory at the time of carrying out the experimental work. A proper 
comparison should be made in order to confirm this and the work is in progress in our 
laboratory at the moment. 
Chapter 7 
Conclusion 
Since its cloning in 1986, the complete picture of the function of the ERCC1 gene and 
its encoded protein has remained a mystery. ERCC1 is known to play an essential role 
in nucleotide excision repair (NER) and a defect in ERCC 1 function renders the cells 
hypersensitive to killing by UV—induced damage as well as damage induced by other 
chemical agents. In humans, defects in genes involved in NER result in a number 
of complex syndromes such as xeroderma pigmentosum (XP), Cockayne's syndrome 
(CS) and trichothiodistrophy (TTD), which share a number of clinical and cellular 
features, such as hypersensitivity to sunlight, slow growth, mental retardation, and 
impaired sexual development. In addition, there are several variants amongst XP, CS 
and TTD patients as well as combinations of XP and CS features (XP-CS) depending 
on which NER protein function is defective. Also, the incidence of features such as 
skin cancer susceptibility, neurological abnormalities and UV—sensitivity vary amongst 
the different syndromes and their variants. 
The complexity of these syndromes has been shown to be due to the dual roles of some 
of the NER proteins, such as XPB and XPD, which appear to function as part of the 
cellular transcription machinery as well as the NER machinery. Thus, different defects 
in these proteins can affect their repair function only, resulting in XP, their transcrip-
tion function only, resulting in repair—proficient TTD or both functions, resulting in 
repair—deficient TTD and the combined XP-CS. Defects in genes that are only involved 
in NER, such as XPA and XPC give rise to XP features only. 
10 
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7.1 Why does the ERCC1 model differ from other XP 
mouse models? 
Mouse models have helped to understand the genetic and biochemical basis behind 
these syndromes. For example, good XP-A (Nakane et al., 1995; deVries et al., 1995) 
and XP-C (Sands et al., 1995) mouse models that resemble most of the pathological 
changes shown by the human patients suffering from these types of XP have been 
developed. A knock out (k/o) mouse model for ERCC1 also exists (developed by 
McWhir et al. in 1993), but despite the initial expectations, the ERCC1 k/o mouse 
did not present any of the XP-related clinical features. This may not come as a 
complete surprise since ERCC1 was known to be unique in that, although its function 
is essential for NER, and indeed it corrects the UV-sensitive phenotype in one type 
of CHO mutants, it does not correct any of the XP complementation groups and 
there is no human syndrome associated with it. These facts led to the theory that an 
ERCC1-deficiency may be developmentally lethal, or alternatively, that ERCC1 may 
have additional functions (as happens with XPB and XPD) which, if defective, would 
result in a syndrome that does not resemble any of the NER-related pathologies. This 
function would be unique to ERRC1 and therefore, XPA or XPC mouse models would 
not show the additional ERCC1-related pathologies. 
Support for this latter theory comes from studies that suggest that ERCC1 may be 
involved in recombination repair which has led to the proposition that the observed 
phenotype in the ERCC1 k/o mouse may be related to a defect in the recombination 
repair pathway as opposed to the NER pathway. Support for this theory comes from 
studies of the yeast ERCC1-XPF complex homolog, the RadlO-Radi complex in S. 
cerevisiae, the S. pombe homolog swilO which have shown that these proteins do play 
an important role in recombinational repair and mating-type switching, respectively 
(Bardwell et al., 1994; Rodel et al., 1992). XPF has also been shown to have a homolog 
in S. pombe, rad16, and a homolog in D. melanogaster called mei-9 (Brookman et al., 
1996), which has been shown to be required for meiotic recombination (Sekelski et al., 
1995).Clues into the understanding of the ERCC1 function and its possible role in the 
pathology of disease may come from the ERCC1 k/o mouse model. 
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Mice deficient in ERCC1 show runting at birth, early death before weaning possibly due 
to hepatic failure, liver aneuploidy and polyploidy and elevated levels of p53 in liver, 
brain, and kidney (McWhir et al., 1993a). Interestingly, a k/o mouse model has been 
developed that is deficient in XPG (Harada et al., 1999), the 3' specific endonuclease 
that performs the dual incision with the XPF/ERCC1 5' endonuclease. XPG—deficient 
mice present a similar phenotype to the ERCC1 k/o mice in that they show retarded 
growth and die before weaning. Embryonic primary fibroblasts from these mice are 
sensitive to UV irradiation and are defective in NER and these cells show premature 
senescence. No ERCC1—like liver phenotype was apparent in the XPG null mice. Based 
on these findings XPG has also been proposed to have additional roles, such as repair 
of oxidative damage, outside NER. (Harada et al., 1999). The work presented in this 
thesis attempts to show the mechanisms underlying the ERCC 1—deficient phenotype. 
7.2 The liver phenotype in ERCC1—deficient mice 
From the studies presented in this thesis it is clear that the ERCC1—deficient phenotype 
is mainly due both to defects in the regulation of the cell cycle of the affected cells and 
defects in DNA damage—induced response mechanisms. 
7.2.1 Liver morphology studies 
Support for the first affirmation comes from morphology, immunohistochemistry and 
immunocytochemistry studies performed on livers from ERCC1 deficient animals along 
with ERCC1/p53 double null mice and wild type and p53—deficient mice as controls. It 
has been shown that in ERCC 1—deficient livers the process of binucleation is inhibited 
and that this inhibition is bypassed in the absence of p53. Since binucleation is a 
process that requires consecutive rounds of replication, it is not surprising that p53 
has a role in its regulation which coincides with its well characterised role in the control 
of the GuS transition. We have also shown that ERCC1—deficient hepatocytes have 
elevated levels of the cyclin—dependent kinase inhibitor, p21, which is independent of 
their p53 status and that they are arrested mainly in G2. We propose that p21, in a 
p53—dependent manner, may be involved in the G2 arrest seen in the ERCC 1—deficient 
hepatocytes and that it may also have a p53—independent role in the formation of 
CHAPTER 7. CONCLUSION 	 191 
polyploidisation and premature ageing characteristics seen in ERCC1 null livers. 
Support for the results discussed here comes from the study of another ERCC1-
deficient mouse model (Weeda et al., 1997). Weeda and co-workers present morpho-
logical studies of hepatocyte nuclear size distribution in the liver of ERCC1-deficient 
and wild type animals that coincides with the data shown here. p21 levels in ERCC1-
deficient animals are also reported to be elevated in their k/o mouse, although no data 
are shown. Weeda et al. also report that the primary fibroblasts derived from their 
ERCC 1-deficient animals present characteristics typical of premature senescence in 
culture such as polyploidy. We have been consistently unable to due to the see such 
behaviour in our primary fibroblast cultures. This difference is probably due to the 
different genetic background of the two mouse models used in these experiments. 
7.2.2 UV irradiation studies 
Support for the second affirmation comes from the study of the cell cycle control mech-
anisms elicited in ERCC1-deficient cells under conditions of exogenous DNA damage 
(UV irradiation). It is known that after UV mammalian cells inhibit DNA synthesis, 
albeit transiently, before proceeding with DNA replication. In human cells, if the DNA 
damage occurs while cells are replicating (S phase), this DNA synthesis inhibition is 
accompanied by a long delay in the entry of these cells into mitosis which allows the 
cells to repair the damage inflicted to their DNA. It is also known that this delay is 
significantly shorter in rodent cells (CHO cells reach mitosis 15 hours after UV and 
entry of human cells is delayed by 30 hours). From our studies it was clear that the 
UV-induced replication arrest shown by both the wild type and the ERCC 1-deficient 
mouse and hamster cell lines was shorter than that shown by human cells defective 
in DNA repair (XP-A complementation group). This indicates that bypass of fork 
progression-arrest is NER independent in rodent cells, whereas there is a requirement 
for proficient DNA repair in order for human cells to recover from such arrest. How-
ever, and despite preliminary positive indications, it was also clear that there was no 
difference in the replication arrest kinetics seen in ERCC1- and ERCC2-deficient cell 
lines after UV, suggesting that there is no specificity for the requirement of ERCC1 
in the UV-induced inhibition of DNA synthesis. In order to elucidate the mechanisms 
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that the cell uses to signal DNA damage and to see if ERCC1, as part of the NER ma-
chinery, is involved in this signalling process, we have studied the p53 and p21 response 
of ERCC 1-deficient and wild type primary fibroblasts to UV-induced damage. Both 
p53 and p21 have been shown to be part of the cellular mechanisms to signal and pre-
vent DNA damage from perpetuating, either through DNA replication (this is achieved 
via a p53/p21-induced G1/S arrest) or mitosis (this is achieved via a p53/p21-induced 
G2 arrest). We have shown that ERCC1-deficient mouse primary fibroblasts accumu-
late p53 protein at lower UV doses (5 J/m 2 ) than NER proficient primary fibroblasts 
(20 J/m2 ) which is consistent with the fact that ERCC 1-deficient fibroblasts cannot re-
pair their DNA and therefore they accumulate DNA lesions at low UV doses. In terms 
of the p21 response to UV it has been shown that, after high UV fluences (50 J/m 2 ), 
the induction of p21 transcription is impaired in the ERCC1-deficient fibroblasts. 
7.3 A model for the observed phenotype in ERCC 1-deficient 
mice 
Taking all the previous data into account, we propose a model to explain the phenotype 
observed in the ERCC 1-deficient mice. In the absence of ERCC1, endogenous damage 
is accumulated in the liver which prompts the accumulation of p53 and p21. p 53 
and p21, in a p53-dependent manner, are likely to be involved in the control of the 
arrest that in hepatocytes occurs at the G2 checkpoint in the absence of proficient 
NER. p21 may also have an active role in a p53-independent manner in the regulation 
of the G2/M checkpoint control, promoting G2 arrest, and, more likely, controlling 
the hepatocyte differentiation and senescence processes. Both the p53-dependent and 
the p21-dependent mechanisms would have as an overall result the premature hepatic 
polyploidisation process seen in the ERCC1-deficient livers and their aged appearance. 
7.3.1 Why ERCC1? 
As mentioned before, other mouse models deficient in different proteins involved in 
NER exist (XPA, XPC and XPG), but none of them present the severe phenotype 
associated with the deficiency of ERCC1. There is extensive evidence that ERCC1 
may be involved in recombinational processes both from studies of the ERCC1 protein 
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function and from analogy to ERCC1 homologues in other species (Rolig et al., 1995; 
Sargent et al., 1997; Bardwell et al., 1993; Bardwell et al., 1994; Rodel et al., 1992; 
Rodel et al., 1997; Ivanov and Haber, 1995). Following this line of thought it has 
already been proposed that the non-NER phenotype of the ERCC1-deficient mice is 
due to impairment of an additional ERCC1 function in another biological pathway, 
such as oxidative damage repair (McWhir et al., 1993a). Weeda et at. also propose 
that the reduced life span, the growth retardation and the liver, kidney and spleen 
manifestations they observe in ERCC1-deficient mice are most likely derived from 
impairment of the interstrand cross-link repair pathway. They also suggest that this 
is the basis for the features they observe in the ERCC 1-mutant primary fibroblasts, 
i.e., enlarged polyploid nuclei and nuclear inclusions as well as replicative senescence 
(Weeda et al., 1997). As mentioned before, we fail to observe such a severe phenotype in 
kidney and spleen but this most likely due to the different life spans of the two models, 
and the fact that our mice die before such characteristics are developed. Another 
possibility is that the differences in the organ and primary fibroblasts phenotypes 
between the two models are due to the different genetic backgrounds of the mice used 
by the two laboratories. 
7.3.2 Why liver? 
Liver is an organ that is required for a large number of metabolical processes, such as 
lipid peroxidation, intermediate metabolism of carbohydrates and proteins, synthesis of 
proteins and detoxification and removal of foreign material such as bacteria, drugs and 
other noxious substances. All this results in the liver cells being exposed and producing 
large quantities of endogenous damaging agents such as oxigen-free radicals and toxic 
metabolic byproducts, such as malondialdehyde (MDA), a carbonyl compound which 
is the major by-product of arachidonic acid metabolism and lipid peroxidation (Weeda 
et al., 1997). MDA produces adducts and induces interstrand crosslinks which have 
been detected in liver DNA (Weeda et al., 1997). 
If ERCC 1, but none of the other NER genes, is involved in interstrand crosslink repair 
and/or oxidative damage repair it is possible that in its absence the liver accumulates 
endogenous DNA damage that is not properly repaired. As explained elsewhere in this 
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thesis (see Chapter 3, section 3.3)the liver responds to damage by becoming polyploid 
and this tendency to polyploidisation is very marked in mouse liver, compared to rat or 
human liver. Polyploidisation is also a marker of hepatocyte terminal differentiation. 
In the ERCC1-deficient liver the unrepaired damaged-DNA would elicit a damage re-
sponse unique to the liver tissue that involves premature polyploidisation and terminal 
liver differentiation, probably through a p21-dependent pathway. This response to 
the existing unrepaired endogenous damage would explain the phenotype observed in 
these transgenic mice. It would be of interest to see what the outcome would be if p21 
null mice were to be crossed with the ERCC1 null mice. It is possible, if the above 
theory is true, that the liver phenotype could be rescued in this way and the effects 
of an ERCC1 deficiency in other organs could be studied in the resulting longer-lived 
double null mice. 
7.4 A role for ERCC1 in inhibition of replication after 
UV damage and premature ageing? 
ERCC1 does not seem to play a role in the UV-induced DNA synthesis arrest seen in 
mammalian cells, although there is an indication that its absence affects the long-term 
induction of p21 after UV irradiation. Through these studies it has also been possible 
to verify the different response of rodent and human cells to UV-induced DNA damage 
and the consequences these differences may have in the way humans and rodents deal 
with deficiencies in the same genes. 
Since the liver phenotype in ERCC 1-deficient mice is reminiscent of premature ageing, 
the possibility that ERCC1 may be connected to the process of human accelerated age-
ing has also been investigated. ERCC1 RNA and protein levels as well as its genomic 
structure and cDNA sequence have been assessed in human primary fibroblasts derived 
from a patient suffering from Hutchinson-Gilford progeria (a rare human premature 
ageing syndrome). No evidence for mutations in the ERCC1 gene was found. However, 
the levels of ERCC1 mRNA and protein were found to be reduced in these fibroblasts 
compared to wild type transformed fibroblasts, but the reduction also affected other 
proteins involved in a variety of cellular functions indicating that the defect seen in 
these cells is probably of a complex origin. Furthermore, no detectable p53 or p21 
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response was detected in the progeria cells after UV irradiation, which opens up a 
number of interesting questions. These cells have already been shown to have a defect 
in the process of repair synthesis after UV, but no mechanism has been proposed to 
explain this phenomenon. It is possible that progeria cells are impaired in the detec-
tion of DNA damage and that therefore, DNA repair mechanisms are not efficiently 
elicited in these cells, resulting in accumulation of endogenous damage and premature 
senescence. This idea has also been tested by Weeda and collaborators who chose to 
study the possible involvement of ERCC1 in Roberts syndrome (Roberts syndrome 
patients display a variety of developmental abnormalities, including renal defects and 
malignancies and some patients exhibit, at the cellular level, nuclear abnormalities and 
UV sensitivity as well as cross-link sensitivity) but they failed to find defects in ERCC1 
at the DNA and RNA level (Weeda et al., 1997). However, these two experiments do 
not rule out the possibility that ERCC1 mutations exist in other patients. 
Overall, this thesis has brought together DNA repair, cell cycle regulation, responses 
to UV-induced and endogenous damage and cellular differentiation mechanisms to 
explain the liver phenotype observed in the ERCC1-deficient mice. This work has also 
opened the door for the study of a human premature ageing syndrome in the context 
of DNA repair and control of the cellular DNA damage-induced responses. 
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